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Abstract 
 
The bHLH transcription factor Ptf1a is crucial for the generation of a 
GABAergic neuronal cell fate over an excitatory glutamatergic fate. Ptf1a is a 
component of a heterotrimeric transcription factor complex, which in addition 
to Ptf1a, is comprised of a commonly expressed bHLH E-protein such as E12 
and Rbpj. Interaction with Rbpj is essential for the GABAergic cell fate inducing 
and glutamatergic repressing activities of Ptf1a. In the absence of Rpbj binding, 
Ptf1a maintains its proneural activity, however, the induced neurons express 
marker genes indicative of a glutamatergic excitatory neuronal cell fate. In this 
thesis, the temporal and selective induction of target genes by Ptf1a was 
further analyzed as well several Ptf1a mutants characterized with respect to 
the neurotransmitter inducing properties using X. laevis as a model system. 
A point mutation within the C-terminus of Ptf1a that leads to the induction of a 
mixed glutamatergic and GABAergic neuronal transmitter phenotype was 
identified and characterized (Ptf1T243A). BiFC analysis revealed that the mixed 
neuronal transmitter phenotype is not due to an impairment of the interaction 
with Rbpj or E12, but may be due to enhanced interaction with Prdm13. The 
global temporal transcriptional program induced Ptf1a was also studied in 
pluripotent embryonic cells by RNAseq. While some Ptf1a direct target genes 
such as prdm13, are induced within three hours (early genes), others, 
including neurog2 and gad1a are induced only after 12 h (late genes). To gain 
insight if chromatin accessibility plays a role in the delayed activation, Brg1, 
which is one of the catalytic subunits of the chromatin remodeling BAF complex, 
was knocked down. Brg1 was found to be required for Ptf1a-induced neuronal 
differentiation as shown by the loss of neural-specific tubulin. Only a subset of 
late induced Ptf1a target genes required Brg1 with most Brg1 dependent target 
genes being indirect Ptf1a target genes. Furthermore, ATAC-seq suggests that 
target gene activation by Ptf1a is likely independent of chromatin accessibility. 
Taken together, these data suggest that Ptf1a acts as a pioneer transcription 
factor to activate its target genes. 
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1. Introduction 
 
1.1 Neurogenesis in Xenopus laevis 
 
The African clawed frog Xenopus laevis (X. laevis) has several advantages 
that make it a highly suitable model system to study early vertebrate 
developmental events including the development of the nervous system (Pratt 
and Khakhalin, 2013; Kofent and Spagnoli, 2016; Borodinsky, 2017; Droz and 
McLaughlin, 2017; Dubey and Saint-Jeannet, 2017; Lee-Liu et al., 2017). X. 
laevis embryos are quite large (>1mm), undergo an external development, can 
easily be manipulated by microinjection of mRNA or morpholino antisense 
oligonucleotides as well as used for CRISPR/Cas9 mutagenesis (Mimoto and 
Christian, 2011; Wang et al., 2015). Furthermore, pluripotent ectodermal 
explants can be isolated from the animal half of the embryo at blastula stage 
and used for in vitro differentiation studies using embryos manipulated with the 
aforementioned techniques (Borchers and Pieler, 2010). 
In X. laevis, there are two distinct phases of neurogenesis (Hartenstein, 1989; 
Roberts, 2000; Thuret et al., 2015). The first phase is termed primary 
neurogenesis and generates the neurons responsible for the movements and 
sensation of the tadpole (Hartenstein, 1989; Hartenstein, 1993; Roberts, 2000). 
This phase of neurogenesis starts at the open neural plate stage and slowly 
declines until the mid-tadpole stage, where it remains minimally active (Thuret 
et al., 2015). A second phase of neurogenesis occurs during metamorphosis, 
in which most early-born neurons are replaced generating the nervous system 
of the adult frog (Schlosser et al., 2002; Wullimann et al., 2005). 
The first primary neurons are born within 24 h after fertilization, in three 
longitudinal domains (medial, intermediate and lateral) along the dorsal midline 
and will give rise to neurons of the hindbrain and spinal cord and in the 
trigeminal placodes (Chitnis and Kintner, 1995). In the anterior neural plate, 
which gives rise to the forebrain and midbrain, neuronal differentiation starts 
at the tailbud stage (Papalopulu and Kintner, 1996). After the neual plate rises 
and folds into the neural tube, the progenitors in the medial domain will reside 
ventrally and differentiate into motor neurons, those from the intermediate 
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domain into interneurons, while the progenitors from the lateral domain at the 
neural plate border will be located most dorsally and differentiate into sensory 
neurons (Hartenstein, 1989; Chitnis and Kintner, 1995). In the X. laevis tadpole 
there are 10 distinct classes of neurons (Roberts et al., 2012). The first neurons 
to gain their functionality are the Rohon-beard sensory neurons located 
adjacent to the roof plate in the dorsal neural tube (Lamborghini, 1980; Rossi 
et al., 2009). Subsequently, the ventral motor neurons and Kolmer-Agdhur 
cells (Rossi et al., 2008; Rossi et al., 2009; Groves and LaBonne, 2014) and 
then seven subpopulations of interneurons are formed (Roberts et al., 2012) 
(Fig 1.1).  
 
 
Figure 1.1: Neurogenesis in X. laevis 
The first primary neurons are born at the open neural plate stage in three longitudinal 
domains along the dorsal midline. After neural tube closure, the medial domain will 
give rise to motor neurons in the ventral neural tube, the lateral domain will give rise 
to sensory neurons in the dorsal neural tube and the intermediate domain will be 
located medially in the neural tube and give rise to interneurons. tp: trigeminal 
placodes dla, dlc: dorsolateral ascending and dorsolateral commissural sensory 
interneurons; dIN, cIN, aIN: descending, commissural, and ascending premotor 
interneurons; dlNr: descending repetitive excitatory interneurons; ecIN: excitatory  
 
1.2 Neural induction 
 
The development of the nervous system is initiated during neural induction 
where subpopulations of the ectoderm are specified to a neural fate (Rogers 
et al., 2009). In X. laevis, the neural fate is induced during gastrulation 
(Hamburger, 1969; Sanes et al., 2011) and requires the inhibition of BMP 
signaling (Hemmati-Brivanlou et al., 1994; Hemmati-Brivanlou and Melton, 
1994; De Robertis and Kuroda, 2004). The inhibition of BMP signaling occurs 
through multiple mechanisms, which includes the secretion of BMP 
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antagonists from the blastula Chordin- and Noggin-expressing (BCNE) center, 
which is located in dorsal animal cells at the blastula stage (Kuroda et al., 2004) 
and during gastrulation from the Spemann Organizer through Chordin (Piccolo 
et al., 1996; Sasai et al., 1996), Noggin (Zimmerman et al., 1996), Follistatin 
(Hemmati-Brivanlou et al., 1994) and Cerberus (Bouwmeester et al., 1996; 
Piccolo et al., 1999). In addition to BMP signaling, a requirement for FGF 
signaling in the process of neural induction has been established (Launay et 
al., 1996; Sasai et al., 1996). FGF signaling results in MAPK-induced 
phosphorylation of Smad1, the intracellular transducer of BMP signaling, 
resulting in an inhibition of BMP activity (Hardcastle et al., 2000; Pera et al., 
2001; Richard-Parpaillon et al., 2002; Pera et al., 2003). In addition to its role 
in inhibiting BMP, FGF is required for the induction and maintenance of several 
neural genes (Rogers et al., 2011). Furthermore, Ca2+ transients are present 
in the dorsal ectoderm during neural induction and blocking of calcium release 
prevents the expression of neuronal markers (Leclerc et al., 1997; Leclerc et 
al., 2000; Leclerc et al., 2012). 
Neural induction leads to the expression of several genes in the forming neural 
plate including members of the Sox family (sox2, sox3 and sox15, formally 
known as soxD), Zic family (zic1-3) and Iroquois family (iro1-3), as well as the 
forkhead box protein foxD5 and geminin (Nakata et al., 1997; Bellefroid et al., 
1998; Brewster et al., 1998; Gomez-Skarmeta et al., 1998; Kroll et al., 1998; 
Mizuseki et al., 1998; Mizuseki et al., 1998; Sölter et al., 1999; Uchikawa et al., 
1999; Sullivan et al., 2001; Graham et al., 2003; Penzel et al., 2003; Pevny 
and Placzek, 2005; Pitulescu et al., 2005; Seo and Kroll, 2006; Kroll, 2007; 
Lefebvre et al., 2007; Houtmeyers et al., 2013).  
The genes induced by neural induction regulate multiple processes including 
progenitor maintenance (sox2, sox3 and zic2) (Brewster et al., 1998; 
Hardcastle et al., 2000; Ellis et al., 2004; Pevny and Placzek, 2005; Rogers et 
al., 2009), the onset of neuronal differentiation (zic1, zic3, sox15, iro1, iro2 and 
iro3) (Nakata et al., 1997; Mizuseki et al., 1998; Rogers et al., 2009) and 
control of progenitor proliferation (geminin, foxD5) (Kroll et al., 1998; Sullivan 
et al., 2001; Pitulescu et al., 2005; Seo and Kroll, 2006; Kroll, 2007; 
Papanayotou et al., 2008). 
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1.3 bHLH transcription factors and their role during neuronal 
differentiation and determination 
 
Transcription factors of the basic helix-loop-helix (bHLH) transcription factors 
are involved in many developmental processes including muscle development 
(Weintraub, 1993), mesodermal determination (Burgess et al., 1995), skeletal 
development (Cserjesi et al., 1995) and neural development (Lee, 1997; 
Bertrand et al., 2002). Members of the bHLH transcription factor family can be 
categorized into three classes (Murre et al., 1989). Class A bHLH proteins form 
homo or heterodimers and are ubiquitously expressed genes such as E12, 
E47 or daughterless. Class B bHLH transcription factors form heterodimers 
with class A bHLH proteins and show a tissue specific expression pattern, 
while class C bHLH transcription factors do not interact with either of the class 
A or class B bHLH transcription factors (Murre et al., 1989). The formed homo- 
or heterodimers bind to an E-box motif (CANNTG) on the DNA, usually through 
the basic region, while the HLH domain is involved in the dimerization (Murre 
et al., 1989). The activity and DNA target choice of bHLH transcription factors 
can be regulated via the interaction with co-factors (Ma et al., 2008; Mattar et 
al., 2008; Rodolosse et al., 2009; Li et al., 2011). 
Neuronal differentiation is initiated by the expression of proneural genes, which 
drive the determination and differentiation of progenitor cells to a neuronal cell 
fate (Bertrand et al., 2002). The proneural genes are mainly class B bHLH 
transcription factors (Bertrand et al., 2002) belonging to the drosophila 
archaete-scute and atonal family.  Proneural bHLH transcription factors can be 
categorized in two distinct subgroups according to their function during 
neuronal differentiation and based on the timing of their expression: neuronal 
determination genes and neuronal differentiation genes (Lee, 1997; Farah et 
al., 2000; Bertrand et al., 2002). Neuronal determination genes such as 
neurog2 or ascl1 are expressed early during neurogenesis in the mitotically 
active progenitors, which in the neural tube, are found in the inner ventricular 
zone (Lee, 1997; Bertrand et al., 2002). Neuronal differentiation genes such 
as neurod1 are expressed slightly later compared to the determination genes 
and are positively regulated by the proneural determination genes (Lee, 1997; 
Bertrand et al., 2002). During neuronal differentiation, bHLH transcription are 
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involved in the regulation of several processes (Fig.1.3), which in the following 
will be demonstrated by the multiple activities of the proneural bHLH 
transcription factor Neurog2. 
 
Figure 1.2: Overview over Archaete-Scute and Atonal family members of 
proneural bHLH transcription factors 
Scheme showing the relationship between different families of bHLH proteins involved 
in neuronal differentiation.  bHLH proteins are mainly divided in ubiquitously 
expressed E-proteins, which are orthologs to drosophila Daughterless and the 
proneural families that are homologue to the drosophila Atonal and Achaete-Scute. 
The Atonal family can be further divided in several subfamilies, which includes the 
Neurogenin family, the Olig family and the Atonal family. Blue shading highlights the 
invertebrate family members, while red highlights vertebrate family members. 
(Modified from Bertrand et al. (2002). 
 
Neurog2 is a member Neurogenin family of the atonal-like bHLH transcription 
factors. This family consists of three distinct members (Neurog1, Neurog2 and 
Neurog3) (Sommer et al., 1996; Nieber et al., 2009), all of which are expressed 
during gastrulation in X. laevis. (Nieber et al., 2009). Transcripts of neurog1 
and neurog2 are present in the three longitudinal domains of primary 
neurogenesis in open neural plate stages, with the expression of neurog2 
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being broader than neurog1 (Ma et al., 1996; Nieber et al., 2009). Neurog3 
expression, in comparison, is restricted to the medial domain (Nieber et al., 
2009). 
Among the members of the Neurogenin family, the function of neurog2 is best 
characterized in X. laevis. Overexpression of neurog2 is sufficient to drive 
neuronal differentiation of the non-neural ectoderm (Ma et al., 1996). 
Furthermore, Neurog2 induces the expression of other later expressed 
proneural bHLH transcription factors such as neurod1, which on the other hand, 
is not capable of inducing neurog2 (Ma et al., 1996). Other early expressed 
bHLH transcription factors such as Ascl1, which activates neurod1 expression 
(Cau et al., 1997), while Neurod1 levels do not affect ascl1 expression (Gao et 
al., 2009).  
It has been demonstrated that in mammalian cell lines, Neurog2 can act as a 
pioneer transcription factor, initiating target gene transcription on nucleosome 
bound regions (Chen and Dent, 2014). Often the binding of a pioneer 
transcription factor will initiate events that lead to an opening of the chromatin 
and the recruitment of active histone marks stabilizing target gene transcription 
(Zaret and Carroll, 2011; Zaret and Mango, 2016). Neurog2, for example, 
binds to regions of non-accessible chromatin (Smith et al., 2016) and promotes 
the removal of repressive histone marks and the addition of active histone 
marks at the neurod1 and tubb2b promoters by interacting with the H3 lysine 
9 demethylase Kdm3a (Lin et al., 2017). Several other proneural bHLH 
transcription factors such as Ascl1 or Neurod1 have been demonstrated to act 
as pioneer transcription factors in murine ES cells and fibroblasts (Wapinski et 
al., 2013; Pataskar et al., 2016), indicating a general role of proneural bHLH 
transcription factors in initiating and stabilizing the onset of neuronal gene 
expression. 
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Figure 1.3: Multiple roles of the proneural bHLH transcription factor Neurog2 
during neurogenesis. bHLH transcription factors like Neurog2 are involved during 
many processed in regulating neurogenesis. Neurog2, for example is activating a 
cascade of proneural genes driving neuronal determination and differentiation 
(Bellefroid et al., 1996; Ma et al., 1996). It is furthermore involved in activating cell 
cycle regulators and Notch ligand dll1 and thereby controls the cell cycle length and 
lateral inhibition (de la Calle-Mustienes et al., 2002; Kiyota and Kinoshita, 2002; 
Souopgui et al., 2002; Bray, 2006). In addition, Neurog2 activates genes involved in 
the specification of distinct neuronal subtypes (Bertrand et al., 2002).  
 
The proneural bHLH proteins lead to the transcription of other bHLH 
transcription factors that are involved in the differentiation to neuronal cells, 
such as the HLH transcription factors ebf2 (Dubois et al., 1998) and ebf3 
(Pozzoli et al., 2001), the atonal family members atoh1 (Kim et al., 1997) and 
atoh7 (Kanekar et al., 1997), as well as the neuronal differentiation factors 
neurod1 (Ma et al., 1996) and neurod4 (Perron et al., 1999). For example, the 
overexpression of the bHLH transcription factor Atoh1 is sufficient to program 
ectodermal cells to express neuronal differentiation markers in X. laevis 
without inducing early neuronal differentiation marker genes such as neurog2 
or neurod1 (Kim et al., 1997).  
Besides driving neuronal differentiation, proneural bHLH transcription factors 
also influence the length of the cell cycle. Neurog2 indirectly represses cyclins 
D, E1 and E2 involved in G1-phase progression and G/S-phase transit in chick 
embryos (Lacomme et al., 2012; Pfeuty, 2015). Furthermore, Neurog2 induces 
the cell cycle inhibitor genes gadd45-γ and pak3 in X. laevis, leading to cell 
cycle withdrawal (de la Calle-Mustienes et al., 2002; Souopgui et al., 2002). 
The involvement of proneural bHLH proteins in regulating the cell cycle is 
further supported by studies in mouse, Ascl1 activates several cell cycle 
regulators that are essential for G1/S transition (e2f1, cdk1, cdk2, and skp2) 
or entry into mitosis (cdk1 and cdc25b) (Castro et al., 2006; Castro et al., 2011), 
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but also other factors associated with cell cycle arrest (fbxw7, gadd45g, 
ccng2h, and prmt2), indicating that Ascl1 has a role in regulating progenitor 
proliferation as well as in cell cycle exit of progenitor cells (Castro et al., 2011).  
Furthermore, many bHLH transcription factors are involved in the regulation of 
lateral inhibition mediated by the Notch pathway, which controls the number of 
cells that undergo neuronal differentiation (Lewis, 1998; Bray, 2006; 
Kageyama et al., 2008; Ahnfelt-Rønne et al., 2012).  
 
1.4 Lateral inhibition 
 
The decision as to which cells will differentiate to functional neurons from an 
equivalent population of cells is under control of lateral inhibition, which is 
mediated by the Notch signaling pathway (Beatus and Lendahl, 1998; Bray, 
2006; Kageyama et al., 2008) (Fig. 1.4A).  
During X. laevis neuronal differentiation, the expression of Neurog2 and the 
achaete-scute family member Ascl1 leads to the induction of the Notch-ligands 
dll1 and dll4 and jagged (Kiyota and Kinoshita, 2002; Bray, 2006) (Fig. 1.4B). 
The Notch ligands are transmembrane proteins that recognize and bind to 
Notch transmembrane receptors on the neighboring cell (Chitnis and Kintner, 
1995; Bray, 2006). This leads to several cleavage events on the Notch receptor, 
which results in the release of intracellular domain of the Notch receptor (NICD) 
(Schroeter et al., 1998; Selkoe and Kopan, 2003) (Fig 1.4b). The NICD then 
translocates to the nucleus where it interacts with CSL DNA binding protein 
Rbpj and induces the expression of bHLH transcription factors of the hairy and 
enhancer of split (hes) family (Sasai et al., 1992; Wettstein et al., 1997; 
Ohtsuka et al., 1999; Davis and Turner, 2001; Bray, 2006). The hes genes are 
transcriptional repressors of proneural genes such as neurog2, so that in the 
end the expression of dll1 in the neighboring cell is inhibited as well as the 
activation of downstream differentiation factors (Dawson et al., 1995; Wettstein 
et al., 1997; Li and Baker, 2001; Schneider et al., 2001; Cau et al., 2002; Louvi 
and Artavanis-Tsakonas, 2006) (Fig 1.4B). This leads to the differentiation of 
the dll1 expressing cell, while the Notch expressing cell will remain 
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undifferentiated and can differentiate at a later time into a neuron or a glial cell 
(Sasai et al., 1992; Ohtsuka et al., 1999; Davis and Turner, 2001).  
 
Figure 1.4: Specification of neuronal progenitors via lateral inhibition. 
(A) After neural induction, the neural plate consists of equipotent neural progenitor 
cells. During lateral inhibition, cells get specified by signaling of repressive signals to 
their neighboring cells, leading signaling cells becoming neuronal progenitor cells, 
while receiving cells remain undifferentiated and will later give rise to stem cells or 
glial cells. (B) Overview of the Notch signaling pathway. Expression of proneural 
genes leads to the expression of the Notch ligands such as delta, which binds to the 
transmembrane Notch receptor on the neighboring cell. The binding of the ligand to 
the receptor leads to cleavage events at the Notch receptor, so that the notch 
intracellular domain, NICD, will be released. NICD enters the nucleus and binds to 
Rbpj activating repressor bHLH proteins such as the hes genes. The Hes proteins in 
turn, suppress the expression of proneural genes and so to a reduction of delta 
production in the receiving cell. In the end, the cell receiving the smallest amount of 
repressing signals will differentiate further. 
 
Overexpression of NICD in X. laevis embryos leads to an inhibition of neuronal 
differentiation, while the overexpression of a dominant negative dll1 increases 
the number of neurons in the territories of primary neurogenesis (Chitnis and 
Kintner, 1995). These findings demonstrate the importance of lateral inhibition 
in the balance between proliferation and differentiation, In X. laevis, Neurog2 
also activates the zinc finger gene myt1 (Bellefroid et al., 1996), which allows 
the cell to escape lateral inhibition (Bellefroid et al., 1996). After neural tube 
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closure, Notch signaling remains important for preserving a neural progenitor 
pool in the ventricular zone of mouse and rat embryos (Lindsell et al., 1996; 
Imayoshi and Kageyama, 2011).   
It has been demonstrated in mouse and zebrafish that the expression levels of 
proneural genes are oscillating within the cell, thereby establishing a dose-
dependent regulation of neuronal differentiation mediated by lateral inhibition 
(Horikawa et al., 2006; Kageyama et al., 2008; Shimojo et al., 2008; Oginuma 
et al., 2010; Niwa et al., 2011; Okubo et al., 2012; Roese-Koerner et al., 2017). 
The expression levels of the bHLH repressor hes1 are inversely oscillating with 
those of other proneural genes like neurog2, ascl1 and dll1 in a 2-3 h period 
(Ohtsuka et al., 1999; Kageyama et al., 2008; Shimojo et al., 2008; Maurer et 
al., 2014; Pfeuty, 2015). Hes1 oscillation itself is established by a double 
negative feedback loop with the miRNA-9 (miR-9), which leads to the 
degradation of hes1 mRNA, while the Hes1 protein inhibits miR-9 expression 
(Bonev et al., 2012; Roese-Koerner et al., 2017). Furthermore, miR-9 also 
directly binds to the NICD-Rbpj transcription factor complex leading to 
attenuation of Notch-signaling and promotion of neuronal differentiation 
(Roese-Koerner et al., 2016; Roese-Koerner et al., 2017). The importance of 
gene oscillation is supported by the findings that continuous expression of 
hes1 and dll1 lead to defects during neurogenesis (Shimojo et al., 2008; 
Shimojo et al., 2016). 
 
1.5 Neuronal subtype specification 
 
During neurulation, the identity of the distinct neurons is defined by their 
positioning in the closing neural tube (Bertrand et al., 2002; Hori and Hoshino, 
2012; Roberts et al., 2012). Depending on their position, the differentiating 
neuronal precursor cell will receive different signals, leading to its development 
to a certain neuronal subtype identity (Bertrand et al., 2002). In X. laevis, ten 
distinct neuronal subpopulations exist, which are the Rohon-Beard sensory 
neurons, the ventral motor neurons and Kolmer-Agduhr cells, and seven 
distinct interneuronal subtypes (Roberts et al., 2012). How the different 
neuronal subpopulations are defined in X. laevis is not well established. 
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However, the combinatorial of transcription factors for each progenitor domain 
and post-mitotic neuron has been well characterized in mice and chick 
embryos, and for those genes studied in X. laevis, a conservation of function 
and expression is preserved. 
 
In contrast to X. laevis where the first primary neurons arise already at the 
open neural plate stage, in mouse and chick, the first neurons are born in the 
progenitor domains of the closed neural tube (Aaku-Saraste et al., 1996). The 
neural tube is patterned by the secretion of two morphogens at the dorsal and 
ventral side (Le Dréau and Martí, 2012). On the dorsal side, the neural 
ectoderm and the roof plate secrete BMP, while the notochord secretes Sonic 
hedgehog (Shh), which induces the overlying floor plate to secrete Shh to the 
ventral neural tube (Jessell and Dodd, 1990; Liem et al., 1997). Through the 
different dosages of Shh and BMP signaling, the neural tube is patterned to 
give rise to eleven progenitor domains of neuronal subtypes (Hori and Hoshino, 
2012).  
The different dosages of Shh and BMP signaling lead to the expression of 
domain specific combinations of bHLH and homeodomain transcription factors 
(Briscoe et al., 2000; Briscoe and Ericson, 2001; Helms and Johnson, 2003; 
Hernandez-Miranda et al., 2017). For example, Ascl1 is expressed in 
populations that will later develop into dI3-6 and dIL interneurons (Gross et al., 
2002; Müller et al., 2002), while cells expression Neurog1 and 2 will give rise 
to dI2 interneurons (Gowan et al., 2001).  
The progenitor domains can all be characterized by giving rise to excitatory or 
inhibitory neuronal subpopulations. Most excitatory neurons will secrete 
glutamate as a neurotransmitter, while inhibitory neurons secrete γ-
aminobutyric acid (GABA) or glycine and are involved in balancing the 
excitatory signals (Hori and Hoshino, 2012). In the mouse dorsal neural tube, 
six progenitor domains are present (Helms and Johnson, 2003), which give 
rise to six early (dI1-6) and two late (dILA and dILB) subpopulations of 
interneurons. The five ventral progenitor domains give rise to five early 
developing classes of neurons (V0-3 and VMN). The V0 and V2 domain will 
further develop into two subpopulations expressing different neuronal 
transmitters (Hori and Hoshino, 2012) (Fig. 1.4). 
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Figure 1.5 Dorsal-ventral patterning of the neural tube 
In mice, the neural tube gives rise to six early and two late dorsal population of 
neurons (dI1-6, dILA/B) and five ventral neurons (V0-V3, MN). The identity of the 
distinct neuronal progenitor populations is defined by expressing a unique 
combination of transcription factors, which is established by gradients of Shh and 
BMP signaling form the dorsal and ventral neural tube (Hernandez-Miranda et al., 
2017). 
 
Interestingly, many bHLH transcription factors involved in converting the 
ectoderm to a general neuronal fate also drive the development of the induced 
neurons to a distinct neuronal subtype (Bertrand et al., 2002). Moreover, 
regulation of subtype specification by bHLH transcription factors is highly 
regulated by co-factor interaction. For instance, in the mouse, Neurog1 and 
Neurog2, induce the expression of sensory neuronal marker genes (Fode et 
al., 2000). Overexpression of Neurog2 in chick embryos together with the 
bHLH transcription factor Olig2, however, induces motor neuron cell fate 
(Mizuguchi et al., 2001), while overexpression of Neurog2 alone induces the 
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expression of the glutamatergic sensory marker gene tlx3 (Patterson and Krieg, 
1999; Perron et al., 1999). In contrast, the progenitors with expression of 
Mash1 undergo a GABAergic cell fate in mice (Fode et al., 2000; Parras et al., 
2002), but Mash1 together with Phox2b induces the expression of phox2a 
leading to the development of noradrenergic neurons (Pattyn et al., 2000).  
 
1.6 Role of phosphorylation in regulating neurogenesis 
 
Impairments during neurogenesis are associated with severe diseases 
including epilepsies, amyotrophic lateral sclerosis or even to agenesis of entire 
brain areas (Sellick et al., 2004; Allain et al., 2011; Poduri and Lowenstein, 
2011). Thus, strict regulation of neurogenesis is essential for the development 
of a functional nervous system. It is therefore not surprising that most aspects 
of neurogenesis are under a high degree of regulation ranging from 
transcriptional, post-transcriptional and to changes on the epigenome 
(Ubersax and Ferrell, 2006; Yao and Jin, 2014; Hsieh and Zhao, 2016; Yao et 
al., 2016). 
Since cells differentiate after they leave the cell cycle, the timing of cell cycle 
exit and length of the cell cycle is essential for the balance between neural 
progenitor cell maintenance and differentiation (Lange et al., 2009; Lange and 
Calegari, 2010; Miyata et al., 2010; Hardwick et al., 2015). Cell cycle is mainly 
under the control of cell cycle dependent kinases (Cdk) that transfer a 
phosphate group to serine or threonine residues of target proteins and in this 
way regulates their activity (Vernon, 2003; Richard-Parpaillon et al., 2004). 
Serine or threonine residues, that are modified by Cdk phosphorylation, are 
often directly followed by a proline residue (SP or TP sites) (Ubersax and 
Ferrell, 2006). 
The importance of cell-cycle-dependent-phosphorylation in neuronal 
differentiation is supported by the findings that many proneural genes such as 
Neurog2 or Neurod1 are phosphorylated at several S/T-P residues (Ali et al., 
2011; Hardwick and Philpott, 2015). Cell-cycle-dependent-phosphorylation on 
SP sites in Neurog2 negatively affects its stability and thus decreases its 
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activity in inducing neuronal differentiation (Vosper et al., 2007; Ali et al., 2011). 
Furthermore, overexpressing of Neuorg2, where all the serine residues at SP 
sites were mutated to alanine in X. laevis embryos, showed an increase in 
protein stability (Ali et al., 2011). Corresponding with this increased stability 
comes an increased activity compared to the wild-type Neurog2 in promoting 
neuronal differentiation (Ali et al., 2011).  
On the other hand, it has been demonstrated that phosphorylation on a 
conserved serine residue within the HLH domain of Neurog2 and Ascl1 
regulates the selectivity of target gene activation during neuronal subtype 
specification in drosophila and mouse (Quan et al., 2016). Furthermore, 
Neurog2 phosphorylation at the C-terminus (S231and S234) has a direct 
influence on the interaction with binding partners during neuronal subtype 
specification as it facilitates the interaction with LIM homeodomain 
transcription factors Lhx3 and Isl1/2 during murine motor neuron specification 
(Ma et al., 2008). 
 
1.7 Epigenetic regulation of neurogenesis 
 
The influence of epigenetic regulation of gene expression has drawn increased 
attention in the last years, as malfunctions in epigenetic regulation have been 
associated with the development of severe diseases including several types 
on cancer (Hsieh and Zhao, 2016). Epigenetic mechanisms also play a critical 
role in neural development and function, with epigenetic dysfunction 
associated with several neurological disorders (Banik et al., 2017; Delgado-
Morales et al., 2017). Gene transcription can be affected through multiple 
epigenetic events including DNA methylation, regulation via miRNAs or 
ncRNAs, chromatin remodeling and the modification of histone proteins (Fig. 
1.6A) (Hsieh and Zhao, 2016). 
Chromatin is a nucleoprotein complex of 147 bp of DNA surrounding a core 
particle (nucleosomes). One nucleosome core particle consists of DNA 
wrapped around two copies of the histone proteins H2A, H2B, H3 and H4 
(Luger and Richmond, 1998). Depending on the density of the nucleosomes, 
transcription of a target gene can be facilitated or hindered. Relatively open 
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accessible chromatin regions are referred to as euchromatin, while those 
chromatin regions, in which the histone proteins are densely packed and the 
accessibility of the DNA is reduced is referred to as heterochromatin (Gao, 
2017). 
 
Figure 1.6: Overview of epigenetic mechanisms controlling the transcription of 
DNA  
(A) DNA transcription can be affected by four primary mechanisms: Through ncRNAs, 
DNA methylation, histone modification and chromatin remodeling (Hsieh and Zhao, 
2016) (B) Overview of active and inactive chromatin: Active chromatin is defined by 
activating histone marks such as acetylation or activating methylation on lysine 
residues. Inactive chromatin is characterized by repressive histone marks such as 
inactivating methylation on lysine residues or by methylated DNA. 
 
The tails of histone proteins are target for covalent modifications such as 
acetylation, methylation, ubiquitination, SUMOylation, ribosylation and 
phosphorylation (Jenuwein and Allis, 2001; Bernstein et al., 2007). Depending 
on the type and site of modification, a modification can be referred to as 
activating or repressing. In general, acetylation and phosphorylation of 
residues is associated with the activation of transcription (Strahl and Allis, 
2000), while for histone methylation, it depends on the modified residue and 
the number of methyl groups that are transferred to this residue to define if the 
modification is activating or repressing (Mosammaparast and Shi, 2010) (Fig. 
1.6B). Examples for activating histone modifications are the acetylation of the 
lysine 9 or the lysine 14 of histone H3 (H3K9ac, H3K14ac), the di- or 
trimethylation of lysine 4 of histone H3 (H3K4me2 H3K4me3) or the 
phosphorylation of serine 10 of histone H3 (H3S10p) (Hsieh and Zhao, 2016). 
Examples for repressing marks are the demethylation of lysine 9 of histone H3 
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(H3K9me2) or di- and trimethylation of lysine27 at histone H3 (H3K27me2, 
H3K27me3) (Hsieh and Zhao, 2016). 
Methylation can also be detected on the DNA itself. Here, methylation occurs 
at position 5 of cysteine residues (Yao and Jin, 2014). In most cases, these 
cysteine residues are immediately followed by a guanine residue (CpG islands) 
(Simmen, 2008). The presence of methylated CpG islands is associated with 
gene silencing, for example the silencing of the X chromosome (Jaenisch and 
Bird, 2003) (Fig. 1.6C). Furthermore, during neurogenesis CpG methylation is 
involved in the silencing of pluripotency genes in neural progenitor cells (Mohn 
et al., 2008). Gene silencing via DNA methylation can occur by blockage of 
transcription factor binding, recruitment of methylcytosine binding proteins or 
induction of other repressive histone modifications (Cedar and Bergman, 
2009). 
DNA methylation can also occur on cysteine residues that are not adjacent to 
a guanine residue (CpH) (Mo et al., 2015). The formation of CpH islands, for 
example, could be detected in mature mouse cortical neurons (Mo et al., 2015). 
Interestingly, neuronal subtypes can be clearly differentiated by their specific 
methylation pattern, demonstrating the changes in DNA methylation pattern 
occurs during differentiation and specification (Hontelez et al., 2015; Mo et al., 
2015). CpH methylation levels are low in actively transcribed genes and 
increase in silenced transcription factor positions on the DNA. So, by 
comparing the CpH methylation levels over time, the developmental history of 
cells in the adult embryo can be captured (Mo et al., 2015).  
Interestingly, studies in X. tropicalis demonstrated that many epigenetic 
activating or repressing marks like H3K4me3 and H3K27me3 are maternally 
provided and are located close to the transcriptional start site of genes, while 
epigenetic marks achieved zygotically are located at a more distant position 
and are mainly close to enhancer elements (Hontelez et al., 2015).   
The state of the chromatin itself can be changed by chromatin remodeling 
complexes such as the BAF chromatin remodeling complex (also known as 
the SWI/SNF complex), which is essential for vertebrate neurogenesis (Seo et 
al., 2005; Bachmann et al., 2016). The BAF complex consists of at least 15 
subunits (Ho et al., 2009), with the subunits of the complex differing depending 
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on the cell type or the time of expression (Lessard et al., 2007; Ho et al., 2009; 
Kadoch et al., 2013; Ronan et al., 2013; Narayanan and Tuoc, 2014). The BAF 
complex always contains either Brm or Brg1 as the catalytic subunit, and the 
three invariant core units BAF47, BAF155 and BAF170 (Lessard et al., 2007; 
Ronan et al., 2013). The remaining subunits show a high variability, where 
some subunits are more generally distributed, while many BAF complexes 
have their unique composition of subunits (Lessard et al., 2007; Ho et al., 2009; 
Kadoch et al., 2013; Ronan et al., 2013). Nevertheless, it has been 
demonstrated, that either Brg1 or Brm together with the three core units is 
sufficient to remodel nucleosomes (Phelan et al., 1999). 
 
 
Figure 1.7 Composition of the BAF chromatin remodeling complex 
The BAF chromatin remodeling complex consist of one of two catalytic core units 
(Brg1 or Brm) (red), three invariant core units (BAF47, BAF155 and BAF177) and a 
various number of context depending variant subunits (blue). 
 
Neurogenesis is impaired in BAF mutants demonstrating the importance of 
chromatin remodeling via this complex (Matsumoto et al., 2006; Lessard et al., 
2007; Narayanan and Tuoc, 2014). A loss of Brg1, for example, leads to severe 
defects in neurogenesis due to impairments in neuronal differentiation 
(Bachmann et al., 2016; Sokpor et al., 2017). Specific knock-out of Brg1 in 
murine neural progenitor cells leads to a reduced size of the brain, due to a 
lack of the cerebellum and a thinning of the midbrain, which results in a 
malformed cortex (Matsumoto et al., 2006; Lessard et al., 2007). Mice 
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heterozygotic for Brg1 suffer from exencephaly, indicating a dosage 
dependency for Brg1 (Matsumoto et al., 2006; Lessard et al., 2007). 
Furthermore, a knock-down of Brg1 prevents the induction of neuronal 
differentiation by proneural genes such as neurog2 or neurod1 and leads to 
developmental arrest of X. laevis embryos at gastrula or open neural plate 
stage (Wagner et al., 2017).  
Interestingly, the BAF chromatin remodeling complex can function as a 
transcriptional activator or as transcriptional repressor by directly binding to 
different proteins (Zhan et al., 2011; Tuoc et al., 2013). Basal expression of 
shh, for example, is repressed by BAF complex binding to Gli3, while 
interaction with Gli co-repressor histone deacetylase activates shh target 
genes (Zhan et al., 2011). 
In addition to the BAF chromatin remodeling complex, there exist three other 
families of SWI-like ATPase dependent chromatin remodeling complex 
families, namely the ISWI complexes, the CHD complexes and the INO80 
complex. ISWI complexes have SNF2H or SNF2L as their catalytic subunit 
and are involved in transcriptional activation and repression as well as the 
regulation of the chromatin structure, the replication of the DNA through 
heterochromatin and the segregation of chromosomes (Ho and Crabtree, 2010; 
Goodwin and Picketts, 2017). CHD complexes are subdivided in in three 
subfamilies. In mice, subfamily I members (CHD1 and CHD2) are mainly 
involved in the preservation of pluripotency (Gaspar-Maia et al., 2009), while 
subfamily II members (CHD3 and CHD4) are members of complexes 
containing histone deacetylases and function as transcriptional repressors 
(Zhang et al., 1998). CHD7, the best studied CHD family III member, however, 
is involved in transcriptional activation of tissue-specific genes during 
differentiation (Schnetz et al., 2009). Furthermore CHD8 homologue Duplin 
has been shown to be a negative regulator of canonical Wnt signaling in X. 
laevis (Heasman et al., 2000; Sakamoto et al., 2000). For nearly all of the CHD 
family members, essential regulatory functions during neurogenesis have 
been reported (Gaspar-Maia et al., 2009; Nieberler, 2012; Egan et al., 2013; 
Jones et al., 2015; Shen et al., 2015; Durak et al., 2016). A depletion CHD5 in 
the murine neocortex, for example, leads to an increase of undifferentiated 
progenitor cells and the expression of genes that normally are repressed 
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(Egan et al., 2013), while CDH8 promotes the transcription of cell-cycle 
regulators (Durak et al., 2016). INO80 family members INO80 and SWR1 form 
large complexes with in vitro nucleosome-remodeling activity and are involved 
in transcriptional regulation (Bao and Shen, 2007). 
 
1.8 Changes in the epigenetic landscape during development 
 
At the time of fertilization, the fertilized oocyte is a totipotent cell, which can 
develop into cells of all three germ layers (Wobus and Boheler, 2005; Mitalipov 
and Wolf, 2009). During development, the cells become committed to a certain 
cell fate and so develop to multipotent progenitor cells, which then give rise to 
specialized cells (Wobus and Boheler, 2005; Mitalipov and Wolf, 2009). Since 
limitations in specification of the cells are achieved during development, the 
chromatin in the early X. tropicalis embryo or undifferentiated murine 
embryonic stem cells is characterized by quite accessible chromatin (Hontelez 
et al., 2015). In X tropicalis embryos, the chromatin itself is relatively 
unmodified at early stages (Hontelez et al., 2015). While chromatin 
modifications increase during development, at the tailbud stage, 67% of the 
total chromatin still remains naïve (Hontelez et al., 2015), The first global 
changes in the chromatin landscape occurs at the transition from maternal to 
zygotic transcription, with an increase in histone marks such as H3K4me3 or 
H3K9ac (Hontelez et al., 2015). Interestingly, most of H3K4me3 or H3K9ac 
marks are already established without the influence of zygotic factors and can 
be found even at promoters of late expressed genes, indicating that the 
presence of active histone marks is not sufficient to drive active transcription 
(Hontelez et al., 2015). This is supported by the observation that promoters of 
late expressed genes often are found in hypomethylated regions (Hontelez et 
al., 2015; Mo et al., 2015). However, after transcription the level of methylation 
at those genes increases, corresponding with gene silencing (Mo et al., 2015).  
High levels of DNA methylation do not necessarily correspond to 
transcriptional repression, as relatively high DNA methylation upstream and 
downstream of promoter regions is still compatible with transcriptional activity 
(Bogdanovic et al., 2012). In addition, DNA methylation does not lead to 
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transcriptional repression in early embryos, but does so in oocytes and late 
embryos (Bogdanovic et al., 2012). This is supported by the findings that 
epigenetic marks achieved by zygotic regulation in X. tropicalis were mostly 
located in regulatory regions of the DNA characterized by large distances from 
the promoter region and high degree of DNA methylation (Hontelez et al., 
2015). Many marks for enhancers could be found in these regions, indicating 
that regulation via enhancers is not dependent on accessible chromatin 
(Hontelez et al., 2015). 
Interestingly, several bHLH transcription factors involved in neuronal 
differentiation can work as pioneer transcription factors and do not need 
accessible chromatin to induce target gene expression. The neuronal 
differentiation gene Neurod1, for example, can induce target gene activation 
prior to chromatin opening (Pataskar et al., 2016). Furthermore, Neurod1 itself 
can alter the state of the chromatin surrounding its target genes (Pataskar et 
al., 2016). Other bHLH transcription factors like Neurog2 and Ascl1 have also 
been shown to bind non-accessible regions on the DNA (Smith et al., 2016).  
 
1.9 Ptf1a 
 
Pancreatic transcription factor 1a (Ptf1a) is a bHLH transcription factor that 
was first identified as a member of a trimeric transcription factor complex 
involved in the development of the exocrine pancreas (Cockell et al., 1989). In 
X. laevis, Ptf1a expression can first be detected in two longitudinal stripes 
along the dorsal midline. During subsequent stages of development, ptf1a 
expression becomes restricted to the developing hindbrain, spinal cord, the 
retina and the early pancreas anlagen (Afelik et al., 2006) (Fig. 1.7A). 
Transversal sections at tailbud stage indicate that the expression domain of 
Ptf1a in the neural tube is restricted to the intermediate zone, in which the 
dorsal inhibitory interneuron population arise (Fig 1.7B). 
Ptf1a is best characterized for its role during development of the pancreas, 
where it is involved in the specification of pancreatic precursor cells 
(Kawaguchi et al., 2002; Afelik et al., 2006). At later stages, it contributes to 
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the formation of the exocrine pancreas and the induction of digestive enzymes 
(Cockell et al., 1989; Krapp et al., 1996; Krapp et al., 1998; Kawaguchi et al., 
2002). The importance of Ptf1a in pancreas development can be demonstrated 
in ptf1a knockout-mice, which suffer from a complete loss of the exocrine 
pancreas and while just a few endocrine cells are present, they are 
mislocalized to the spleen (Krapp et al., 1998). Correspondingly, a knock-down 
of ptf1a in X. laevis and X. tropicalis embryos leads to the loss of exocrine 
marker genes and pancreatic tissue (Afelik et al., 2006; Lei et al., 2012). 
Furthermore, mutations affecting Ptf1a activity are found in humans who suffer 
from neonatal diabetes due to pancreatic agenesis (Hoveyda et al., 1999; 
Sellick et al., 2004; Tutak et al., 2009; Al-Shammari et al., 2011; Weedon et 
al., 2014). 
 
 
Figure 1.8: Expression pattern of Ptf1a 
(A) At tailbud stage X. laevis embryos, Ptf1a is expressed in the retina (r), the 
hindbrain (hb) and the early pancreas anlagen (p). Dashed line indicating the 
positioning of the cross-section on the right. r: retina, hb: hindbrain, p: pancreas (B) 
Transversal section of X. laevis at the level of the hindbrain. Ptf1a is expressed in the 
dorsal in the progenitor domain, where the dorsal interneuron populations arise. 
 
In addition to its essential role in pancreas development, Ptf1a is also required 
during early embryogenesis for the establishment of the nervous system 
(Sellick et al., 2004; Glasgow et al., 2005; Hoshino et al., 2005; Dullin et al., 
2007; Nakhai et al., 2007; Pascual et al., 2007; Hanotel et al., 2014). In this 
context, Ptf1a is best characterized for its ability to drive the development of 
GABAergic inhibitory neurons at the expanse of a glutamatergic cell fate in the 
retina, the hindbrain and the dorsal spinal cord (Glasgow et al., 2005; Hoshino 
et al., 2005; Fujitani et al., 2006; Dullin et al., 2007; Pascual et al., 2007). In 
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the mouse hindbrain and dorsal spinal cord, Ptf1a controls the development of 
dI4 and dILA interneuron populations that express the homeodomain 
transcription factors pax2 and lhx1/5 (Glasgow et al., 2005). In Ptf1a null 
mutant mice, those progenitor domains are completely absent, while the dI5 
progenitor population is increased (Glasgow et al., 2005). In the cerebellum, 
Ptf1a is essential for the formation of all types of GABAergic neurons (Hoshino 
et al., 2005; Kani et al., 2010; Mizuhara et al., 2010; Nishida et al., 2010), while 
in the retina, it drives the development of GABAergic amacrine and horizontal 
cells at the expanse of retinal ganglion and photoreceptor cells (Fujitani et al., 
2006; Dullin et al., 2007; Nakhai et al., 2007; Lelievre et al., 2011). However, 
lineage tracing of Ptf1a positive cells in mice and chick embryos demonstrate 
that progenitors expressing Ptf1a can also develop into other neuronal 
subtypes. For example, Ptf1a cooperates with Olig3 in the differentiation of 
glutamatergic climbing fiber neurons in the inferior olivary nucleus (Yamada et 
al., 2007; Storm et al., 2009), while subpopulations of Ptf1a expressing cells 
in the dorsal spinal cord will give rise to glycinergic neurons (Huang et al., 2008; 
Bessodes et al., 2017). Furthermore, it has been suggested that Ptf1a 
expressing cells might also be involved in the formation of serotonergic 
neurons in the zebrafish enteric nervous system (Uribe et al., 2016). 
Besides its involvement in driving the development to distinct neuronal 
subtypes, Ptf1a also promotes neuronal differentiation, with overexpression of 
Ptf1a in X. laevis embryos and ectodermal explants being sufficient to 
ectopically drive the non-neural ectodermal cells to develop into post-mitotic 
neurons (Dullin et al., 2007). Interestingly, although Ptf1a and Neurog2 both 
promote general neuronal differentiation, Neurog2 drives the development of 
glutamate expressing excitatory neurons (Patterson and Krieg, 1999; Perron 
et al., 1999), while Ptf1a promotes a GABAergic cell fate (Glasgow et al., 2005; 
Hoshino et al., 2005; Li et al., 2006; Dullin et al., 2007; Hedderich, 2008). 
Overexpression of Neurog2 and Ptf1a in X. laevis embryos and animal caps 
demonstrates that Ptf1a can alter the neuronal transmitter phenotype induced 
by Neurog2 to a GABAergic cell fate (Hedderich, 2012). In a similar way, mis-
expression of Ptf1a in ascl1 expressing cells will also change the induced 
neuronal transmitter cell fate from glutamatergic to GABAergic (Chang et al., 
2013; Borromeo et al., 2014). 
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1.10 Ptf1a forms a trimeric transcription factor complex 
 
Ptf1a is a bHLH protein that functions as a heterotrimeric transcription complex 
that recognizes a bipartite binding motif on target genes (Roux et al., 1989; 
Krapp et al., 1996; Beres et al., 2006; Masui et al., 2007; Hori et al., 2008). 
Ptf1a binds with a ubiquitously expressed class A bHLH transcription factor, 
(E2A/p75/HEB/TCF12), which recognizes E-box motifs (CANNTG) on the 
DNA (Murre et al., 1989; Beres et al., 2006). Furthermore, Ptf1a binds to a 
CSL family member, which binds to an adjacent TC box motif (TTTCCCA) on 
the DNA, in a distance of 1-3 helical turns (Beres et al., 2006; Meredith et al., 
2013) (Fig. 1.8A). In mammals, two closely related CSL family members are 
found, Rbpl and Rbpj. While Rbpj is the component of the Ptf1a trimeric 
complex in the nervous system and pancreatic progenitor cells, the interaction 
with Rbpl is restricted to the adult pancreatic tissue (Beres et al., 2006; Hori et 
al., 2008). In contrast to mammals, there are two homeologs of the CSL family 
in X. laevis and both are closely related to Rbpj (Beres et al., 2006). The 
interaction with mouse Rbpj is mediated by two tryptophan residues within two 
highly conserved motifs on the Ptf1a C-terminus (C1: HSLSW and C2: 
VWTPEDPR) (Beres et al., 2006; Hori et al., 2008). This interaction can be 
disrupted through mutation of the tryptophan residues in the C1 and C2 domain 
to alanine (Hori et al., 2008). While the C1 domain of the mouse Ptf1a is more 
important for binding Rbpl, mutation of the C2 domain is sufficient for disruption 
of binding of Ptf1a to Rbpj (Beres et al., 2006). Complete disruption of Ptf1a 
with X. laevis Rbpj requires mutation at the corresponding tryptophan residues 
in both the C1 and C2 domains (Ptf1aW224A/W242A) (Hanotel et al., 2014).  
The binding of Rbpj is thought to be essential for Ptf1a function, since 
mutations that results in truncation at the Ptf1a C-terminus have been found in 
children suffering from cerebellar agenesis (Sellick et al., 2004). Furthermore, 
mutations in the Ptf1a C2 domain in chick embryos result in loss of GABAergic 
dI4 and dILA neurons, a phenotype that is similar to those of Ptf1a knock-out 
mice (Hori et al., 2008). Interestingly, overexpression of a Ptf1a C1C2 mutant 
(Ptf1aW224A/242A) in X. laevis embryos and C-terminal truncation mutants known 
to cause cerebellar agenesis in humans, still induce neuronal differentiation 
(Hedderich, 2008; Hedderich, 2012; Richts, 2013). However, the induced 
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neuronal subtype is changed from a GABAergic to glutamatergic cell fate (Fig 
1.8B). Loss of Ptf1a in the mouse brain will not affect the generation of the 
formerly Ptf1a expressing progenitor populations, but instead, those cells will 
either migrate to the brainstem or undergo apoptosis (Millen et al., 2014; 
Iskusnykh et al., 2016). 
Rbpj not only binds to Ptf1a, but also binds to the Notch intracellular domain 
(Nishimura et al., 1998). It has been shown that the interaction of Ptf1a and 
NICD with Rbpj is mutually exclusive, suggesting that Ptf1a and NICD might 
compete with each other in binding Rbpj (Beres et al., 2006). 
 
Figure 1.9: Ptf1a forms a heterotrimeric complex 
Ptf1a (green) forms a trimeric complex with a class A bHLH protein (blue), binding an 
E-box motif on the DNA and to Rbpj (orange) binding an adjacent TC-box motif. 
Interaction with Rbpj is established by two highly conserved motifs (C1 and C2). 
Interaction with Rbpj can be disrupted by inducing point mutations from tryptophan to 
alanine within these motifs. While both mutants can promote neuronal differentiation, 
the wild-type Ptf1a promotes a GABAergic cell fate, while the Ptf1aW224A and 
Ptf1aW224A/242A mutant induces a glutamatergic cell fate. 
  
1.11 Gene induction and regulation by Ptf1a 
 
In the developing pancreas, Ptf1a directly binds the pdx1 promoter and drives 
the development of the early pancreas (Wiebe et al., 2007). Furthermore, Ptf1a 
is well known for activating genes associated with the maturation of the 
exocrine pancreas and for the induction of digestive enzymes (Cockell et al., 
1989; Krapp et al., 1996; Krapp et al., 1998; Kawaguchi et al., 2002; Masui et 
al., 2010). Ptf1a is autoregulated by binding to its own promoter in a positive 
feedback loop (Masui et al., 2008).  
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In contrast to pancreas development, only a few downstream target genes of 
Ptf1a are known during neurogenesis. Ptf1a directly activates neurog2 
expression in chick and mouse embryos (Henke et al., 2009). Furthermore, 
the two immunoglobulin superfamily members, nephrin and neph3 (also known 
as kirrel2) are direct target genes of Ptf1a in mouse (Nishida et al., 2010). As 
kirrel2 is expressed in Purkinje progenitor cells, it is suggested that its 
activation by Ptf1a plays a role in GABAergic neuronal subtype specification 
(Mizuhara et al., 2010). As in pancreas development, it has been shown that 
Ptf1a expression is under the control of a positive feedback loop, by binding to 
its own promoter (Meredith et al., 2009). Furthermore, barhl2 could be shown 
to act downstream of Ptf1a in the development of amacrine cells in the 
zebrafish retina (Jusuf et al., 2012). In addition, the zinc finger histone 
methyltransferase gene Prdm13 has been shown to be a direct Ptf1a target 
gene in mouse and X. laevis and is required to repress a glutamatergic 
excitatory neuronal cell fate (Chang et al., 2013; Hanotel et al., 2014). Prdm13 
inhibits the Neurog2- or Ascl1-induced expression of the glutamatergic 
selector gene tlx3 via interaction with its regulatory sequences and direct 
interaction with Ascl1 (Chang et al., 2013; Hanotel et al., 2014; Mona et al., 
2017). In addition, Prdm13 inhibits the expression of its own inducer, Ptf1a, in 
subpopulations of Ptf1a expressing cells that will develop into glycinergic cell 
fate (Bessodes et al., 2017; Mona et al., 2017). In X. laevis ectodermal 
explants, activation of direct target genes by Ptf1a underlies a temporal 
selection (Hedderich, 2012). While some direct target genes like prdm13 are 
activated immediately by Ptf1a, other direct target genes like neurog2 undergo 
a delayed activation (Hedderich, 2012). 
Similar to many bHLH proteins, Ptf1a contains S/T-P residues, which are 
putative targets of Cdk-mediated phosphorylation (Ubersax and Ferrell, 2006). 
Preventing phosphorylation at those sites, through mutation of these sites in 
Neurog2, leads to an increase in activation of the pan-neuronal marker tubb2b 
(Ali et al., 2011). No increase in neuronal inducing activity of Ptf1a was 
detected upon overexpression of a murine Ptf1a in which all eight S/T-P 
residues were mutated to alanine (mPtf1a8S/TA) in X. laevis embryos and 
animal caps, (Richts, 2013). Surprisingly, additional to its ability to induce 
markers for a GABAergic cell fate, mPtf1a8S/TA also induced the glutamatergic 
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marker gene tlx3, a gene that is normally repressed by Ptf1a. Mutating the 
alanine residue at position 299 back to threonine (mPtf1a7SA) could prevent 
the mixed induced neuronal transmitter phenotype back to an induced 
GABAergic cell fate (Richts, 2013), suggesting that the mutation of the T299 
was responsible for this activity.  
 
1.12 Aims 
 
The bHLH transcription factor Ptf1a is sufficient to promote neuronal 
differentiation (Dullin et al., 2007; Hedderich, 2008; Hedderich, 2012) and is 
able to drive the development of a GABAergic neuronal subtype at the expense 
of a glutamatergic neuronal subtype in the vertebrate brain, dorsal spinal cord, 
and retina (Glasgow et al., 2005; Hoshino et al., 2005; Dullin et al., 2007; 
Pascual et al., 2007). In recent years, Ptf1a mutants were identified that alter 
the induced neuronal transmitter phenotype (Hedderich, 2008; Hori et al., 2008; 
Richts, 2013). In this thesis, the selective induction of target genes by Ptf1a 
will be further analyzed. Therefore, Ptf1a C2 domain mutants inducing various 
neuronal call fates will be investigated by their activation of target genes and 
for potential mechanisms causing the alterations in the induced neuronal 
subtypes by those mutants. Furthermore, the function of chromatin remodeling 
in controlling the delay in the activation of target genes by Ptf1a will be 
analyzed. This will be investigated by studying the dependency of Ptf1a target 
gene activation on chromatin remodeling by the BAF complex and directly 
studying changes chromatin accessibility over time. 
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2. Materials and Methods 
 
2.1 Materials 
 
2.1.1 X. laevis 
 
X. laevis pigmented males and females were purchased from Nasco (Ft. 
Atkinson, USA). Developmental stages were defined according to Nieuwkoop 
and Faber (1967). 
 
2.1.2 Bacteria 
 
The chemical competent Escherichia coli strand XL1-Blue (recA1, endA1, 
gyrA96, thi-1, hsdR17, supE44, relA1, lac[FproAB, laclqZ∆M15, Tn10(Tetr)]c ) 
was used for molecular biology standard methods. 
 
2.1.3 Chemicals 
 
Chemicals used were ordered from the following companies: ApplChem, 
Merck, Roche, Roth, Sigma-Aldrich 
 
2.1.4 Antibiotics and Media 
 
Bacteria culture medium was made by dissolving 32 g Luria Bertani (LB) in 1 l 
dH2O. LB Medium was autoclaved at 121 °C and then cooled down on 50 °C. 
Ampicillin (working concentration: 100 µg/ml, diluted from a 100 mg/ml in dH2O 
stock solution) was added and the medium transferred to petri dishes and 
stored at 4 °C. 
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2.1.5 Oligonucleotides 
 
Oligonucleotides for cloning and RT-PCR were purchased from Sigma-Aldrich 
and were dissolved in dH2O to a 100 µM or 500 µM stock solution. Antisense 
morpholino oligonucleotides were purchased from Gene Tools and dissolved 
in RNase-free water to a concentration of 20 ng/nl. The morpholinos were 
stored at 4 °C and were heated for 5 min at 65 °C before use. 
 
2.1.5.1 RT-PCR oligonucleotides 
 
As X. laevis is allotetraploid all chromosomes are present in a large (.L) and a 
small (.S) copy. The homeolog targeted by the oligonucleotide is indicated 
behind the gene name. 
 
Oligonucleotide Orien-
tation 
Sequence TA  °C Cycles 
odc.L 
(Heasman et al., 
2000) 
for 
5´-
GCCATTGTGAAGACTCTCT
CCATTC-3´ 
57 25 
odc.L 
(Heasman et al., 
2000) 
rev 
5´-
TTCGGGTGATTCCTTGCCA
C-3´ 
57 25 
n-tubulin.L + S 
(Stancheva and 
Meehan, 2000) 
for 
5´-
ACACGGCATTGATCCTACA
G-3´ 
56 32 
n-tubulin.L + S 
(Stancheva and 
Meehan, 2000) 
rev 
5´-
AGCTCCTTCGGTGTAATGA
C-3´ 
56 32 
gad1a.L 
(Dullin et al., 2007) 
for 
5´-
ATGGGCGTCTTACTCCAAT
G-3´ 
60 32 
gad1a.L 
(Dullin et al., 2007) 
rev 
5´-
ATGTCTACATGGCGACCA
CA-3´ 
60 32 
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tlx3.S 
(Dullin et al., 2007) 
for 
5´-
GCCAACAAGTACAAGTGC
ACAG-3´ 
62 27 
tlx3.S 
(Dullin et al., 2007) 
rev 
5´-
CAGGAGCCAGACTCACAT
TGAC-3´ 
62 27 
prdm13.S 
(Hanotel et al., 
2014) 
for 
5´-
CTGCCGACACATGATGAA
AAAGG-3´ 
63 27 
prdm13.S 
(Hanotel et al., 
2014) 
rev 
5´-
AGATTTTGGGGGAGGCAG
AAAAG-3´ 
63 27 
neurog2.L for 
5´-
TTTGTTAAGGGCGAATGTC
A-3´ 
62 34 
neurog2.L rev 
5´-
ATCCGGGAAGGTGAAAAA
GT-3´ 
62 34 
Table 2.1 List of RT-primers and their PCR parameters 
 
2.1.5.2 Sequencing oligonucleotides 
 
Oligonucleotide Sequence 
T3 5´-TTAACCCTCACTAAAGG-3´ 
T7 5´-TAATACGACTCACTATAGG-3´ 
SP6 5´-ATTTAGGTGACACTATAG-3´ 
Ptf1a rev 5´-CATCAGTCCATGAGAGAG-3´ 
Table 2.2 List of sequencing oligonucleotides 
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2.1.5.3 Morpholino oligonucleotides 
 
Morpholino Sequence 
Brg1-MO (Seo et al., 2005) 5´-TCACTGCTAACCTGTCCCCGAATCC-3´ 
Standard control MO  
(GeneTools) 
5´-CCTCTTACCTCAGTTACAATTTATA-3´  
Table 2.3 List of morpholino oligonucleotides 
 
 
2.1.6 Sense RNA constructs 
 
Construct Vector 
Restriction 
enzyme 
Polymerase Reference 
Ptf1a pCS2+GR NotI SP6 
(Afelik et al., 
2006) 
Ptf1aW242A pCS2+GR NotI SP6 
(Hanotel et al., 
2014) 
Ptf1aW224A/W242A pCS2+GR NotI SP6 
(Hanotel et al., 
2014) 
Ptf1aT243A pCS2+GR NotI SP6 This thesis 
Ptf1aT243E pCS2+GR NotI SP6 This thesis 
Ptf1a-Vn pCS2+Vn NotI SP6 
(Hedderich, 
unpublished 
data) 
Ptf1aW224A/W242A-
Vn 
pCS2+Vn NotI SP6 
(Hedderich, 
unpublished 
data) 
Ptf1aT243A-Vn pCS2+Vn NotI SP6 This thesis 
Ptf1aT243E-Vn pCS2+Vn NotI SP6 This thesis 
Rbpj-Vc pCS2+Vc NotI SP6 
(Hedderich, 
unpublished 
data) 
Prdm13-Vc pCS2+Vc NotI SP6 This thesis 
Neurog2-Vn pCS2+Vn NotI SP6 This thesis 
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Table 2.4 List of overexpression constructs 
 
Overexpression constructs: 
 
E12-VcpCS2+ (prepared by M. Hedderich and K. Ditter): 
E12-VcpCS2+ contains the open reading frame of Rbpj fused at its N-terminus 
with the C-terminus of Venus YFP (aa 155-238). E12-VcpCS2+, was 
generated by PCR amplification of the E12 open reading frame using 
XE12pSP64XBm (obtained from Eric Bellefroid) as a template and the 
following primers: for, 5´-GTACCGGTGGTGGTGGTGGTGGTAATCAGCAG 
CAGAGGATG-3´ and rev, 5´-GGGTACGTATCACATGTGTCCCACTGG-3´. 
The PCR product was inserted into VcpCS2+ (Saka et al., 2007) using AgeI 
and SnaBI restriction sites. For preparation of sense RNA, the construct was 
linearized with NotI and transcribed with SP6 polymerase.  
 
Ptf1a-VnpCS2+ (prepared by M. Hedderich and K. Ditter): 
Ptf1a-VnpCS2+ contains the open reading frame of Ptf1a fused at its N-
terminus with the N-terminus of Venus YFP (aa 1-154). Ptf1a-VnpCS2+, was 
generated by PCR amplification of the Ptf1a open reading frame using Ptf1a-
GRpCS2+ (Afelik et al., 2006) as a template and the following primers: for, 5´-
TACCGGTGGTGGTGGTGGTGGTGAAACGGTCCTGGAGC-3´ and rev, 5´-
GGGTACGTATCACATATCAAGGCACAAAG-3´. The PCR product was 
inserted into VnpCS2+ (Saka et al., 2007) using AgeI and SnaBI restriction 
sites. For preparation of sense RNA, the construct was linearized with NotI and 
transcribed with SP6 polymerase. 
 
 
 
E12-Vc pCS2+Vc NotI SP6 
(Hedderich, 
unpublished 
data) 
β-Gal pCS2+ NotI SP6 
(Chitnis and 
Kintner, 1995) 
 NotI SP6 (Bier et al., 
1989) 
 
mRFP pCS2+ NotI SP6 
(Saka et al., 
2007) 
Materials and Methods   32 
 
Rbpj-VcpCS2+ (prepared by M. Hedderich and K. Ditter): 
Rbpj-VcpCS2+ contains the open reading frame of Rbpj fused at its N-terminus 
with the C-terminus of Venus YFP (aa 155-238). Rbpj-VcpCS2+, was 
generated by PCR amplification of the Rbpj open reading frame using Rbpj-
GRpCS2+ (Hedderich, 2012) as a template and the following primers: for, 5´-
GTACCGGTGGTGGTGGTGG TGGTCAACCTGGCATTCCTAAATAC-3´ and 
rev, 5´-GGGTACGTATTAGGACACTACTGCTGCAGTG-3´. The PCR product 
was inserted into VcpCS2+ (Saka et al., 2007) using AgeI and SnaBI restriction 
sites. For preparation of sense RNA, the construct was linearized with NotI and 
transcribed with SP6 polymerase. 
 
Ptf1aW224A/W242A-VnpCS2+ (prepared by M. Hedderich and K. Ditter): 
Ptf1aW224A/W242A-VnpCS2+ contains the open reading frame of Ptf1a fused at 
its N-terminus with the N-terminus of Venus YFP (aa 1-154). Ptf1aW224A/W242A-
VnpCS2+, was generated by PCR amplification of Ptf1a open reading frame 
using Ptf1aW224A/W242A-GRpCS2+ (Hedderich, 2008) as a template and the 
following primers: for, 5´-TACCGGTGGTGGTGGTGGTGGTGAAACGGT 
CCTGGAGC-3´ and rev, 5´-GGGTACGTATCACATATCAAGGCACAAAG-3´. 
The PCR product was inserted into VnpCS2+ (Saka et al., 2007) using AgeI 
and SnaBI restriction sites. For preparation of sense RNA, the construct was 
linearized with NotI and transcribed with SP6 polymerase. 
 
Ptf1aT243A-GRpCS2+ (prepared by M. Hedderich and K. Ditter): 
Ptf1aT243A-GRpCS2+ contains the open reading frame of Ptf1a with putative 
phosphorylation site threonine 243 mutated to alanine. To synthesize 
Ptf1aT243A-GRpCS2+, the threonine residue in position 243 was mutated using 
the QuickChange XL Site Directed Mutagenesis Kit (Stratagene) and the 
following primers (mutations are indicated in red): for, 5´-GGCCAAAGTGTGG 
GCTCCTGAGGATCCC-3´ and rev, 5´-GGGATCCTCAGGAGCCCACAC 
TTTGGCC-3´ and Ptf1a-GRpCS2+ as a template. For preparation of sense 
RNA, the construct was linearized with NotI and transcribed with SP6 
polymerase. 
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Ptf1aT243E-GRpCS2+: 
Ptf1aT243E-GRpCS2+ contains the open reading frame of Ptf1a with putative 
phosphorylation site threonine 243 mutated to glutamate. To synthesize 
Ptf1aT243E-GRpCS2+, the threonine residue in position 243 was mutated using 
the QuickChange XL Site Directed Mutagenesis Kit (Stratagene) and the 
following primers (mutations are indicated in red): for, 5´-CGGC 
CAAAGTGTGGGAGCCTGAGGATCCCAGG-3´ and rev, 5´-CCTGGGATCC 
TCAGGCTCCCACACTTTGGCCG-3´ and Ptf1a-GRpCS2+ as a template. For 
preparation of sense RNA, the construct was linearized with NotI and 
transcribed with SP6 polymerase. 
 
Ptf1aT243A-VnpCS2+: 
Ptf1aT243A-VnpCS2+ contains the open reading frame of Ptf1aT243A fused at 
its N-terminus with the N-terminus of Venus YFP (aa 1-154). To synthesize 
Ptf1aT243A-VnpCS2+, the threonine residue in position 243 was mutated using 
the QuickChange XL Site Directed Mutagenesis Kit (Stratagene) and the 
following primers (mutations are indicated in red): for, 5´-GGCCAAAGT 
GTGGGCTCCTGAGGATCCC-3´ and rev, 5´-GGGATCCTCAGGAGCCC 
ACACTTTGGCC-3´ and Ptf1a-VnpCS2+ as a template. For preparation of 
sense RNA, the construct was linearized with NotI and transcribed with SP6 
polymerase. 
 
Ptf1aT243E-VnpCS2+: 
Ptf1aT243E-VnpCS2+ contains the open reading frame of Ptf1aT243E fused at its 
N-terminus with the N-terminus of Venus YFP (aa 1-154). To synthesize 
Ptf1aT243E-VnpCS2+, the threonine residue in position 243 was mutated using 
the QuickChange XL Site Directed Mutagenesis Kit (Stratagene) and the 
following primers (mutations are indicated in red): for, 5´-CCTGGGATC 
CTCAGGCTCCCACACTTTGGCCG-3´ and rev, 5´-CGGCCAAAGTGTG 
GGAGCCTGAGGATCCCAGG-3´ and Ptf1a-VnpCS2+ as a template. For 
preparation of sense RNA, the construct was linearized with NotI and 
transcribed with SP6 polymerase. 
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Neurog2-VnpCS2+: 
Neurog2-VnpCS2+ contains the open reading frame of Neurog2 fused at its 
N-terminus with the N-terminus of Venus YFP (aa 1-154). Neurog2-VnpCS2+, 
was generated by PCR amplification of the Neurog2 open reading frame using 
Neurog2-HApCS2+ (Hedderich, unpublished data) as a template and the 
following primers: for, 5´-GTACCGGTGGTGGTGGTGGTGGTGTGCT 
GCTCAAGTGCG-3´ and rev, 5´-GGGTACGTATCAAATGAAAGCGCTGCT-
3´. The PCR product was inserted into VnpCS2+ (Saka et al., 2007) using the 
AgeI and SnaBI restriction sites. For preparation of sense RNA, the construct 
was linearized with NotI and transcribed with SP6 polymerase. 
 
Prdm13-VcpCS2+: 
Prdm13-VcpCS2+ contains the open reading frame of Prdm13 fused at its N-
terminus with the C-terminus of Venus YFP (aa 155-238). Prdm13-VcpCS2+, 
was generated by PCR amplification of the Prdm13 open reading frame using 
cDNA as a template and the following primers: for, 5´-
ATGCATTGCAACAGGGCTC-3´ and rev, 5´-TTAGGGTTCCTTGCTG 
CTTCC-3´. The insert was subcloned into pGemTeasy vector, which was then 
used as a template for PCR amplification of the Prdm13 open reading frame 
using the following primers: for, 5´-GTACCGGTGGTGGTGGTGGTGGTC 
ATTGCAACAGGGCTCTG-3´ and rev, 5´-GGGTACGTATTAGGGTTCC 
TTGCTGCTTC-3´. The PCR product was inserted into VcpCS2+ (Saka et al., 
2007) using the AgeI and SnaBI restriction sites. For preparation of sense RNA, 
the construct was linearized with NotI and transcribed with SP6 polymerase. 
 
2.1.7 Antisense RNA constructs 
 
Construct Vector 
Restriction 
enzyme 
Polymerase Reference 
tubb2b  pBst KS BamHI T3 
(Chitnis and 
Kintner, 1995) 
gad1a  
pCMV-
Sport6ccdB 
NotI SP6 (Dullin et al., 2007) 
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tlx3  BStEII Stu1 T3 
(Patterson and 
Krieg, 1999)  
Table 2.5 List of RT-primers and their PCR parameters 
 
2.2 Methods 
 
2.2.1 In vitro synthesis of capped sense RNA 
 
Capped sense RNA was synthesized using the Ambion SP6 mMessage 
mMachine Kit according to manufacturer’s instructions. For a 20 µl total 
reaction volume, 1 µg of linearized plasmid DNA was used. The transcription 
reaction was incubated for 2 h at 37 °C, followed by a 30 min DNA digest using 
1 U Turbo DNase I. The synthesized sense RNA was purified using the Illustra 
RNAspin Mini kit (GE Healthcare) according to the manufacturer’s instructions 
and was eluted in 30 µl RNase free water at 80 °C. The RNA quality was 
checked on a 1% agarose gel and the RNA concentration was determined by 
loading 1 µl of purified RNA on a NanoDrop 2000c spectrophotometer (Thermo 
Scientific). The RNA was stored in 2-4 µl aliquots at -80 °C. 
 
2.2.2 Xenopus methods 
 
Unless stated otherwise, standard X. laevis methods were done according to 
Sive et al. (2000) 
5x MBS 440 mM NaCl, 5 mM KCl, 4.1 mM MgSO4, 12 mM NaHCO3,  
2.05 mM CaCl2, 1.65 mM Ca(NO3)2, 50 mM HEPES, pH 7.8 
Cysteine: 2% Cysteine-HCl in 0.1x MBS, pH 8 
Injection buffer: 2% Ficoll in 1x MBS 
1000x Dexamethasone: 4 mg/ml dexamethasone in 100% EtOH 
 
2.2.2.1 Priming of X. laevis frogs 
 
Female frogs were stimulated by injecting 800 U human chorionic 
gonadotropin (Ovogest, MSD animal health) into the dorsal lymph sac the 
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evening before egg-laying. Primed frogs were kept overnight at 16 °C. Egg 
laying started approximately 16 h after hCG priming.  
 
2.2.2.2 Preparation of the testis 
 
Male frogs were anesthetized by putting them for 30 min in narcotic (1g/l 
tricaine methanesulfonate, 0.1% Na2HPO4, pH 7) (Guénette et al., 2013). The 
testis was isolated and stored at 4 °C in 1x MBS. Prior to usage, a testis lysate 
was made by macerating a small piece of testis in a small petri dish containing 
1.5 ml 1x MBS using a scalpel. 
 
2.2.2.3 In vitro fertilization 
 
By applying gentle pressure on the back of female frogs, eggs were collected 
in a petri-dish and fertilized by the addition of testis lysate 1:10 diluted with 
H2O. Typically, between 100 µl and 150 µl of testis lysate were used. After 15-
30 min, the eggs were covered with 0.1x MBS and stored at 12.5 °C. 
 
2.2.2.4 Microinjection 
 
Prior to the injection, the embryos were dejellied in a 2% cysteine solution and 
transferred to injection buffer. Injection needles were made by pulling small 
glass capillaries (GB100F-8P, Science Products GmbH) in a needle-puller 
(PN-30, Science Products GmbH). Needles were back-loaded with the desired 
injection mix and then attached to an microinjector PV 820 (H. Sauer). Using 
a micrometer scale, the injection drop was adjusted to a final volume of 4 nl. 
The injection buffer was exchanged 1-2 h after injection with 0.1x MBS and the 
injected embryos were cultivated at 12.5-18°C until the desired stage. 
 
2.2.2.5 Preparation of ectodermal explants (animal caps) 
 
Blastula staged embryos were transferred to a petri-dish coated with 1% 
agarose containing 0.8x MBS. The vitelline membrane was removed and 
explants of the animal cap were made using a gastromaster (Xenotech 
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Engineering) with a 500 µm yellow tip and “high” intensity. Animal caps were 
transferred to a fresh agarose-dish containing 0.8x MBS and cultured at 12-18 
°C until they reach the desired stage. To fix the caps, the embryos were placed 
in an Eppendorf tube and the buffer was removed. The embryos were frozen 
in liquid N2 and stored at -80 °C. 
 
2.2.2.6 Dexamethasone treatment 
 
At the desired time (stage 10.5 for embryos or after excision of animal caps) 
dexamethasone in a final concentration of 4 µg/ml (from a 1000x stock solution) 
was added to the culture medium. The embryos or animal caps were cultured 
in the dark at 14-18 °C until they reached the desired stage (as determined 
from sibling control embryos). For collecting stage 14 animal caps or collecting 
early time points (3, 6 or 9 h incubation time), caps were cultivated at 14 °C.  
For later time points (12, 15 or 25 h), caps were cultivated at 18 °C. Animal 
caps were fixed by freezing in liquid N2 and were stored them at -80 °C. 
 
2.2.2.7 Bimolecular Fluorescent Complementation assay (BiFC) 
 
BiFC (Saka et al., 2007) was used to visualize protein-protein interaction in 
vivo. Therefore, 500 pg of each sense RNA encoding for the Vc- or Vn-fusion 
proteins was injected in both animal blastomeres at two cell stage X. laevis 
embryos. To label injected cells, 100 pg mRFP sense RNA was co-injected. At 
blastula stage (stage 8), the cells were dissociated by transferring the embryos 
to accutase (Sigma Aldrich) and culturing them for 5-6 h. Fluorescence 
microscopy was done by using an Axioplan2 fluorescent microscope (Zeiss) 
and pictures were taken using an Intas camera. 
 
2.2.2.8 In vitro synthesis of antisense RNA 
 
To prepare antisense RNA for whole mount in situ hybridizations (WMISH), a 
25 µl reaction containing 1 ng linearized plasmid, 1x Transcription buffer 
(Fermentas), 1 mM 1mM rATP (Boehringer), 1 mM rGTP (Boehringer), 1mM 
rCTP (Boehringer), 0.64 mM rUTPs (Boehringer), 0.34 mM Digoxigenin-rUTP 
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(Boehringer), 0.03 µM DTT, 40 U Ribolock RNase inhibitor (Fermentas), 30 U 
T3 or SP6 RNA-Polymerase in RNase-free water was used. The in vitro 
transcription was incubated at 37 °C for two hours. Afterwards, the template 
was digested by a 30 min incubation with 1 U TurboDNase I (Ambion) at 37 
°C. Purification of the antisense RNA was done using the RNeasy Mini kit 
(Qiagen) according to manufacturer’s instructions. The RNA was eluted two 
times with 50 µl RNase-free water at 80 °C. The RNA quality was checked on 
a 1% agarose gel. Afterwards, the antisense RNA was diluted in 1 ml of 
hybridization buffer (see in situ hybridization) and stored at -20 °C. 
 
2.2.2.9 Whole mount in-situ hybridization (WMISH) 
 
10x MEM: 1 M Mops, 20 mM EGTA, 10 mM MgSO4, pH 7.4 (stored in the dark) 
10x PBS: 1.75 M NaCl, 1 M KCl, 65 mM Na2HPO4, 18 mM KH2PO4, 
pH 7.4 
K3FE(CN)6: 0.5 M in H2O (stored in the dark) 
K4FE(CN)6: 0.5 M in H2O (stored in the dark) 
MEMFA: 4% (v/v) formaldehyde (37%) in 1x MEM 
X-Gal: 40 mg/ml 5-Bromo-4-chloro-3-indolyl-b-D-galactopyranoside in 
formamide (stored -20 °C in the dark) 
X-Gal staining solution: 1 mg/ml X-Gal, 5 mM K3FE(CN)6, 5 mM 
K4Fe(CN)6, 2 mM MgCl2 in 1x PBS 
PTw: 0.1% Tween-20 in 1x PBS 
Proteinase K: 5 μg/ml proteinase K (Merck) in 0.1x PBS 
Triethanolamine: 0.93 g triethanolamine in 50 ml H
2
O (0.1 M), pH 7.5 
PTw/FA: 4% (v/v) formaldehyde in PTw 
Hybridization Mix: 50% formamide, 1 mg/ml Torula RNA, 10 μg/ml Heparin, 
1x Denhardt's, 0.1% Tween-20, 0.1% CHAPS, 10 mM EDTA in 5x SSC 
20X SSC: 3 M NaCl, 0.3 M NaCitrate, pH 7.2-7.4 
100x Denhardts solution: 2% BSA 2% Polyvinylpyrollidone (PVP), 2% Ficoll 
RNAse Solution: 10 μg/ml RNAse A, 0.01 U/ml RNAse T1 in 2X SSC 
MAB: 100 mM maleic acid, 150 mM NaCl, pH 7.5 
MAB/BMB: 2% BMB in 1x MAB 
MAB/BMB/HS: 2% BMB, 20% heat-treated horse serum in 1x MAB 
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APB: 100 mM Tris-HCl, pH 9.0, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-
20, pH 9.0 
NBT: 100 mg/ml in 70% dimethylformamide, stored in the dark 
BCIP: 50 mg/ml in 100% dimethylformamide, stored in the dark  
Staining solution: 80 μg/ml NBT, 175 μg/ml BCIP in APB 
Bleaching solution: 5% formamide, 1.5% H
2
O
2 
in 0.5x SSC 
 
WMISH was used to identify the endogenous temporal and special expression 
of RNA transcripts. WMISH was performed (Harland, 1991; Hollemann et al., 
1996) with minor modifications. For detection, digoxigenin-labeled antisense 
RNA was used, and visualized using an α-dig antibody coupled to alkaline 
phosphatase. All steps, if not otherwise indicated, were performed at room 
temperature with mild shaking. 
 
2.2.2.9.1 Fixation and X-Gal staining 
 
For the identification of the injected side of the embryos and to analyze the 
distribution of the injected material, embryos were co-injected with 75 pg β-gal 
mRNA. Embryos were fixed in MEMFA in small glass vials for 20 min, followed 
by washing three times with 1x PBS for 10 min. To visualize the β-gal 
distribution, X-Gal staining was performed (Hardcastle et al., 2000). Embryos 
were incubated in X-Gal staining solution in the dark until the desired staining 
intensity (approx. between 20-30 min). Afterwards, the staining solution was 
removed and the embryos were washed three times with 1x PBS for 10 min 
each washing. Embryos were fixed in MEMFA for 25 min and then washed 
three times with 100% ethanol for 5 min. Embryos were stored at -20 °C in 
100% ethanol. 
 
2.2.2.9.2 Rehydration 
 
The embryos were rehydrated by several washing steps in which ethanol was 
stepwise replaced by 1x PBS (75%, 50%, 25% ethanol). Following 
Rehydration, the embryos were washed four times with PTw for 5 min each 
washing. 
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2.2.2.9.3 Proteinase K treatment 
 
To make the cells of the embryo accessible for the antisense RNA, the 
embryos were permeabilized by proteinase K treatment. The duration of the 
treatment was dependent on the developmental stage of the embryo. Stage 
28 embryos were treated for 17 min in 2 ml proteinase K solution. The 
treatment was stopped by immediately proceeding with the acetylation. 
 
2.2.2.9.4 Acetylation 
 
Embryos were washes two times for 5 min with triethanolamine. To prevent 
nonspecific antisense RNA interaction, the embryos were acetylated by 
incubation with 25 µl acetic anhydride in 4 ml triethanolamine. The embryos 
were then washed two times for 5 min in PTw and refixed with PTw/FA for 20 
min. The fixation solution was removed by washing the embryos five times for 
5 minutes with PTw. 
 
2.2.2.9.5 Hybridization reaction 
 
Embryos were pre-hybridized in Hybridization mix for 5 h at 65 °C. Afterwards, 
the embryos were incubated with Hybridization mix containing the antisense 
RNA overnight at 65 °C.  
 
2.2.2.9.6 Washings 
 
On the next morning, embryos were washed three times with 2x SSC for 15 
min at 60 °C. Non-hybridized antisense RNA was removed by RNase 
treatment for 60 min at 37 °C. The RNases were washed with 2x SSC for 10 
min at RT followed by two 30 min washes with 0.2x SSC at 60 °C. For 
preparation of the AB reaction, the embryos were washed two times with MAB 
for 15 min at RT. 
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2.2.2.9.7 Antibody reaction 
 
Before the antibody reaction, several blocking steps were performed by 
incubating the embryos for 20 min in MAB/BMB, followed by incubation for 40 
min of with MAB/BMB/HS. Alkaline phosphatase-coupled anti-Dig antibody 
(1:5000 in MAB/BMB/HS, Sigma-Aldrich) was used for detection. The AB 
reaction took place overnight at 4 °C. 
 
2.2.2.9.8 Staining reaction 
 
On the next day, the embryos were washed at least five times for 10 min in 
MAB, followed by two washes with freshly made APB for 5 min at 4 °C. 
Afterwards, the embryos were stained in staining solution in the dark at 4 °C. 
The staining reaction typically took between one and five days. 
 
2.2.2.9.9 Background removal and bleaching 
 
To stop the staining reaction and to reduce the background staining, the 
embryos were washed in 100% methanol until the wash solution is not stained 
anymore. The methanol was the stepwise removed by washing in 75%, 50% 
and 25% methanol. The embryos were fixed in MEMFA for 30 min. To bleach 
the embryos, they were washed two times in 0.5x SSC and incubated in 
bleaching solution until the pigmentation was gone (typically between 1 and 4 
h). The embryos were washes two times in 0.5x SSC and stored indefinitely in 
MEMFA. 
 
2.2.3 Agarose gel electrophoresis 
 
TAE (Tris-acetate-EDTA): 40 mM Tris-acetate, 2 mM EDTA, pH 8.5 
 
Analysis of PCR products or DNA fragments was performed by agarose gel 
electrophoresis (Sharp et al., 1973). Agarose gels were made by melting a 
final concentration of 1-2% (depending on the expected size of the fragments) 
agarose powder (Roth) in TAE buffer. TAE buffer was used as running buffer. 
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To determine the size of the DNA fragments, standard DNA ladders (Fast 
Ruler DNA ladder, Fermentas) were used. To visualize the DNA fragments, 30 
µg (0.5 µg/ml) ethidium bromide was added to the agarose gel. For 
documentation, a ChemiDoc (Bio-Rad) chamber using an Intas camera and 
software was used. 
 
2.2.4.1 PCR cloning 
 
For cloning, template DNA was amplified via PCR with the High Fidelity 
enzyme mix (Thermo Scientific) in a total reaction volume of 50 µl reaction 
containing 1x High Fidelity Buffer with 15 mM MgCl2, 0.2 mM of each dNTP 
(Thermo Scientific), 0.2 µM of each primer, 0.02 U High Fidelity PCR enzyme 
mix (Thermo Scientific) and 100 ng template DNA. PCR was done in a 
thermocycler using the following settings: 5 min at 95 °C, 45 s at 95 °C, 45 s 
at Tm of the primer -2 °C, 60 s/kb length 72 °C, 5 min 72 °C. Steps no 2-4 were 
repeated in a various number of cycles (~30-40 cycles) depending on the 
primer pairs used. 
 
2.2.4.2 Gel purification of PCR and restriction fragments 
 
PCR fragments from PCR or restriction reactions, were isolated on an agarose 
gel, the desired fragment was excised and the purified by using the “GFX PCR 
DNA and Gel Band Purification" kit (GE Healthcare) according to the 
manufacturer’s instruction. 
 
2.2.4.3 DNA restriction digestion 
 
Restriction digestion was performed using Fermentas Life Science restriction 
endonucleases according to manufacturer’s instructions. 
 
2.2.4.4 Ligation 
 
Standard ligation reactions were performed using a 20 µl reaction containing 
1x T4 DNA Ligase buffer (Fermentas Life Science)., 1U T4 DNA ligases, 100 
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ng linear vector DNA and insert DNA in a 1:1 to 5:1 ratio. The ligation reaction 
was incubated overnight at 16 °C. 
 
2.2.4.5 Chemical transformation of bacterial cells 
 
Plasmid DNA was added to 100-200 µl thawed chemical competent cells, and 
incubated on ice for 30 min. Heat-shock was performed by incubating the cells 
for 60 s at 42°C for retransformation or 90 s at 42 °C for ligation reactions, 
followed by immediately cooling on ice for 3 min. Afterwards, 800 µl of LB 
medium was added to the cells, followed by incubation under constant shaking 
(300 rpm) for 30 min at 37°C for retransformation or 45 min at 37 °C for cloning. 
The cells were then centrifuged for 30 s at 10,000 rpm and 800 µl of LB-
medium was removed. The cells were resuspended in the remaining medium 
and plated on a LB agar plate containing the selective antibiotic and incubated 
overnight at 37 °C. 
 
2.2.4.6 Plasmid DNA preparation 
 
Bacteria were cultured in 4 ml LB media together with the selective antibiotic 
overnight at 37 °C with shaking at 250 rpm. For mini plasmid preparation, 3 ml 
of the bacteria suspension was centrifuged for 2 min at 13,000 rpm. Plasmid 
DNA was isolated using the GeneJET Plasmid Miniprep kit (Fermentas) 
following manufacturer’s instructions. For isolating preparative amounts (1 
µg/µl) the NucleoBond Xtra Midi kit (Macherey-Nagel) was used according to 
the manufacturer’s instruction. To quantify the concentration, 1 µl of the DNA 
was applied on the NanoDrop 2000c spectrophotometer (Thermo Scientific). 
 
2.2.4.7 DNA sequencing 
 
DNA sequencing was performed by “SEQLAB Sequence Laboratories 
Göttingen GmbH”, according to the company’s instructions using 1.2 µg of 
DNA for sequencing.  
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2.2.5 ATAC sequencing 
 
Lysis buffer 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% Igepal 
CA-630, (can be stored at 4 °C for one week) 
 
To identify open chromatin regions on the DNA, ATAC-sequencing was used. 
ATAC sequencing was performed after (Buenrostro et al., 2013) with 
modifications. For each sample 40 animal caps previously frozen in liquid N2 
and stored at -80 °C were used. 
 
2.2.5.1 Transposition reaction 
 
Animal caps were carefully lysed in 100 µl fresh ATAC-lysis buffer using a 
pestle, followed by centrifugation for 5 min at 2000 rpm at 4 °C. The 
supernatant was removed and the nuclei pellet resuspended on ice in a 50 µl 
transposition solution containing 2x TD reaction buffer (Nextera DNA Library 
Prep kit, Illumina), 2.5 µl TDE1 (Nextera DNA Library Prep kit, Illumina) and 
incubated for 30 min at 37 °C. The transposition reaction was immediately 
stopped by purifying the DNA using the NucleoSpin Gel and PCR Clean-up kit 
(Macherey-Nagel) according to the manufacturer’s instructions. The DNA was 
eluted in 10 µl Elution buffer (10 µM Tris-HCl, pH 8). 
 
2.2.5.2 Library preparation 
 
Transposed DNA (10 µl) was added to a total 50 µl reaction mix containing 
1.25 µM PCR primer1 (Illumina), 1.25 µM barcoded PCR primer2 (Illumina) 
and NEBNext High-Fidelity PCR Master mix. The samples were first amplified 
in the thermocycler using the following program: 5 min at 72 °C, 30 s at 98 °C, 
followed by 5 cycles of 10 s at 98 °C, 30 s at 63 °C and 1 min at 72 °C. 
Afterwards, the appropriate number of PCR cycles was determined using 
qPCR by combining 5 µl of the previously amplified DNA with a 10 µl reaction 
containing, 1.25 µM PCR primer 1, 1.25 µM PCR primer 2, 1x SYBR Green I 
and 1x NEBNext High-Fidelity PCR Master Mix. The qPCR was performed 
using a CFX96TM Real-Time System (Bio-Rad) with the following program (30 
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s at 98 °C, followed by 20 cycles of 10 s at 98 °C, 30 s at 63 °C and 1 min at 
72 °C). Afterwards, the remaining 45 µl PCR reaction was further amplified by 
30 s at 98 °C, followed by a custom number of PCR cycles (10 s at 98 °C, 30 
s at 63 °C and 1 min at 72 °C), where the number of remaining PCR cycles is 
the number of cycles that corresponded to one-third of maximum fluorescent 
intensity in the qPCR. The quality of the library was checked using the 
Bioanalyzer 2000c (Agilent). 
 
Sample Number of PCR cycles 
CC 3 h replicate 1 10x 
Ptf1a 3 h replicate 1   7x 
CC 12 h replicate 1 16x 
Ptf1a 12 h replicate 1 12x  
CC 3h replicate 2 14x 
Ptf1a 3 h replicate 2 16x 
CC 12 h replicate 2 16x 
Ptf1a 12 h replicate 2 12x 
Table 2.6 List of PCR cycles for each ATAC sample 
 
2.2.5.3 Sequencing (by TAL) 
 
Sequencing was performed by the University Medical Center Göttingen (UMG) 
-Transcriptome and Genome Analysis Laboratory (TAL) with the HiSeq 2500 
in the 50 bp paired end mode, with a density of 150,000,000 reads. Two 
biological replicates were used for each reaction. Sequencing quality was 
analyzed using the FastQ software (http://www.bioinformatics. 
babraham.ac.uk/projects/fastqc/). 
 
2.2.5.4 Sequencing alignment and processing (performed by TAL) 
 
The sequence reads were aligned to the X. laevis genome (J-strain v 9.2) 
(Bowes et al., 2007). Mapping was performed using Bowtie2 (version 2.5) 
(Langmead and Salzberg, 2012). For processing and filtering of the data 
SAMtools (version 1.1) (Li et al., 2009) was used. Picard (version 1.126) was 
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then used to calculate the number and percentage of duplicates. The filtered 
BAM file was converted into a tagAlign file containing the genomic 
coordinates of each read using Bedtools (v2.20.1) (Quinlan and Hall, 2010). 
 Peaks were called using MACS2 (version 2.1.1.20160309) (Feng et al., 2012) 
using smoothing window 150 and p-value threshold of 0.01 for calling peaks. 
Peaks were merged a differential peak analysis was done using the DESeq2 
package (version 1.16.1) (Love et al., 2014) within the R/Bioconductor 
environment (www.bioconductor.org). Peaks determined as significantly 
enriched were those with adjusted p-value < 0.1. 
 
2.2.6 Gene expression analysis by semiquantitative RT-PCR or 
quantitative Nanostring analysis 
 
2.2.6.1 Total RNA isolation from ectodermal explants and whole 
embryos 
 
X. laevis embryos (5) or ectodermal explants (50) were fixed in liquid nitrogen 
and stored at 80 °C. The animal caps or embryos were then lysed in 400 µl 
preqGOLD TriFast reagent (Preqlab) using a 29-gauge syringe and incubated 
at room temperature for 10 min. During that time, they were vortexed for 30 s. 
Afterwards, 80 µl of chloroform (Roth) was added followed by vortexing for 30 
s and 10 min centrifugation at 13,000 rpm at 4 °C. The upper phase (200 µl) 
was transferred into a new eppendorf tube and then mixed with 1 volume (200 
µl) chloroform by vortexing for 30 s. After centrifugation for 5 min at 13,000 
rpm and 4 °C, the upper phase (200 µl) was transferred into a new eppendorf 
tube and 1 volume of 2-propanol was added. After mixing, precipitation took 
place at -20 °C for at least 2 h. Afterwards, the precipitated RNA was 
centrifuged for 30 min at 4 °C. The supernatant was removed and the pellet 
was washed with 400 µl 75% ethanol. The air-dried pellet was dissolved in 
12.5 µl RNase-free water and DNase digest using 0,75 U DNase I (Thermo 
Scientific) was performed for 1.5 h at 37 °C. DNase activity was stopped by 
incubation at 70 °C for 10 min. The RNA concentration was determined on the 
NanoDrop 2000c spectrophotometer (Thermo Scientific). To check for 
genomic DNA contamination, a control PCR with 100 ng RNA using primer for 
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the housekeeping gene ornithine decarboxylase (odc) was performed and 
analyzed on a 2% agarose gel. 
 
2.2.6.2.1 Reverse transcription 
 
To synthesize 10 µl cDNA, 100 ng of total RNA was used in a reaction mix 
containing 1x Go Taq flexi buffer (Promega), 5 mM MgCl
2 
(Fermentas), 2.5 
mM random hexamer (Invitrogen), 1 mM dNTP mix (Thermo Scientific), 0,16 
U Ribolock RNase inhibitor (Thermo Scientific), and 0,8 U MulV reverse 
transcriptase (Roche). The reaction took place in a thermocycler (Biometra) 
using the following program: 20 min at 20 °C, 1 h at 42 °C, 5 min at 95 °C. 
 
2.2.6.2.2 Reverse transcription-PCR (RT-PCR) 
 
Semiquantitative RT-PCR was performed using a total volume of 12.5 µl 
containing 1x GoTaq green reaction buffer (Promega), 0.2 µM of both forward 
and reverse primer and 0.5 units GoTaq DNA polymerase (Promega). For 
each reaction 2.5 µl cDNA was used as a template for PCR. Amplification took 
place in a thermocycler (Biometra) using the following program: 2 min at 95 °C, 
45 s at 95 °C, 45 s at Tm of the primer -2 °C, 45 s at 72 °C, 5 min at 72 °C. 
Steps no 2-4 were repeated in a various number of cycles (~25-35 cycles), 
which is dependent on the specific primer pairs, before proceeding with step 
5. RT-PCR reactions were analyzed on a 2% agarose gel as described above. 
 
2.2.6.3 Quantitative Nanostring analysis 
 
Quantitative analysis was performed using 700 ng of total RNA on the 
Nanostring digital multiplexed expression analysis system. The analyzed 
genes as well as the target region are shown in the appendix. Data analysis 
was performed by using the nSolver software (version 2.5). For normalization, 
the counts were first normalized to the mean of the positive control counts. 
Afterwards, the counts were normalized for the geometric mean of the 
housekeeping genes odc, rplp0 and ppi1l. If several developmental stages 
were analyzed at the same time, normalization was performed to the geometric 
Materials and Methods   48 
 
mean of the housekeeping gene ppi1l only. Background subtraction was 
performed by subtracting the mean value and two times the standard deviation 
of the eight negative control counts for each lane. Negative values were set to 
1. Data from three independent experiments (A, B and C) were analyzed. 
 
2.2.7 RNA sequencing 
 
2.2.7.1 RNA isolation 
 
RNA isolation for RNA sequencing was performed similar to isolating RNA for 
RT-PCR with the following adjustments to the protocol: 
 
RNA from 50 animal caps was extracted as described above until the first step 
of precipitation with isopropanol. Afterwards, the precipitated RNA was 
centrifuged for 30 min at 4 °C. The supernatant was removed and the pellet 
was washed with 400 µl 75% ethanol. The air-dried pellet was dissolved in 47 
µl RNase-free water. DNA digest was performed by incubating the isolated 
RNA for 1 h at 37 °C in a 50 µl total reaction volume containing 1x DNase I 
reaction buffer (Thermo Scientific), 1 U DNase I (Thermo Scientific) and 0.4 U 
RNase inhibitor (Thermo Scientific). DNA digest was stopped by the addition 
of 150 µl RNase-free water. Phenol-chloroform-isoamylalcohol (Roth) (200 µl) 
was added and the samples were vortexed for 30 s, followed by 10 min 
centrifugation at 13,000 rpm at 4 °C. To the upper phase (200 µl), 1 volume 
(200 µl) of chloroform-isoamylalcohol (ratio 24:1) was added. After vortexing 
for 30 s, the samples were centrifuged for 5 min at 13,000 rpm and 4 °C. 1/10 
volume (20 µl) ammonium acetate and 1 volume (200 µl) 2-propanol were 
added and incubated for at least 2 h at -20 °C. The precipitate was centrifuged 
for 30 min at 13,000 rpm at 4 °C and then washed by 400 µl of 75% ethanol. 
The RNA pellet was then dissolved in 20 µl RNase-free water. To check for 
genomic DNA contamination, a control PCR with 100 ng RNA using 
oligonucleotides for housekeeping gene ornithine decarboxylase (odc) was 
performed and analyzed on a 2% agarose gel. RNA quality was checked by 
use of the 2100 Bioanalyzer (Aglient). 
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2.2.7.2 Sample preparation and sequencing 
 
Library preparation and sequencing was performed by the University Medical 
Center Göttingen (UMG) - Transcriptome and Genome Analysis Laboratory 
(TAL). Libraries were prepared with the TruSeq RNA Sample Prep Kit v2 
(Illumina) following the manufacturer’s instructions. Sequencing was 
performed with the HiSeq 2500 in the 50 bp single end mode. Two or three 
biological replicates were used for each reaction. Sequencing quality was 
analyzed using the FastQ software (http://www.bioinformatics.babraham. 
ac.uk/projects/fastqc/). 
 
2.2.7.3 Sequencing alignment (performed by TAL) 
 
The sequence reads were aligned to the X. laevis genome (J-strain v 9.2) 
(Bowes et al., 2007). Mapping was performed using the software the STAR 
alignment software (ver. 2.5) (Dobin et al., 2013).  
 
2.2.7.4 Statistical analysis (performed by TAL) 
 
 Normalization of the library samples and the differential gene analysis was 
performed using the DESeq2 package (version 1.16.1) (Love et al., 2014) 
within the R/Bioconductor environment (www.bioconductor.org). Candidate 
genes had a two-fold change induction compared to control samples and a 
FDR-corrected p-value of <0.05. 
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3. Results 
 
3.1 Mutation of a single threonine residue in the Ptf1a C2 domain is 
sufficient to induce a mixed induced neuronal transmitter phenotype 
 
Similar to many bHLH proteins, Ptf1a contains multiple S/T-P residues, which 
are putative targets of cdk-dependent phosphorylation (Ubersax and Ferrell, 
2006; Richts, 2013).  Preventing of phosphorylation at those sites through 
mutation in Neurog2 leads to an increase in activation of the pan-neuronal 
marker tubb2b (Ali et al., 2011).  To evaluate the role of such phosphorylation 
sites in Ptf1a activity, a mutant of the mouse Ptf1a in which all eight serine and 
threonine residues were mutated to alanine (mPtf1a8S/TA) was evaluated in 
gain of function studies using pluripotent X. laevis embryonic cells (animal cap 
explants) in comparison to the wild-type Ptf1a.  In contrast to Neurog2, no 
increase in neuronal-inducing activity of by the Ptf1a8S/TA mutant was 
observed. However, in addition to its ability to induce markers for a GABAergic 
cell fate, the Ptf1a8S/TA mutant also induced the glutamatergic marker gene 
tlx3, a gene that is normally repressed by Ptf1a (Richts, 2013). Mutating the 
alanine residue at position 299 back to threonine (mPtf1a7SA) abolished the 
tlx3 induction (Richts, 2013), suggesting that the mutation of the T299 was 
responsible for this mixed neuronal transmitter phenotype activity  (Richts, 
2013). 
To investigate if the mixed neuronal subtypes activity of the Ptf1a threonine 
mutant is conserved and is indeed sufficient to induce a mixed neuronal 
phenotype, the X. laevis variant (Ptf1aT243A) of the mouse Ptf1aT299A was 
created (Fig. 3.1A and B). The activity of this construct was compared with the 
wild-type Ptf1a, which promotes GABAergic markers and represses 
glutamatergic markers, as well as with the Rbpj-binding deficient mutant 
(Ptf1aW224A/W242A), which promotes a glutamatergic fate (Fig. 3.1A and B) 
(Hedderich, 2008; Hori et al., 2008; Hedderich, 2012; Hanotel et al., 2014) as 
the mutated threonine residue in the Ptf1aT243A mutant is directly adjacent to 
the Rbpj binding tryptophan residue within the Ptf1a C2 domain (Fig. 3.1B) 
The wild-type and mutated versions of Ptf1a were fused to the ligand binding 
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domain of the glucocorticoid receptor (GR) (Gammill and Sive, 1997) to allow 
control over protein activity. In one blastomere at the two-cell, 20 pg mRNA 
encoding the Ptf1a-fusion proteins was injected together with 75 pg of β-
galactosidase mRNA to allow identification of the injected side of the embryo. 
The protein activity was induced via dexamethasone treatment at gastrula 
stage (stage 10.5) and at tailbud stage (stage 28), embryos were collected and 
whole mount in-situ hybridization against the pan-neuronal marker tubb2b, the 
GABAergic marker gad1a, and the glutamatergic marker tlx3 performed. 
 
Figure 3.1: Overview X. laevis Ptf1a mutants 
(A) Schematic overview over the Ptf1a constructs used for overexpression studies. 
Grey asterisks highlight the position of a mutated T-P site in the Ptf1a C2 domain. 
Red crosses indicate a mutation in a conserved Rbpj binding site. (B) Alignment of 
the highly conserved Ptf1a C1 and C2 domains of all Ptf1a constructs. The C1 and 
C2 domain are highlighted in blue, mutated residues are highlighted in red. 
 
As shown in Figure 3.2B and consistent with previous reports, overexpression 
of wild-type Ptf1a promotes ectopic expression of tubb2b and gad1a, while tlx3 
expression was suppressed. Ptf1aW224A/W242A also induces ectopic expression 
of tubb2b, but these ectopic neurons express tlx3 (Hedderich, 2008; Hedderich, 
2012). 
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Figure 3.2: Ptf1aT243A mutant induces a mixed neuronal transmitter phenotype 
in embryos 
(A) Experimental procedure: 20 pg of ptf1a-GR, ptf1aW224A/W242A-GR or ptf1aT243A-GR 
mRNA were injected in one animal blastomere at two-cell stage. For recognition of 
the injected side β-galactosidase RNA was co-injected. Protein activity was induced 
by addition of dexamethasone at stage 10.5. Embryos were collected for WMISH at 
stage 28. (B) Overview of WMISH for neuronal differentiation (tubb2b), GABAergic 
(gad1a) or glutamatergic (tlx3) cell fate of embryos overexpressing Ptf1a-GR, 
Ptf1aW224A/W242A-GR or Ptf1aT243A-GR. Shown is the injected side of the embryo. For 
comparison non-injected embryos were shown at the top. Percentages refer to the 
total number of embryos showing the shown phenotype in relation to the total numbers 
of embryos showing β-gal expression (n). Black arrows refer to the induced phenotype 
(upregulation, downregulation or not affected). White arrowhead highlights the area 
of downregulation of endogenous tlx3 expression by the Ptf1aT243A mutant.  
 
In contrast, overexpression of Ptf1aT243A leads to an activation of all three 
markers, supporting our previous observations with the mouse Ptf1aT299A 
mutant. Interestingly, overexpression of Ptf1aT243A still results in a repression 
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of the endogenous tlx3 expression on the injected side of the embryo. However, 
ectopic tlx3 expression is now observed (Fig3.2B).  
 
 
Figure 3.3 Ptf1aT243A mutant induces a mixed neuronal transmitter phenotype in 
ectopic explants 
(A) Experimental procedure: 20 pg of ptf1a-GR, ptf1aW42A-GR, ptf1aW224A/W242A-GR or 
ptf1aT243A-GR mRNA were injected in animally in both blastomeres of two-cell stage 
embryos. At blastula stage, animal caps were excised and protein activity induced by 
dexamethasone treatment for 25 h. (B) RT-PCR analysis against markers for 
neuronal differentiation (tubb2b), GABAergic (gad1a) or glutamatergic (tlx3) cell fate, 
as well as two target genes for the trimeric Ptf1a complex (prdm13, neurog2). The 
housekeeping gene odc was used as a loading control. As additional controls, cDNA 
from total RNA isolations of noninjected control caps (CC) and non-injected control 
embryos (of the same developmental stage) were analyzed. 
 
As the mutated threonine residue in the Ptf1aT243A mutant is located adjacent 
to a known Rbpj binding site (Beres et al., 2006) in the Ptf1a C2 domain (Fig. 
3.1B), a comparison of the overexpression phenotype between the Ptf1aT243A 
and the Ptf1aW242A mutants was performed by injection 20 pg of ptf1a-GR, 
ptf1aW242A-GR ptf1aW224A/W242A-GR or ptf1aT243A-GR mRNA in the animal 
hemisphere of both blastomeres at two-cell stage. At blastula stage, the animal 
caps were excised and cultured for 25 h in the presence of dexamethasone to 
induce protein activity. Afterwards, RNA was isolated and semi-quantitative 
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RT-PCR was performed against tubb2b, tlx3 and gad1a expression (Fig. 3.3A). 
As expected, overexpression of all four constructs promotes neuronal 
differentiation as shown by the increase in tubb2b expression (Fig. 3.3B). 
While the wild-type Ptf1a leads to an induction of gad1a, but not tlx3, the 
Ptf1aW224A/W242A and Ptf1aW242A mutants strongly induce tlx3 but not gad1a. In 
contrast, overexpression of Ptf1aT243A induces both gad1a and tlx3 (Fig. 3.3B), 
indicating that the phenotype is specific for the mutation in the T243 residue. 
To better understand the differential gene induction by the wild-type Ptf1a and 
Ptf1a mutants, either ptf1a-GR, ptf1aW224A/W242A-GR, or ptf1aT243A-GR mRNA 
(20 pg) were injected in the animal hemispheres of both blastomeres of two-
cell stage X. laevis embryos. At blastula stage, the animal caps were excised 
and cultured in the presence of dexamethasone for 25 h to induce the protein 
activity. Afterwards, RNA was isolated and quantitative Nanostring analysis 
was performed using a codeset containing known Ptf1a dimeric and trimeric 
target genes, as well as markers of neuronal differentiation and subtype 
specification (Fig. 3.4A). 
All three Ptf1a constructs were able to upregulate markers for pan-neuronal 
differentiation such as tubb2b, myt1, ebf2 or dll1. (Fig. 3.4C-E; Table S1). 
Consistent with previous observations, the wild-type Ptf1a but not Rbpj-binding 
deficient mutant (Ptf1aW224A/W242A), upregulated genes associated with the 
development of a GABAergic cell fate such as gad1a and prdm13, while 
Ptf1aW224A/W242A strongly upregulated tlx3 expression, which was not activated 
by the wild-type Ptf1a (Fig. 3.4F-H). As previously demonstrated, the Ptf1aT243A 
mutant upregulated markers associated with a GABAergic cell fate such as 
gad1a, prdm13, slc32a1 and pax2 as well as tlx3 expression (Fig. 3.4F-H; 
TableS1). Comparing the expression levels induced by the different Ptf1a 
constructs showed that the strength of induction by the Ptf1aT243A mutant of 
GABAergic marker genes such as prdm13 and gad1a was lower than for the 
wild-type Ptf1a (Fig. 3.4G, H). Moreover, the induction of tlx3 expression was 
weaker than that induced by Ptf1aW224A/W242A (Fig. 3.4F), highlighting the mixed 
identity of the Ptf1aT243A mutant. Interestingly, the levels of activation of genes 
(e.g. tubb2b, ebf2, myt1, dll1) induced by Ptf1a and Ptf1aW224A/W242A differed 
(Fig. 3.4C-E, Table S1). Those markers showed a weaker induction by the  
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Figure 3.4: Activities of distinct Ptf1aT243 mutants  
(A) Experimental procedure: 20 pg of ptf1a-GR, ptf1aT243E-GR, ptf1aW224A/W242A-GR or 
ptf1aT243A-GR mRNA were injected in both animal blastomeres of two-cell stage. At 
blastula stage, animal caps were excised. Protein activity was induced by 
dexamethasone treatment for 25 h. (B) Shown is the average fold-change induction 
over non-injected control caps from three individual replicates. Data were normalized 
for the induction of tubb2b. The gene analyzed can be found on the x-axis (C-H) 
Results of the quantitative Nanostring analysis. Shown are the average expression 
levels of marker genes from three biological replicates. Error bars refer to the standard 
error of the mean. Data were normalized for the three housekeeping genes odc, ppi1l 
and rplp0. .S and .L refer to the corresponding X. laevis homeolog targeted by the 
Nanostring probe. Note the different scales in each diagram. 
  
Ptf1aW224A/W242A and the Ptf1aT243A mutants, compared to the wild-type Ptf1a. 
These differences between versions of Ptf1a constructs were detected 
consistently in all three replicates (Table S2). To exclude that the differences 
in the induction of subtype specific marker genes gad1a and tlx3 had their 
cause in a different efficiency of neuronal differentiation, the Nanostring data 
were normalized for tubb2b and the fold-change induction by wild-type and 
mutant Ptf1a compared to non-injected control caps. Considering the tubb2b 
levels, the differences in the induction of gad1a between Ptf1a and Ptf1aT243A 
was lower, but still significant. Moreover, normalization to tubb2b did not alter 
the observed gene induction by the different Ptf1a constructs, as gad1a was 
still induced by Ptf1a and Ptf1aT243A but not by Ptf1aW224A/W242A, while tlx3 
expression was only induced by Ptf1aW224A/W242A and Ptf1aT243A (Fig. 3.4B).   
 
3.2 Introducing a negative charge at the Ptf1aT243 residue induces a 
more wildtype Ptf1a like phenotype  
 
 As the mutated threonine residue in the Ptf1aT243A is a putative target of cell 
cycle dependent phosphorylation, a phosphomimic mutant was created in 
which threonine 243 was exchanged for glutamate (Ptf1aT243E-GR) and 
analyzed in analogous gain of function assays (Fig. 3.1). 
Similar to the wild-type Ptf1a and the Ptf1a mutants, the Ptf1aT243E mutant 
induced pan-neuronal differentiation markers (myt1, zc3h12c, tubb2b, ebf2, 
dll1), but the strength of induction was similar to the wild-type Ptf1a with the 
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other mutants inducing a much lower induction (Fig. 3.4, Table S1). In addition, 
the strength of the GABAergic markers genes (gad1a and prdm13) 
upregulation was much stronger for the phosphomimetic Ptf1aT243E, compared 
to the phosphorylation-null mutant (Ptf1aT243A), further indicating this mutant 
behaved more like the wild-type Ptf1a (Fig. 3.4G, H). However, both Ptf1aT243E 
and Ptf1aT243A induced similar levels of the glutamatergic selector gene tlx3 
(Fig. 3.4F). To identify if the more wild-type like activity of Ptf1aT243E is only the 
result of its stronger neuronal differentiation promoting activity compared to 
Ptf1aT243A, gad1a and tlx3 activation by those two constructs was investigated 
after normalization to tubb2b expression. Although the expression levels of 
gad1a were very similar after tubb2b normalization, expression of other 
markers for a GABAergic lineage such as prdm13 (Fig3.4B; Table S1) were 
stronger activated by Ptf1aT243E than by Ptf1aT243A, while the glutamatergic 
markers tlx3 and slc17a7 induction was stronger by Ptf1aT243A (Fig. 3.4B; Table 
S1). Altogether these results indicate that although Ptf1aT243E-GR is still 
inducing a mixed neuronal transmitter phenotype, this mutant behaved more 
like the wild-type Ptf1a.      
 
3.3 The mixed neuronal transmitter phenotype induced by Ptf1aT243A is 
not the result of an impaired interaction with Rbpj 
 
As the interaction with Rbpj is essential for promoting a GABAergic cell fate 
and suppression of a glutamatergic cell fate, the mixed neuronal transmitter 
phenotype by Ptf1aT243A might be the result of an impairment of Rbpj 
interaction (Hori et al., 2008; Hanotel et al., 2014). Therefore, to study the 
binding of Rbpj and Ptf1a in vivo, a biomolecular fluorescence 
complementation assay (BiFC) was performed (Fig. 3.5A). Towards this end, 
constructs were created in which Ptf1a, Ptf1aW224A/242A or Ptf1aT243A were fused 
to the N-terminus of Venus EYFP (Ptf1a-Vn, Ptf1aW224A/W242A-Vn, Ptf1aT243A-
Vn) as well as a construct in which the C-terminal fragment of Venus EYFP 
was fused to Rbpj. As a positive control, the C-terminal fragment of Venus 
EYFP was fused to the ubiquitously expressed class A bHLH protein E12. For 
BiFC, 500 pg of ptf1a-Vn, ptf1aW224A/W242A-Vn or ptf1aT243A-Vn mRNA was co-
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injected together with 500 pg rbpj-Vc or e12-Vc mRNA animally in both 
blastomeres of two-cell stage X. laevis embryos. To identify injected cells, 100 
pg mRFP mRNA was also co-injected. At blastula stage, the embryos were 
dissociated to single cells and imaged (Fig. 3.5B).  
All three Ptf1a-Vn constructs, when co-injected with E12-Vc, showed a strong 
nuclear BIFC signal, demonstrating their universal ability to form heterodimers 
with E12 (Fig. 3.5C and D). A nuclear BiFC signal could be detected in 49% of 
RFP positive cells expressing Rbpj-Vc together with Ptf1a-Vn but not with 
Ptf1aW224A/W242A-Vn (Fig. 3.5 C, D). This recapitulates previous results 
indicating the importance of these two tryptophan residues in the C-terminus 
of Ptf1a for the interaction with Rbpj and demonstrates the functionality of the 
BiFC assay (Beres et al., 2006; Hori et al., 2008). In contrast to 
Ptf1aW224A/W242A-Vn, a strong nuclear BiFC signal was observed between Rbpj-
Vc and Ptf1aT243A-Vn (Fig. 3.5C and D), demonstrating that the mutation in the 
threonine does not significantly alter binding to Rbpj.  
Altogether, those data show that the induced mixed neuronal transmitter 
phenotype by Ptf1aT243A is not the result of an impaired interaction with Rbpj, 
suggesting that another mechanism is responsible for the induced neuronal 
transmitter phenotype. 
 
3.4 Ptf1aT243 mutants strongly bind to Prdm13 
 
 Ptf1a suppressed a glutamatergic cell fate through the direct activation of 
Prdm13, which in turn inhibits the expression of the glutamatergic selector 
gene tlx3 (Chang et al., 2013; Borromeo et al., 2014; Hanotel et al., 2014). 
Furthermore, it has been shown that Prdm13 directly binds to the tlx3 
regulatory regions and suppress tlx3 expression in mouse in a mechanism that 
involves direct binding to the DNA by Prdm13, as well as recruitment to the 
promoter of tlx3 by the bHLH transcription factor Ascl1 (Chang et al., 2013). 
Interestingly, overexpression of Ptf1aT243A in X. laevis ectodermal explants 
induces prdm13 expression as well as the expression of tlx3, which would 
somehow contradict the previous studies demonstrating that in the presence 
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of Prdm13, tlx3 expression is inhibited. In subpopulations of prdm13-
expressing cells, Prdm13 represses its own activator, Ptf1a, through directly  
 
Figure 3.5: Ptf1aT243A mutation does not affect its ability to bind Rbpj 
 (A) Overview bimolecular fluorescence complementation assay (BiFC). Proteins 
were fused to the N- or C-terminus of Venus-EYFP. Interaction of proteins of X and Y 
will lead to the formation of a complete EYFP, which can be detected by its 
fluorescence. (B) Experimental procedure: 500 pg of ptf1a-Vn, ptf1aT243E-Vn, 
ptf1aW224A/W242A-Vn or ptf1aT243A-Vn mRNA were co-injected with 500 pg of either rbpj-
Vc or e12-Vc mRNA and with 100 pg of mRFP mRNA in both animal blastomeres of 
two-cell stage. At blastula stage, cells were dissociated by the use of accutase and 
analyzed for fluorescence. (C) Results of the BiFC analysis. On the top, the injected 
construct carrying the c-terminal Venus EYFP is shown. The corresponding N-
terminal Venus EYFP construct is shown on the left. Red fluorescence indicated 
injected cells due to the expression of mRFP, green fluorescence is the corresponding 
YFP signal. (D) Quantification of the BiFC analysis. The given numbers and ratios all 
refer to the total amount of mRFP positive cells that have been analyzed. Error bars 
refer to the standard error of the mean. 
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binding Ptf1a and inhibiting its positive autoregulation (Bessodes et al., 2017; 
Mona et al., 2017). Interestingly, in the X. laevis retina, those cells where 
Prdm13 inhibits ptf1a will later gain a glycinergic instead of GABAergic cell fate 
(Bessodes et al., 2017). Considering the outcome of Ptf1aT243A overexpression 
in inducing prdm13 as well as GABAergic and glutamatergic marker genes, it 
might be that Prdm13 needs to interact with Ptf1a to actively suppress 
glutamatergic markers such as tlx3.  
To test this hypothesis, Prdm13 was fused to the C-terminal half of Venus 
EYFP and BiFC was performed by co-injecting prdm13-Vc and mRFP mRNA 
together with ptf1a-Vn, ptf1aW224A/W242A-Vn, ptf1aT243A-Vn or ptf1aT243E-Vn 
mRNA in both blastomeres of two-cell stage X. laevis embryos. At blastula 
stage, the embryos were dissociated and fluorescence microscopy performed 
to visualize BiFC (Fig. 3.6A).  
Interestingly, a BiFC signal could be observed in a very low number of cells 
(<1%) when Ptf1a-Vn or Ptf1aW224A/W242A-Vn was co-injected with Prdm13 (Fig. 
3.6B and C). Surprisingly, a quite strong BiFC signal could be detected in 
approximately half of the Ptf1aT243A-Vn and Prdm13-Vc injected cells (Fig. 3.6B 
and C). Interestingly, in some of the cells showing EYFP fluorescence, the 
BiFC signal was not restricted to the nucleus, but additionally scattered in 
several aggregations throughout the cytoplasm (Fig. 3.6D). Surprisingly, a 
strong BiFC signal could be detected when Ptf1aT243E-Vn was co-expressed 
with Prdm13-Vc (Fig. 3.7B). Here too, aggregates of EYFP signal could be 
detected in several cells. Quantification showed that the number of cells 
showing interaction with Prdm13 resembled those of Ptf1aT243A-Vn (Fig. 3.6C).  
Altogether, the data show that the Ptf1aT243 play an essential role in the 
neuronal cell fate inducing activity and mutations in it, lead to a strong 
interaction of Prdm13, but do not alter its association with Rbpj or E12. 
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Figure 3.6: Ptf1aT243A and Ptf1aT243E mutants strongly interact with Prdm13. 
(A) Experimental procedure: 500 pg of ptf1a-Vn, ptf1aT243E-Vn, ptf1aW224A/W242A-Vn or 
ptf1aT243A-Vn mRNA were co-injected with 500 pg of prdm13-Vc mRNA and with 100 
pg of mRFP mRNA in animally both blastomeres of two-cell stage embryos. At 
blastula stage, cells were dissociated by the use of accutase and analyzed for 
fluorescence. (B) BiFC analysis. Indicated on the top are the injected constructs 
carrying the C-terminal Venus-EYFP. The corresponding N-terminal Venus-EYFP 
construct is shown left. Injected cells are stained red due to their expression of mRFP, 
while green is the corresponding EYFP signal indicating BiFC. C) Quantification of 
the BiFC analysis. The given numbers and ratios all refer to the total amount of mRFP 
positive cells that have been analyzed. Error bars refer to the standard error of the 
mean. D) Example for a “scattered” distribution of the EYFP signal within a cell. Given 
are the channels for mRFP (left) and EYFP (middle) alone and merged (right). 
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3.5 Ptf1a induces direct target genes at different time points 
 
For a better understanding of the mechanisms driving the development to a 
distinct neuronal subtype induced by Ptf1a, it is important to understand which 
genes were induced by Ptf1a. Previous studies investigating the transcriptional 
program induced by Ptf1a after 6 and 25 h in X. laevis ectodermal explants, 
afforded insight into the temporal control of Ptf1a gene induction (Hedderich, 
2012). In another analysis, Ptf1a was overexpressed in animal caps in the 
presence of the translational inhibitor cycloheximide (CHX) to identify direct 
target genes of Ptf1a. Through comparison of both analysis, it could be shown 
that several Ptf1a direct target genes were not activated in an immediate early 
fashion, but were delayed in their activation (Hedderich, 2012). Direct target 
genes showing an immediate activation by Ptf1a consist mostly of genes 
involved in neuronal differentiation such as the Notch ligand delta1 (dll1) or the 
neuronal differentiation genes ebf2 or myt1, as well as prdm13. Among the 
delayed direct target genes were genes like gad1a, barhl2, kirrel2 or neurog2. 
To get a better understanding in the mechanics for the delayed target gene 
induction, the exact onset of Ptf1a target gene induction needs to be defined. 
Therefore, 20 pg of ptf1a-GR mRNA was injected into the animal hemispheres 
of both blastomeres at the two-cell stage. At blastula stage, the animal cap 
was excised and protein activity was induced for 3, 6, 9, 12, 15 and 25 h. The 
RNA was isolated and analyzed by quantitative Nanostring analysis using a 
codeset consisting of known early and late Ptf1a target genes and neuronal 
marker genes (Fig. 3.7A, Table S7).  
To ensure that constructs indeed behaved as expected, the late time point at 
the 25 h was first analyzed for known Ptf1a-downstream genes. Compared to 
the non-injected control explants, Ptf1a-injected animal caps strongly 
expressed the pan-neuronal marker tubb2b, the direct target genes of Ptf1a, 
prdm13 and kirrel2 as well as the GABAergic marker gad1a, slc32a1 and pax2, 
but not the glutamatergic selector gene tlx3 and the vesicular glutamate 
transporter slc17a7 (Fig. 3.7B, Table S3). This expression reflects the activities 
of Ptf1a in promoting neuronal differentiation, inducing a GABAergic cell fate 
and inhibiting a glutamatergic cell fate (Glasgow et al., 2005; Hoshino et al., 
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2005; Dullin et al., 2007; Pascual et al., 2007). (Fig. 3.7B). The Ptf1a-induced 
genes analyzed can be classified into groups based on their timing of activation 
(Fig. 3.7 C-H, Table S3). The first group of genes has the onset of their 
activation already at 3 h (dll1, ebf2, myt1, prdm13, prdm14, zc3h12c), the 
second at 6 h (barhl2, kirrel2, lhx1, nr5a2, onecut1.2, tlx3, aldh1b1), the third 
group between 9 and 12 h, with a strong tendency towards 12 h (pax2, tubb2b, 
gad1a, neurog2, pdia2) and one gene at 25 h (slc32a2). Under those genes 
activated at the earliest stages (3 h, 6 h) were direct Ptf1a target genes 
(prdm13, kirrel2) (Nishida et al., 2010; Chang et al., 2013) as well as many 
genes predicted to be direct Ptf1a target genes by their activation in presence 
of the translational inhibitor cycloheximide (CHX) (Schneider-Poetsch et al., 
2010) could be found (dll1, ebf2, myt1, zc3h12c) (Hedderich, 2012), but known 
and predicted direct target genes were also present under those genes 
activated at the 12 h time point (neurog2, gad1a, pdia2) (Henke et al., 2009; 
Hedderich, 2012) (Fig. 3.7C-H, Table S4). Interestingly, the activation of 
delayed Ptf1a target genes followed the activation of the post-mitotic neuronal 
marker tubb2b, which indicates that the expression of those genes may be 
connected with cell cycle exit.  
Interestingly, a significant induction of tlx3 expression by Ptf1a could be 
detected in early stages, which is increasing up to the 9 h time point, but 
afterwards is declines and is no longer detected after 25 h (Fig. 3.7H), 
indicating that during the onset of neuronal differentiation Ptf1a induces tlx3 
expression, which is subsequently suppressed during subtype specification. 
Altogether the data suggest that the delayed activation of Ptf1a direct target 
genes begins their onset of expression 12 h following Ptf1a induction. As only 
a limited number of genes were analyzed, it is unclear if all the delayed target 
genes behave in such a manner. 
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Figure 3.7: Ptf1a is activating its target genes in a temporal manner 
(A) Experimental procedure: 20 pg of ptf1a-GR, mRNA was injected animally in both 
blastomeres of two-cell stage embryos. At blastula stage, animal caps were excised. 
Protein activity was induced by dexamethasone treatment for 3, 6, 9, 12, 15 and 25 
h. Animal caps were collected for RNA isolation at the indicated times and gene 
expression quantified by Nanostring analysis. (B) Results of the quantitative 
Nanostring analysis. Shown are the average expression levels of marker genes from 
three biological replicates. Error bars refer to the standard error of the mean. Data → 
Results   65 
 
were normalized for the expression levels of the housekeeping gene ppi1l. (C-H) 
Results of the quantitative Nanostring analysis. Shown are the average expression 
levels of marker genes from three biological replicates. Error bars refer to the standard 
error of the mean. Data were normalized for the three housekeeping gene ppi1l. .S 
and .L refer to the corresponding X. laevis homeolog targeted by the Nanostring probe. 
Note the different scales in each diagram. CC, control cap. 
  
3.6 Temporal expression of Ptf1a target genes by RNA sequencing 
 
To understand the temporal induction of Ptf1a target genes on a global level, 
RNA sequencing was performed by injecting 20 pg of ptf1a-GR mRNA 
animally in both blastomeres of the two-cell stage blastomeres. At blastula 
stage, animal caps were excised and protein activity was induced by the 
addition of dexamethasone to the culture medium. After 3, 6 or 12 h, the RNA 
was isolated and analyzed by RNA-seq (Fig. 3.8A). 
To get an insight in the similarity between the different replicates, the distinct 
samples were clustered according to their similarity using the R/Bioconductor 
environment (www.bioconductor.org). Analysis clearly showed a high similarity 
in the 3 h and 6 h groups, which much higher similarity than any of these 
groups to the 12 h time point samples, supporting the argumentation that a 
major change at the 12 h time point has occurred (Fig. 3.8B) 
Applying a cutoff of at least a log2 fold-change of two over non-injected control 
caps, 133 genes were upregulated by Ptf1a after 3 h of protein induction, while 
after 6 h and 12 h of protein induction, 241 and 468 genes were upregulated 
(Fig. 3.8B). In contrast, only 15 genes were downregulated after 3 h of protein 
induction, while after 6 h and 12 h, 3 and 20 genes were downregulated. From 
these, 140 and 353 genes also had their onset of induction after 6 h and 12 h. 
Under the genes being upregulated, known Ptf1a target genes like prdm13 
(Hedderich, 2012; Chang et al., 2013) or kirrel2 (Nishida et al., 2010) could be 
found (Table S14-16).  
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Figure 3.8: Summary of the RNAseq 
(A) Experimental procedure: 20 pg of ptf1a-GR, mRNA was injected in both animal 
blastomeres of two-cell stage. At blastula stage, animal cap is excised. Protein activity 
is induced by dexamethasone treatment for 3, 6, and 12 h. Afterwards, the animal 
caps were collected for RNA isolation. RNA expression was analyzed by RNAseq. (B) 
Cluster Dendrogram showing the similarity of the different samples. 
 
To identify the direct target genes being upregulated at the distinct time points, 
the list of upregulated genes from the RNA-seq was compared to a list of genes 
induced by Ptf1a in the presence of the translational inhibitor cycloheximide 
(CHX) (Hedderich, 2012). From the 133 genes upregulated at least four-fold 
after 3 h, 59 genes could be identified as direct target genes (Fig. 3.9C). Of 
the genes upregulated after 6 h, 90 were direct target genes. From those, 41% 
(37 genes) had their onset at 6 h. After 12 h, 99 direct target genes could be 
found. Interestingly, approximately half of the direct target genes (45 genes) 
activated after 12 h of protein induction had their onset at this time point, 
indicating a greater change in the activated target genes occurring at this time 
point 
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Figure 3.9 Comparison of target gene activation by Ptf1a after 3, 6 and 12 h 
Venn diagrams indicating number of upregulated genes at 3, 6 and 12 h by the given 
threshold in general (A) and for direct target genes only (B). Given is the number of 
genes with a log2 fold change higher or equal than 2 compared to non-injected control 
caps. 
 
3.7 Ptf1a target genes are highly enriched for playing roles during 
transcription and neurogenesis 
 
To identify the function of the upregulated genes at the different time points, 
gene ontology analysis was performed using DAVID (Database for Annotation, 
Visualization and Integrated Discovery, http://david,abcc.ncifcrf.gov/).  GO 
analysis revealed an enrichment of the genes upregulated after 3 h involved 
in the positive or negative regulation of transcription (e.g. myt1, dll1, ebf2, 
prdm13), the development of the nervous system (e.g. dll1, olig2, lhx1) or 
neuron fate commitment (e.g. notch1, id2, olig2) (Fig. 3.10A). Gene ontology 
analysis for the genes upregulated after 12 h of protein induction also showed 
a significant enrichment in processes for positive or negative regulation of 
transcription (barlh2, lhx1, neurog1, neuro2, myt1, olig2) and the development 
of the nervous system (lbx1, olig2, barlh2, myT1, lhx1, neurog1, neurog2, 
neurod4) (Fig. 3.10B). At both time points, a high overlap in the genes listed in 
the different GO terms could be detected, as for example dll1, olig2 or myt1 
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were involved in transcriptional regulation as well as in the development of the 
neural system after 3 h. Similarly, neurog1, neurog2, myt1 or barlh2 were 
involved in transcriptional regulation as well as in the development of the 
neural system after 12 h. Nevertheless, no strong differences between the 
gene function between the 3 and 12 h time point could be detected. 
  
 
Figure 3.10: Genes involved in processes involved in neurogenesis are 
enriched in all three time points 
Gene Ontology (GO) analysis was performed using DAVID 
(http://david.abcc.nclfcrf.gov) (Dennis et al. 2003). The number of genes in each 
category is shown as well as the -log10 P-value of false discovery rate. Shown are 
the top listed terms of each category ranked by their P-value. The different diagrams 
refer to genes activated after 3 h (blue) and 12h (red) in general (A) and for direct 
target genes having their onset at the given time point (B) 
 
When considering only those direct target genes that were upregulated at the 
particular time point, however, differences could be found (Fig. 3.10C and D). 
While direct target genes induced after 3 h still were strongest enriched for 
positive or negative regulation of transcription (e.g. ebf2, myt1, prdm13 or dll1) 
(Fig. 3.10C), direct target genes having their onset of expression after 12 h, 
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were involved in axon guidance (e.g. neurog2, tubb3) regulation of membrane 
repolarization during action potential or calcium transport (cacna2d1, cacnb3), 
or neuron differentiation (neurog2, tubb3, unc5a) (Fig. 3.10D)  indicating that 
genes expressed after 12 h play a role in function and maturation  of neurons, 
while early induced genes are more likely involved early neuronal 
differentiation. 
 
3.8 A knock-down of Brg1 affects the induction of indirect Ptf1a target 
genes 
 
Chromatin remodeling mediated by the BAF chromatin remodeling complex 
plays an essential role during vertebrate neurogenesis (Bachmann et al., 
2016). It had been shown that a knock-down of Brg1, one of the two catalytic 
subunits of the BAF complex lead to an impairment in the induction of neuronal 
differentiation by proneuronal transcription factors like Neurog2 (Seo et al., 
2007). As induction of delayed Ptf1a target genes was connected with the 
induction of the post-mitotic neuronal marker tubb2b, the delayed activation of 
direct target genes might be dependent on chromatin remodeling via the BAF 
chromatin remodeling complex. To investigate which genes are affected by a 
Brg1 knock-down in Ptf1a overexpressing animal caps, RNA sequencing was 
performed using stage 14 ectodermal explants from embryos injected with 20 
pg of ptf1a-GR mRNA together with 20 ng of either control morpholino (cMO) 
or Brg1 morpholino (Brg1-MO) previously shown to be effective in knockdown 
of Brg1 by inhibiting translation (Seo et al., 2007) (Fig 3.11A).  
In total, Ptf1a together with the control MO upregulated more than 819 genes 
by applying a threshold of log2 fold-change of two compared to non-injected 
control caps and an FDR value <0.05, while 668 genes were upregulated by 
Ptf1a in the presence of the Brg1-MO.  From these upregulated genes, in total, 
527 genes were shared by both samples, while 236 genes were exclusively 
induced by Ptf1a-GR and the cMO (Fig3.11B) 
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Figure 3.11: Brg1 dependent genes are mostly indirect Ptf1a target genes 
(A) Experimental procedure: 20 pg of ptf1a-GR mRNA was injected individually or 
together with either a control morpholino or a Brg1 morpholino in both animal 
blastomeres of two-cell stage. At blastula stage, animal cap is excised. Protein activity 
was induced by dexamethasone treatment. At stage 14, the animal caps were 
collected for RNA isolation. RNA expression was analyzed by RNA sequencing. (B) 
Venn Diagram showing the number of unique and shared genes being at least four-
fold (left) or 16-fold upregulated by Ptf1a in presence of cMO (blue) or Brg1-MO (red) 
(C) Venn Diagram showing the number of unique and shared genes being at least 
four-fold (left) or two-fold (right) upregulated by Ptf1a and cMO over Ptf1a together 
with the Brg1-MO (blue) and by a list of genes induced by Ptf1a in the presence of 
CHX (Hedderich, 2012) (red).  
 
To identify, which genes were most strongly affected by a Brg1 knock-down, 
the gene expression levels were compared between Ptf1a in the presence of 
the Brg1-MO versus the presence of the control MO. In the presence of the 
Brg1-MO, 56 genes were upregulated and one of these genes were induced 
by Ptf1a in presence of CHX (Hedderich, 2012) and 87 genes were 
significantly reduced by more than two-fold (Fig. 3.11C). As only a limited 
number of genes were altered, the influence of the Brg1 knock-down on target 
gene induction by Ptf1a is specific for selected genes. Tubb2b could be found 
under those genes showing a strong impairment in Ptf1a induction upon Brg1 
knock-down. From the 87 genes negatively affected by the Brg1-MO, only 
eight genes (flnc.S, nr5a2.S, tubb3.S, six3.L, traf4.S, LOC100496628-like.S, 
emilin1.L, st18.L) were identified as direct target genes by Ptf1a based on their 
ability to activated in the presence of CHX (Hedderich, 2012). (Fig. 3.11C)  
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Figure 3.12: Genes affected by an Brg1 knock-down have activities during 
neurogenesis 
GO analysis of genes being at least four-fold downregulated in the presence of the 
Ptf1a together with Brg1-MO versus the control MO. Analysis was performed using 
DAVID (http://david.abcc.nclfcrf.gov) (Dennis et al., 2003). Shown are the top listed 
terms of each category ranked by their P-value. The number of genes in each 
category is shown to the right of the bar diagram. 
 
For identification, which gene functions were affected by a Brg1 knockdown, 
Gene Ontology analysis was performed on the strongest Brg1-MO affected 
genes using DAVID. Corresponding to the Ptf1a gene function, genes affected 
by a Brg1 knock-down were enriched in terms having a function during 
neurogenesis, including “brain development” (nes, bcr, six3), or regulation of 
neuron projection development” (pak3, sfrp2), but also “regulation of cell 
proliferation” (ppp1r9b, nr5a2) (Fig. 3.12). 
Altogether, these data suggest that most Ptf1a direct target genes do not 
require chromatin remodeling by the Brg1 containing BAF complex.  
 
3.9 Induction of selected Ptf1a downstream genes requires Brg1 
 
For verification of the RNA sequencing results, 20 pg of ptf1a-GR mRNA was 
injected alone or in combination with 20 ng of a control MO or the Brg1-MO, in  
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Figure 3.13: Induction of some delayed Ptf1a target genes is depended on Brg1  
(A) Experimental procedure: 20 pg of ptf1a-GR mRNA was injected individually or 
together with either a control morpholino (cMO) or a Brg1 morpholino (Brg1MO) in 
both animal blastomeres of two-cell stage. At blastula stage, animal cap is excised. 
Protein activity was induced by dexamethasone treatment. At stage 14, the animal 
caps were collected for RNA isolation. RNA expression was analyzed by quantitative 
Nanostring analysis. B-F) Examples of Brg1 dependent or independent target genes. 
Shown are the average expression levels of marker genes from three biological 
replicates. Error bars refer to the standard error of the mean. Data were normalized 
for the three housekeeping genes odc, ppi1l and rplp0. Note the different scales in 
each diagram.  
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 both blastomeres at the two-cell stage. At blastula stage, animal caps were 
excised and protein activity was induced by the addition of dexamethasone to 
the culture medium. At the equivalent of stage 14, the RNA of the explants was 
isolated and gene expression was analyzed by quantitative Nanostring 
analysis using a codeset containing Ptf1a direct and indirect early and late 
target genes, as well as selected markers of neuronal differentiation and 
subtype specification (in total 96 genes were analyzed) (Fig. 3.13A, Table S7).  
Overexpression of Ptf1a upregulated almost all investigated target genes 
previously shown to be upregulated by Ptf1a in the RNA-seq (Fig. 3.14, Fig. 
3.15). As it was previously shown for other proneural transcription factors like 
Neurog2 (Seo et al., 2007) and the Ptf1a-Brg1-MO RNAseq analysis, the 
 
 
Figure 3.14 Summary of the Nanostring analysis for genes induced after 3 h 
Shown is a heatmap showing the log2 fold-change activation of target genes by Ptf1a 
(green) or the fold-change reduction when Co-injected with Brg1 morpholino 
compared to the Co-injection with a control morpholino (red). Genes activated by 
Ptf1a in presence of CHX are highlighted in yellow. 
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upregulation of tubb2b expression by Ptf1a was significantly attenuated in the 
presence of the Brg1-MO compared to the control MO (Fig. 3.13B), indicating 
the importance of Brg1 for neuronal differentiation. Ptf1a direct target genes 
such as the early upregulated dll1 or the late upregulated neurog2, were not 
affected by a Brg1 knockdown (Fig. 3.13C, E). Interestingly, with respect to the 
timing of target gene induction, most of the observed genes activated within 3 
h of Ptf1a induction were not affected by a Brg1 knock-down. From those early 
induced target genes being affected by a Brg1 knock-down, four were direct 
target genes (out of 22 direct Ptf1a target genes present for this time point), 
while four were indirect Ptf1a target genes (out of 10 indirect Ptf1a target genes 
present for this time point). In general, in the target genes analyzed, the 
number of indirect target genes affected by the Brg1 knock-down was higher 
than the number of direct target genes (Fig. 3.17G). For later activated genes, 
including both direct (e.g. neurod4 and gad1a) and indirect (e.g. pou3f2 or 
lbx1), the number of Brg1 dependent genes increases. All genes being 
affected the Brg1 knock-down in the RNA-seq that were analyzed, were also 
affected in the Nanostring analysis (Fig. 3.17G). Furthermore, the finding from 
the RNA-seq that many affected genes were indirect Ptf1a target genes could 
be demonstrated in the Nanostring analysis. However, many genes like gad1a 
or prdm13 that showed no significant reduction in the RNA-seq analysis, 
showed a reduction in the induction by Ptf1a in the presence of the Brg1-MO 
(Fig. 3.13D, Fig. 3.14) Altogether, the data suggest that the induction of most 
early target genes by Ptf1a is not dependent of chromatin remodeling via the 
BAF chromatin remodeling complex, while this mechanism becomes more 
important for the induction of selected late target genes. However, BAF-
mediated chromatin remodeling cannot be the only mechanism responsible for 
the delayed target gene activation as even at the 12 h time point, induction of 
several direct Ptf1a target genes is not affected by a Brg1 knock-down.  
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Figure 3.15 Summary of the Nanostring analysis for genes induced after 3 h 
Shown is a heatmap showing the log2 fold-change activation of target genes by Ptf1a 
(green) or the fold-change reduction when Co-injected with Brg1 morpholino 
compared to the Co-injection with a control morpholino (red). Genes activated by 
Ptf1a in presence of CHX are highlighted in yellow. 
 
3.10 Ptf1a can alter the chromatin state of its target genes 
 
Since other chromatin remodeling complexes exist that are Brg1 independent 
it cannot be ruled out that that the delayed activation of Ptf1a is due to 
chromatin accessibility. Therefore, analysis of the chromatin landscape of 
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Ptf1a direct target genes were analyzed by using ATAC-seq (Assay for 
Transposase Accessible Chromatin).  Therefore, 20 pg of ptf1a-GR was 
injected in both blastomeres at the two-cell stage of X. laevis embryos. At 
blastula stage, the animal caps were excised and protein activity induced by 
dexamethasone treatment for 3 (when the earliest target genes are activated) 
or 12 h (the timing when late target genes were activated). Afterwards, ATAC 
sequencing was performed (Fig. 3.16A, B). The results of the ATAC 
sequencing were compared to the expression levels of the genes obtained 
from the RNA-seq to determine the correlation between the chromatin levels 
with the target gene expression. 
In total between 100,000,000 and 200,000,000 reads could be mapped for 
each sample. However, many duplicate reads could be found in the samples, 
so that after removal of those duplicates only between 2,000,000 and 
12,000,000 reads remained, so that the amounts of reads that remained was 
quite low indicating restriction in the analysis due to a non-sufficient quality of 
the samples. 
Nevertheless, genes strongly expressed in the naïve animal cap (3 h, 
equivalent stage 10 or 12 h, equivalent stage 12.5) like odc (data not shown), 
pou5f3.2 or fcgbp could be located in areas of quite open chromatin in the 
presence and absence of Ptf1a (Fig 3.16C). Time dependent changes in the 
loci of genes could be detected, with pou5f3.2 at early stages, for example, 
was located in a quite open area. At later stages, however, the chromatin at 
the pou5f3.2 locus becomes much more closed, which correlated with a 
decrease in pou5f3.2 expression levels (Fig. 3.16C, D). The opposite effect 
could be identified for example on the expression of fcgbp. Here, the fcgbp 
gene locus is located in closed chromatin regions at the 3 h time point. At the 
12 h time point, however, the chromatin at the fcgbp locus is quite accessible, 
matching with a strong increase of fcgbp expression levels (Fig. 3.16E, F). 
These results highlight the correlation between chromatin remodeling and 
gene expression and demonstrate the validity of the analysis. 
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Figure 3.16: Ptf1a overexpression can change the chromatin state of its target 
genes 
(A) Overview ATAC-seq (Scheme modified from (Buenrostro et al., 2013)). Intact 
nuclei were treated with a highly reactive Tn5 transposase. The transposase binds at 
accessible chromatin regions introducing signaling sequences. Accessible regions 
were amplified via PCR against the introduced sequences. PCR library is then 
sequenced with 50 bp paired-end reads. (B) Experimental procedure: 20 pg of ptf1a-
GR, mRNA was injected in both animal blastomeres of two-cell stage. At blastula 
stage, animal cap is excised. Protein activity is induced by dexamethasone treatment 
for 3 and 12 h. Afterwards, the animal caps were collected for ATAC sequencing. (C, 
E, G) ATAC tracks from read coverage files mapped to the X. laevis genome. The  
corresponding sample control Cap (CC) or Ptf1a injected (Ptf1a) and the → 
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corresponding time point is given on the left. The transcriptional direction of the 
investigated gene is indicated with a black arrow. The grey bars represent the total 
numbers of reads at the corresponding position of the genome. (D, G, H) The 
corresponding target gene’s expression level from the RNAseq is shown on the right 
side. Note the different scales.   
 
When looking at the loci of Ptf1a direct target genes (in total 44 genes, from 
those, 6 genes were activated after 3 h, 10 after 6 h and 24 genes after 12 h). 
Ptf1a dependent changes in the chromatin states could be found. At the locus 
of the Ptf1a direct target gene neurod4, for example, a region of open 
chromatin could be detected approximately 5 kb upstream of the transcription 
start site in the Ptf1a injected explants, but not in non-injected control explants 
(Fig. 3.16G). Neurod4 expression levels, however, could not be detected at 
the 3 h time point, even though the open chromatin region appeared at this 
time point in the Ptf1a expressing explants (Fig 3.16H). However, in the RNA-
seq analysis expression of neurod4 becomes detectable at the 6 h time point 
(Table S15), indicating that even though the chromatin at this position is 
accessible, some time is needed until transcription can start. Together, these 
results indicate that overexpression of Ptf1a can lead to changes in the 
chromatin state of selected genes target genes. 
 
3.11 Ptf1a target genes lay in closed chromatin regions  
 
To identify if chromatin remodeling is responsible for the delayed activation of 
target genes, the chromatin state of Ptf1a target gene loci have been 
investigated and compared with their onset of expression. Interestingly most 
of the investigated early and late target genes were located in regions of rather 
closed chromatin, which was even the case for early induced genes like 
prdm13 (Fig 3.17A).  
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Figure 3.17: Chromatin remodeling plays a minor role in the delayed induction 
of Ptf1a target genes 
(A, C, E) ATAC tracks from read coverage files mapped to the X. laevis genome. The 
corresponding sample (control Cap (CC) or Ptf1a injected (Ptf1a) and the 
corresponding time point is given on the left. The transcriptional direction of the 
investigated gene is indicated with a black arrow. The grey bars represent the total 
numbers of reads at the corresponding position of the genome. (B, D, F) The 
corresponding target gene’s expression level from the RNAseq is shown on the right 
side. Note the different scales.  
 
Even though the transcriptional start site was accessible for most genes, no 
significant changes in chromatin accessibility at the loci of those direct target 
genes could be found at the time points analyzed (Fig. 3.17A, C, E). This 
finding was the case for time dependent changes, as well as for Ptf1a 
dependent changes in the chromatin accessibility. Even late induced target 
genes, such as mecom (Fig 3.17E) or neurog2 (Fig 3.17C) showed no 
significant differences in their chromatin levels over time or a change due to 
Ptf1a expression, indicating that Ptf1a indeed does not need chromatin 
remodeling to activate the investigated direct target genes.  
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4. Discussion 
 
4.1 The Ptf1a C-terminus is essential for the induced neuronal 
transmitter phenotype 
 
The bHLH transcription factor Ptf1a not only plays a critical role during 
neuronal subtype specification where it promotes an inhibitory GABAergic cell 
fate and suppresses an excitatory glutamatergic cell fate, it also possesses 
proneural activity (Glasgow et al., 2005; Hoshino et al., 2005; Fujitani et al., 
2006; Dullin et al., 2007; Nakhai et al., 2007; Pascual et al., 2007; Hedderich, 
2008; Lelievre et al., 2011; Hedderich, 2012). The neuronal subtype specificity 
of Ptf1a depends on its interaction with Rbpj via two highly conserved motifs 
in the Ptf1a C-terminus. Ptf1a mutants where the Rbpj binding sites are 
disrupted through mutation of the tryptophan residues in the C1 and C2 
domains to alanine maintain proneural activity, but the induced neurons 
express glutamatergic marker genes rather than GABAergic markers (Dullin et 
al., 2007; Hedderich, 2008; Hedderich, 2012; Hanotel et al., 2014).  
In this work, a new Ptf1a mutant (Ptf1aT243A) was identified, in which the 
threonine residue within the Ptf1a C2 domain was mutated to alanine. 
Overexpression of Ptf1aT243A induces a mixed neuronal transmitter phenotype, 
by activating GABAergic markers like gad1a as well as glutamatergic markers 
like tlx3. This mixed neuronal transmitter phenotype, however, is not due to an 
inhibition of Rbpj binding as demonstrated by the interaction of Rbpj and 
Ptf1aT243A through BiFC as well the upregulation of Ptf1a early (prdm13) and 
late (aldh1b1, barhl2, kirrel2) trimeric target genes. Albeit the induction of these 
genes was lower than that obtained with the wild-type Ptf1a, mutants where 
Rbpj interaction is impaired (Ptf1aW242A, Ptf1aW224A/W242A) do not interact in the 
BiFC assay and these mutants fail to induce the trimeric target genes. 
Studies in mouse and X. laevis embryos demonstrated that overexpression of 
Prdm13 together with Ascl1 or Neurog2 overrides the glutamatergic promoting 
activity of these factors and promotes a GABAergic cell fate (Chang et al., 
2013; Hanotel et al., 2014). However, overexpression of Ptf1aT243A in X. laevis 
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animal caps results in both prdm13 and tlx3 expression. Ptf1aT243A is not as 
effective as the wild-type Ptf1a with regards to prdm13 upregulation (11-fold 
less), thus the amount of Prdm13 may be limiting to suppress a glutamatergic 
fate. However, Ptf1aT243E is only slightly less effective (1.5-fold less) in the 
induction of prdm13 compared to the wild-type Ptf1a, but still induces tlx3 
indicating the possibility that an unknown mechanism induced by Ptf1aT243A 
impairs the ability of Prdm13 to repress tlx3. 
Interestingly, a strong BiFC signal was observed between Ptf1aT243A and 
Prdm13, while only a very week signal and in few cells was observed for Ptf1a 
or Ptf1aW224A/W242A and Prdm13. In subpopulation of Ptf1a-expressing cells in 
the X. laevis retina that will give rise to glycinergic neurons, Prdm13 negatively 
regulates ptf1a (Bessodes et al., 2017). The molecular basis for Prdm13-
repression of ptf1a was shown in the mouse dorsal neural tube, where Prdm13 
is recruited to the Ptf1a autoregulatory enhancer through direct interaction with 
Ptf1a (Mona et al., 2017). Thus, in the Ptf1aT243A mutant, the ability of Prdm13 
to interact with Ptf1a and to suppress its activity may be increased. This would 
lead to a reduced induction of prdm13 by Ptf1a, so that the inhibition of tlx3 is 
not as effective. This hypothesis is supported by the finding that tlx3 is induced 
under CHX by Ptf1a (Hedderich, 2012) and that Ptf1a induced expression of 
tlx3 at early time points (6-9 h) but at later developmental stages tlx3 
expression is silenced.  
Interestingly, overexpressing Ptf1aT243A in X. laevis embryos still affects the 
endogenous tlx3 expression, so that only ectopically induced neurons become 
glutamatergic. This would indicate the presence of a second co-factor, that is 
induced by the wild-type Ptf1a but not by the Ptf1aT243A mutant or co-factor 
present in the neural tube, and needed for Prdm13 to down-regulates tlx3 
expression. So, it would be interesting to identify the transcription factor 
complex controlling the target gene induction by Ptf1a or Ptf1aT243A to prove 
this hypothesis. Furthermore, these data indicate that the induced neuronal 
transmitter phenotype might be the result of a mixed population of cells within 
the ectodermal explants, so that it would be also of interest to investigate the 
target gene induction by the Ptf1aT243A at the single cellular level. This might 
give a better insight in the induced activity of this mutant.  
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4.2 Role of phosphorylation on Ptf1a on its activity 
 
Phosphorylation by Cdks on S/T-P sites in proneural bHLH transcription 
factors like Neurod4, Ascl1 and Neurog2 regulates their activity in inducing 
neuronal differentiation (Ali et al., 2011; Ali et al., 2014; Hardwick and Philpott, 
2015). Although Ptf1a also contains multiple S/T-P sites, an increase in the 
induction of pan-neuronal marker genes could be detected when 
overexpressing murine Ptf1a8S/TA in animal caps compared to overexpression 
of the wild-type murine Ptf1a (Richts, 2013), indicating that strength of Ptf1a 
activity might not be regulated by Cdk dependent phosphorylation. However, 
as previously reported (Richts, 2013), the murine Ptf1a constructs in general 
tend to have a stronger neuronal inducing activity compared to the X. laevis 
Ptf1a when overexpressed in X. laevis embryos. This would mean that 
potential differences in the strength of induction of neuronal differentiation may 
be masked by the general increase in activity of the murine Ptf1a constructs.  
Mutation of a threonine residue to alanine in the Ptf1a C2 domain resulted in 
the up-regulation of marker genes for both GABAergic and glutamatergic cell 
fates. This change in the neuronal transmitter phenotype was conserved 
between the murine and the X. laevis Ptf1a, indicating this residue is required 
and sufficient in the regulation of the induced neuronal subtype. Mutations in 
a single serine residue in the second helix domain for bHLH transcription 
factors such as Ascl1 and Neurog2 disrupts their activity during neuronal 
subtype specification by affecting their binding to certain promoter regions (Ali 
et al., 2011; Hindley et al., 2012; Ali et al., 2014; Quan et al., 2016). However, 
as the C2 domain in Ptf1a is well characterized for the interaction with Rbpj 
(Beres et al., 2006; Hori et al., 2008), such a mechanism is rather unlikely as 
being responsible for the mixed induced neuronal transmitter phenotype. 
Interestingly, the neuronal differentiation promoting activity of Ptf1aT243A was 
reduced compared to the wild-type Ptf1a, a phenotype similar to those of the 
Ptf1aW2424A/W224A mutant. However, the decreased ability to induce neuronal 
differentiation is unlikely the reason for the switch in the induced neuronal 
subtype, as the mixed neuronal subtype induced by Ptf1aT243A can still be 
observed even when normalized for the various strength of neuronal 
differentiation inducing activity. The differences in the ability of the different 
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Ptf1a mutants to promote neuronal differentiation might occur due to 
differences in the protein stability of those mutants. Protein stability was not 
directly measured and would be of interest to determine, but the similar BiFC 
signal observed for all mutants with E12 is not indicative of dramatically 
differences in stability. However, it should be noted that the concentration used 
for the BiFC studies was more than 10-fold higher than used in the ectodermal 
explant assays. 
Direct evidence that Ptf1a is indeed phosphorylated on the T243 position is still 
missing. However, overexpression of the phosphomimic mutant (Ptf1T243E) 
also induces a mixed neuronal transmitter phenotype. The activity of Ptf1T243E 
was more similar to the activity of wild-type Ptf1a indicating that the presence 
of a negative charge at this position may influence the correct neuronal 
subtype inducing activity, supporting a role for phosphorylation at this residue. 
Interestingly, similar to the Ptf1T243A mutant, the Ptf1T243E still strongly interacts 
with Prdm13 in BiFC assays. This may explain why the induced neuronal 
transmitter phenotype by Ptf1T243E is still mixed, even if it resembles more the 
wild-type Ptf1a than Ptf1T243A in GABAergic gene induction. On the other hand, 
the negative charge introduced by a single phosphomimic mutation is less 
strong than a phosphorylated residue (Strickfaden et al., 2007; Pearlman et al., 
2011). So, a complete rescue might not be possible by introducing just a single 
glutamate residue and the introduction of two adjacent phosphomimic 
mutations may be a more suitable construct (Strickfaden et al., 2007; 
Pearlman et al., 2011). In future, it would be interesting to provide evidence 
that the phosphorylation on the T243 residue occurs during neurogenesis on 
Ptf1a to gain a better understanding if phosphorylation indeed regulates Ptf1a 
activity. 
 
4.3 BAF complex mediated chromatin remodeling is important for the 
activation of delayed target gene expression by Ptf1a 
 
The BAF chromatin remodeling complex has been demonstrated to be 
essential for vertebrate neurogenesis (Seo et al., 2005; Narayanan et al., 2015; 
Bachmann et al., 2016). A knock-down of the BAF catalytic core unit Brg1 
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impairs neuronal differentiation induced by proneural transcription factors like 
Neurog2 and Neurod1 (Seo et al., 2005). Further supporting the importance of 
a functional BAF complex for neurogenesis, Ptf1a-induced neuronal 
differentiation is also impaired by a knock-down of Brg1 in X. laevis ectodermal 
explants. Considering the temporal induction of target genes by Ptf1a, only a 
few direct Ptf1a target genes were affected after 3 h (4 out of 22 genes), while 
the amount of affected direct target genes increases for delayed direct target 
genes (12 h, 7 out of 10 genes). Even if this tendency might be the result of a 
bias in the selection of target genes studied by Nanostring analysis, indications 
exist that a functional Brg1 is required for the induction of at least a subset of 
delayed Ptf1a target genes. A similar effect has been shown during 
myogenesis, where BAF complex dependent chromatin remodeling is required 
for the activation of only a subset of target genes involved in muscle 
differentiation (de la Serna et al., 2001; Roy et al., 2002; Berkes et al., 2004). 
However, the general effect of a Brg1 knock-down on the activation of target 
genes by Ptf1a was quite low (53 out of 819 genes). Nevertheless, the finding 
that the most strongly affected genes were indirect Ptf1a target genes 
indicates that additional mechanism are responsible for the delayed activation 
of target genes by Ptf1a. Furthermore, besides of its role in remodeling 
chromatin, the subunits of BAF complex can directly interact with other 
proteins like transcription factors and so activate or inhibit their function (Zhan 
et al., 2011; Ninkovic et al., 2013). It would be of interest for future studies to 
compare Ptf1a overexpressing ectopic explants in presence of a Brg1 
morpholino by ATAC-seq to demonstrate that the effects Brg1 knockdown on 
the upregulations of the identified genes is indeed due to chromatin remodeling. 
However, since it has been reported that a knock-down of Brg1 cannot 
completely abolish Brg1 activity due to putative maternal expression (Li et al., 
2013) and the fact that a down-regulation of Brg1 is associated with cell-cycle 
arrest and so lethal for the cells (Li et al., 2013), meaning that a complete Brg1 
activity cannot be degraded without killing the cells, suggesting that a higher 
number of genes dependent on Brg1 might exist. Furthermore, the BAF 
chromatin remodeling complex can also contain Brm instead of Brg1 as 
catalytic subunit, so that activation of several target genes might not be 
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dependent on Brg1 but on Brm instead. Performing a double-knock-down of 
Brg1 and Brm would give new insights in this matter.  
 
4.4 Ptf1a does not need open chromatin to induce its targets 
 
Active transcription of target genes has been associated with accessible 
chromatin at target genes regulatory regions. It has been reported that 
chromatin regions of many proneural genes become accessible before their 
transcription starts (Chen and Dent, 2014; Hontelez et al., 2015; Mo et al., 
2015). Here, it has been demonstrated that Ptf1a is able to cause changes in 
the state of chromatin of some of its direct targets, although it has not been 
shown if this is a direct or indirect effect. However, most of investigated direct 
Ptf1a target genes lay in quite closed chromatin regions, whose pattern did not 
change over time or in dependency of Ptf1a. Since the quality of the ATAC 
sequencing library was impaired due to redundancy of sequences, these 
results should be viewed caution. Additional open chromatin regions in those 
target genes might be detected in samples with more unique reads. 
Nevertheless, the results indicate that Ptf1a does not need open chromatin to 
drive the activation of its target genes. This is supported by the fact, that other 
proneural bHLH transcription factors like Neurod1, Ascl1 and Neurog2 can 
bind to closed chromatin regions to induce the expression of their target genes 
(Soufi et al., 2015; Pataskar et al., 2016; Smith et al., 2016). In parallel to the 
onset of gene expression, the proneural genes induce changes in the 
chromatin pattern, which then lead to a stabilization of transcription. Studies 
investigating the distribution of maternally provided epigenetic marks in X. 
tropicalis indicate that many marks for enhancer elements are zygotically 
provided and are located in regions characterized by repressive histone marks 
and high levels of methylated DNA (Hontelez et al., 2015), further supporting 
the idea that Ptf1a is a pioneer transcription factor, which does not need open 
chromatin region to activate transcription of their target genes. On the other 
hand, it was reported that the promoter regions of late transcribed genes are 
already poised with activating histone marks and often are hypomethylated at 
a very early stage of the embryo (Hontelez et al., 2015) and that the presence 
of active marks is not sufficient to drive target gene transcription (Hontelez et 
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al., 2015). A similar effect could also be detected in the ATAC sequencing 
since for most of the Ptf1a target genes, open chromatin regions could be 
found at the transcriptional start site of the genes, while the remaining regions 
were in general not accessible, supporting the idea that open chromatin is not 
sufficient for the onset of target gene transcription by Ptf1a. However, whether 
Ptf1a also opens the chromatin of most of its target genes like Neurod1 
(Pataskar et al., 2016) remains unclear. After 12 h of Ptf1a induction, such a 
phenomenon could not be detected. But as also early expressed Ptf1a target 
genes were mostly located in closed chromatin regions, which did not change 
at the later stage, it might be that Ptf1a activates its target genes without 
opening the chromatin. However, at this time point, the expression of delayed 
target genes has just started, so that a change in the chromatin might not be 
detectable at this stage. Performing ATAC sequencing at a later stage after 
Ptf1a induction would give more insights in this question.  
 
4.5 Mechanisms driving the delayed activation of target genes 
 
Nanostring and RNA-seq data from Ptf1a overexpressing animal caps indicate 
that Ptf1a activates its direct target genes at different time points. Interestingly, 
by comparing the induced target genes with a list of genes being activated by 
Ptf1a in the presence of the translational inhibitor CHX (Schneider-Poetsch et 
al., 2010), the time of late target gene induction could be detected at a 12 h 
timepoint after gene induction. This indicates that certain events have to take 
place leading to the activation of first delayed target genes. 
Interestingly, delayed target gene activation correlates with the timing of 
tubb2b activation. As tubb2b is a marker for post-mitotic neurons (Oschwald 
et al., 1991), indicating that the timing of delayed target gene activation may 
correlate with the exit of the cell cycle. Considering that direct target genes 
having their onset after 12 h of Ptf1a induction and are highly enriched for 
functions in neuronal specification, while early activated genes are more 
associated with regulation of transcription and the regulation of the cell cycle, 
would support such a mechanism. Together this would mean that cell cycle 
escape triggers the events leading to the activation of late target genes. 
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However, how cell cycle escape can be associated with the delayed 
expression of Ptf1a late target genes need to be further analyzed. It has been 
reported that the length of the cell cycle plays an essential role in neuronal 
differentiation, as an elongation of the cell cycle is required for inducing the 
onset of differentiation by proneural bHLH transcription factors (Lange et al., 
2009; Lange and Calegari, 2010). Furthermore, the activity of many bHLH 
transcription factors involved in promoting neuronal differentiation including 
Neurog2 or Neurod4, are highly regulated by the cell cycle through Cdk-
mediated phosphorylation (Ali et al., 2011; Hindley et al., 2012; Hardwick and 
Philpott, 2015). As Ptf1a also contains residues that would make it a candidate 
for Cdk-dependent phosphorylation, a cell cycle dependent regulation of Ptf1a 
activity cannot be excluded.  
 Chromatin remodeling has been reported to regulate transcription during 
development since actively transcribed genes are associated with accessible 
chromatin as well as activating histone marks and demethylated DNA (Yao 
and Jin, 2014; Hsieh and Zhao, 2016; Yao et al., 2016). However, the findings 
in ATAC-seq that Ptf1a target genes are located within rather closed chromatin 
regions suggests that chromatin remodeling plays a minor role in the delayed 
activation of Ptf1a target genes. This is further supported by the fact that the 
presence of open chromatin marks is not sufficient for inducing transcription 
(Hontelez et al., 2015) and that high levels of DNA methylation, which is 
associated with transcriptional silencing, does not affect the transcription of 
target genes in the early embryo (Bogdanovic et al., 2012). Considering that 
especially late Ptf1a target genes need Brg1 to be expressed, while induction 
of most direct early Ptf1a target genes is not affected, BAF complex mediated 
chromatin remodeling still has an influence on late target gene activation. The 
finding that Brg1 is required for the activation of several of the late Ptf1a direct 
target genes would support an implement of cell cycle regulation in Ptf1a late 
target gene activation. This is further supported by Brg1 has been reported to 
be involved in the regulation of cell cycle exit via interaction with Geminin (Seo 
et al., 2005). This could also explain that early Ptf1a target genes are mostly 
unaffected by a Brg1 knockdown, because as those genes are mostly involved 
in transcriptional and cell cycle regulation, their activity is required before cell 
cycle exit, which is regulated by Brg1. Nevertheless, chromatin remodeling 
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alone cannot explain the delayed activation of late target genes, indicating that 
several mechanisms drive the delate activation of target genes. A potential 
mechanism might be the presence or absence of a certain Co-factor or 
repressor regulating the transcription of those genes. Such a possibility would 
be supported by findings that the onset of late Ptf1a target gene activation is 
preponed in presence of CHX (Hedderich, 2012). 
Together, these indications lead to a model that Ptf1a induces at least two 
waves of target gene activation. The first one is activated nearly immediately 
and mostly controls the transcription of genes controlling the differentiation of 
the cell to a neuronal cell fate, which leads to a cell cycle escape. An exception 
is Prdm13, which allows for an early bias of the progenitor cell to a GABAergic 
cell fate. At the time of cell cycle arrest, a second wave of target genes are 
activated, which further regulate the subtype specification and function of the 
induced neuron. Activation of these genes is regulated by several mechanisms. 
BAF complex mediated chromatin remodeling is required for the activation of 
a subset of those genes, while another unknown mechanism like the presence 
an unknown Co-factor or repressor controls the expression of the other late 
target genes. This would mean that investigating the Ptf1a transcription factor 
complex at the early and the late time point would be interesting to identify 
which differences occur in the composition of these complexes between those 
two time points.  
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6. Appendix 
 
6.1 Summary of Nanostring data 
Given are the average counts after normalization and background subtraction 
of three independent experiments for each sample and gene, respectively. In 
a second table, the calculated standard error of the mean (SEM) is given for 
each sample and gene, respectively. Data were processed as described in 
Material and Methods. 
 
6.1.1 Ptf1a threonine mutants 
 
Table S1: Summary of average normalized counts of three independent 
Nanostring experiments for each sample and gene 
Gene Name CC Ptf1a Ptf1aW224A/W242A Ptf1aT243A Ptf1aT243E 
odc1.L 15504 20639 18332 17622 20778 
ppi1.l 2825 3110 2921 2912 3073 
rplp0.S 33879 23110 27623 28940 23618 
t.S 81 23 55 47 34 
pax2.L 12 524 11 104 299 
prdm14.L 17 562 789 889 1603 
tubb2b.S 100 17477 5978 9622 24822 
dll1.L 14 168 26 49 134 
ebf2.S 1 493 50 184 476 
lhx1.S 3 779 6 146 904 
myt1.S 430 3173 1560 1697 3389 
prdm13.S 4 3572 33 547 2303 
zc3h12c.L 432 1528 1302 1017 1613 
onecut1.2.L 22 9630 944 4628 9215 
aldh1b1.L 9 235 7 31 148 
barhl2.L 38 238 21 31 169 
gad1.1.L 52 2989 32 981 2435 
kirrel2.L 11 4356 19 406 1494 
neurog2.S 3 244 9 40 129 
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nr5a2.L 9 737 184 507 1082 
tlx3.L 11 70 1336 492 418 
pdia2.L 18 62 13 12 35 
slc17a7.L 2 219 372 377 648 
slc32a1.S 14 583 58 176 773 
 
 
Table S2: Summary of the calculated SEM of the normalized counts shown in 
Table S1 for each sample and gene  
Gene Name CC Ptf1a Ptf1aW224A/W242A Ptf1aT243A Ptf1aT243E 
odc1.L 3578 4765 4568 4501 4749 
ppi1.l 407 479 448 367 307 
rplp0.S 7747 5206 5543 6417 6601 
t.S 29 8 15 20 16 
pax2.L 3 146 5 18 33 
prdm14.L 5 159 203 179 80 
tubb2b.S 22 3230 1981 1686 2168 
dll1.L 4 44 13 9 22 
ebf2.S 1 94 26 33 93 
lhx1.S 1 156 3 31 172 
myt1.S 144 651 625 435 700 
prdm13.S 2 858 16 111 83 
zc3h12c.L 123 275 401 195 324 
onecut1.2.L 5 1484 325 797 1383 
aldh1b1.L 2 54 3 9 14 
barhl2.L 13 38 7 10 10 
gad1.1.L 33 483 8 99 259 
kirrel2.L 2 1082 8 88 217 
neurog2.S 1 85 3 20 33 
nr5a2.L 3 117 61 134 229 
tlx3.L 7 13 400 101 159 
pdia2.L 9 5 0 3 4 
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slc17a7.L 1 75 93 82 77 
slc32a1.S 4 100 19 50 218 
 
 
6.1.2 Time course analysis  
 
Table S3: Summary of average normalized counts of three independent 
Nanostring experiments for each sample and gene 
 3 h 6 h 9 h 12 h 15 h 25 h 
Gene name CC Ptf1a CC Ptf1a CC Ptf1a CC Ptf1a CC Ptf1a CC Ptf1a 
odc1.L 33893 33078 40930 42484 43118 41525 31637 35136 26616 29026 13869 14788 
ppi1.l 2092 2094 2092 2094 2090 2093 2093 2090 2091 2088 2090 2086 
rplp0.S 8787 8936 8803 9148 8850 9127 9872 10422 11934 10118 28671 20126 
t.S 38 169 67 58 57 67 81 45 41 31 140 17 
pax2.L 4 8 5 16 4 24 9 116 11 255 28 403 
prdm14.L 392 705 536 794 349 377 265 365 212 308 7 101 
tubb2b.S 36 46 59 126 69 147 66 348 48 958 59 7236 
dll1.L 61 264 127 672 214 841 72 537 36 530 16 181 
ebf2.S 1 151 1 682 1 451 1 342 1 424 1 234 
lhx1.S 56 77 37 99 2 82 1 93 1 139 1 305 
myt1.S 149 1512 279 9508 590 10047 1099 7541 1400 6967 358 2421 
prdm13.S 1 348 1 2845 1 4498 1 4960 1 4970 1 2172 
zc3h12c.L 118 1845 270 6817 351 5820 157 3947 123 3283 528 1038 
onecut1.2.L 21 18 101 422 508 1966 777 5344 544 6221 10 5517 
aldh1b1.L 2 47 2 169 4 523 1 824 1 786 3 159 
barhl2.L 18 37 15 115 22 476 14 974 9 686 9 118 
gad1.1.L 1 1 1 1 1 14 1 385 1 697 72 1027 
kirrel2.L 1028 938 1251 2695 761 5455 71 6693 26 5610 13 3474 
neurog2.S 182 235 104 120 49 171 20 641 17 667 2 252 
nr5a2.L 2 12 2 146 7 330 83 543 65 538 1 365 
tlx3.L 27 24 31 125 24 326 11 266 23 211 21 11 
pdia2.L 2 19 1 36 1 110 1 162 1 160 12 74 
slc17a7.L 3 2 1 1 1 2 2 1 1 1 1 17 
slc32a1.S 21 21 16 21 7 15 2 44 2 39 2 248 
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Table S4: Summary of the calculated SEM of the normalized counts shown in 
Table S3 for each sample and gene 
 
3 h  6 h  9 h  12 h  15 h 25 h  
Gene Name CC Ptf1a CC Ptf1a CC Ptf1a CC Ptf1a CC Ptf1a CC Ptf1a 
odc1.L 2289 3005 4585 5388 5548 3565 4115 2821 3236 2935 1943 2463 
ppi1.l 37 36 36 37 36 37 37 37 37 39 36 36 
rplp0.S 817 885 956 1333 496 351 794 687 1016 772 2715 2286 
t.S 4 56 32 10 3 35 41 22 17 5 23 3 
pax2.L 2 2 1 6 2 3 2 16 5 27 13 29 
prdm14.L 93 113 58 223 90 57 188 58 157 105 4 17 
tubb2b.S 7 8 10 26 16 29 10 46 7 43 7 237 
dll1.L 30 24 37 70 71 134 17 108 11 98 3 22 
ebf2.S 0 24 0 35 0 54 0 36 0 20 0 15 
lhx1.S 6 4 12 7 1 5 0 17 0 12 0 23 
myt1.S 37 120 63 645 171 1555 138 1048 272 915 51 180 
prdm13.S 0 62 0 323 0 866 0 667 0 527 0 176 
zc3h12c.L 59 286 86 321 106 226 65 380 54 277 97 110 
onecut1.2.L 14 5 35 116 203 830 126 766 60 617 2 349 
aldh1b1.L 1 20 1 65 1 154 0 306 0 245 1 38 
barhl2.L 4 12 5 23 8 194 3 236 3 123 3 12 
gad1.1.L 0 0 0 0 0 0 0 70 0 107 53 134 
kirrel2.L 147 130 150 427 90 1471 17 797 4 582 6 213 
neurog2.S 7 69 13 14 9 42 11 83 11 72 1 30 
nr5a2.L 1 4 1 40 2 103 11 94 15 71 0 46 
tlx3.L 7 4 9 16 2 97 5 50 18 56 11 4 
pdia2.L 1 3 0 11 0 19 0 30 0 14 5 7 
slc17a7.L 1 1 0 0 0 1 0 0 0 0 0 4 
slc32a1.S 3 8 4 4 3 3 1 10 1 12 1 56 
 
 
6.1.2 Brg1 knock-down 
 
Table S5: Summary of average normalized counts of three independent 
Nanostring experiments for each sample and gene 
Gene Name CC Ptf1a Ptf1a + cMO Ptf1a + Brg1MO 
LOC100487395.L 0 0 3 0 
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Xelaev18005831m.g 20 247 280 177 
Xelaev18007508m.g 1 2650 2653 857 
Xelaev18040877m.g 12 877 1020 386 
Xetrov90021170m.L 43 45 37 77 
adamts20.L 1 0 4 5 
aldh1b1.L 1 38 59 24 
arid1b.L 71 1961 2065 1368 
arl4a.S 7406 8582 8358 11119 
b4galnt1.S 9 300 260 86 
barhl2.L 6 484 619 187 
bgn.L 2 771 585 195 
bhlhe40.L 53 244 233 115 
cacna2d2.L 2 69 79 32 
cbfa2t2.S 360 7883 8720 9569 
chst3.L 1 641 762 466 
dll1.L 52 395 403 402 
dmbx1.S 12 71 109 54 
dmrta2.L 6 576 628 141 
dpysl3.L 7 291 311 82 
drgx.L 21 161 177 59 
ebf2.S 1 371 435 261 
efnb1.L 17 19 22 25 
elavl3.L 298 9329 11480 7174 
eya1.L 882 6855 7133 4627 
fam102b.L 85 48 47 96 
fzd10.S 1513 1227 1248 1785 
gad1.1.L 1 1293 764 133 
gas6.L 1146 2812 2280 2107 
gfi1.L 56 345 405 653 
gfra1.S 56 1575 1800 907 
hes3.3.S 1752 3874 4086 4770 
hes5.1.S 819 3827 4457 4893 
hes5.2.S 0 132 143 25 
hes9-1.S 54 524 547 243 
hesx1.S 21 3694 3490 740 
hoxc4.S 3 24 30 22 
hoxd1.L 16 103 95 299 
id2.L 11345 20374 19866 25793 
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id4.S 3645 7030 6969 5193 
insm1.L 258 3388 3753 2799 
kif26a.L 0 31 49 5 
kirrel2.L 30 3798 4499 3343 
klhl14.L 0 0 1 0 
lbx1.S 1 92 122 24 
lhx1.S 2 89 126 23 
map2.S 6 709 741 307 
map3k12.S 13 120 152 48 
mmp28.L 30 653 648 102 
mxra7.L 33 1324 1579 755 
myt1.S 1589 7720 8590 6062 
ncam1.S 76 822 880 159 
nes.L 22 1019 1488 651 
neurod4.L 2 5382 5844 1307 
neurog2.S 10 277 373 428 
nr5a2.L 6 29 37 4 
olig2.S 30 1645 2079 1253 
onecut1.2.L 661 4637 4972 1747 
otx2.L 367 776 1116 663 
pax2.L 2 55 69 33 
pcdh18.L 1 3 9 25 
pck1.L 27 930 715 142 
pdia2.L 1 37 37 38 
plk3.L 177 1473 1625 960 
pou3f1.S 2 1510 2069 1137 
pou3f2.L 37 494 680 238 
ppp1r9b.S 4 418 428 53 
prdm13.S 1 4303 4560 2242 
prdm14.L 337 434 698 680 
prph.S 10 2106 2578 352 
prr15l.S 0 1 1 2 
rapgef5.L 1149 812 690 565 
runx1t1.L 12 482 489 181 
scrt1.S 1 1523 1930 489 
six3.L 75 1025 1181 183 
slc17a7.L 2 0 4 4 
slc18a3.S 9 843 924 751 
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slc32a1.S 2 6 11 2 
slc3a2.L 45 2599 2543 170 
slc43a2.S 29 692 841 351 
snai2.L 85 885 1121 1004 
snap25.L 14 1227 992 377 
snrk.S 179 190 189 405 
sox11.L 906 9292 12047 6872 
sox9.L 15 385 420 166 
t.S 7 8 12 20 
tfap2b.S 21 2824 2672 999 
tlx3.L 22 434 526 428 
tox3.L 543 2779 3087 2363 
tubb2b.S 94 369 494 176 
tubb3.L 1 130 221 24 
vcan.L 9 58 80 86 
zc3h12c.L 222 3702 4360 3906 
odc1.L 25972 27916 29603 24441 
ppi1.l 2249 2365 2324 2117 
rplp0.S 6807 5917 5697 7544 
 
 
TableS6: Summary of the calculated SEM of the normalized counts shown in 
TableS5 for each sample and gene 
Gene Name CC Ptf1a Ptf1a + cMO Ptf1a + Brg1MO 
LOC100487395.L 0.3 0.3 1.4 0.3 
Xelaev18005831m.g 12.0 91.9 73.6 55.1 
Xelaev18007508m.g 0.4 266.0 669.2 53.5 
Xelaev18040877m.g 4.0 125.1 72.8 154.7 
Xetrov90021170m.L 11.4 2.8 8.7 22.0 
adamts20.L 1.2 0.3 1.8 1.4 
aldh1b1.L 0.4 11.9 28.5 4.2 
arid1b.L 6.6 309.4 337.5 162.3 
arl4a.S 1032.3 1162.4 853.1 1197.2 
b4galnt1.S 4.8 86.9 72.1 23.6 
barhl2.L 2.5 67.4 105.4 77.3 
bgn.L 1.9 290.7 129.7 60.9 
bhlhe40.L 6.5 39.2 26.4 11.8 
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cacna2d2.L 0.8 18.6 17.9 11.0 
cbfa2t2.S 122.8 1600.8 1785.0 1799.8 
chst3.L 1.2 120.1 146.5 92.7 
dll1.L 16.8 66.4 106.8 160.9 
dmbx1.S 8.3 4.2 22.9 16.1 
dmrta2.L 4.8 145.0 186.9 58.3 
dpysl3.L 2.5 79.4 84.2 27.8 
drgx.L 4.7 35.7 32.2 1.9 
ebf2.S 0.4 47.0 94.9 38.3 
efnb1.L 6.3 5.0 0.6 2.5 
elavl3.L 20.9 1184.4 1339.5 1441.1 
eya1.L 297.7 1517.1 1473.2 1064.7 
fam102b.L 10.2 13.1 7.0 24.5 
fzd10.S 283.5 294.1 330.8 321.9 
gad1.1.L 0.4 536.2 101.1 78.2 
gas6.L 442.4 971.7 474.5 392.7 
gfi1.L 11.6 74.3 67.4 190.4 
gfra1.S 11.5 77.3 58.4 235.7 
hes3.3.S 561.9 1095.9 1239.8 1551.3 
hes5.1.S 187.4 554.1 541.7 1153.2 
hes5.2.S 0.3 33.1 15.6 6.9 
hes9-1.S 11.2 71.5 51.3 46.0 
hesx1.S 10.9 797.8 641.8 197.8 
hoxc4.S 1.7 7.4 6.0 6.5 
hoxd1.L 6.9 28.7 40.9 81.6 
id2.L 3042.5 6611.5 5984.5 8745.8 
id4.S 835.0 1936.9 1406.9 1060.0 
insm1.L 101.7 844.6 914.4 276.8 
kif26a.L 0.3 13.7 14.7 3.5 
kirrel2.L 7.6 226.6 587.5 105.0 
klhl14.L 0.3 0.3 0.4 0.3 
lbx1.S 0.4 11.5 21.8 12.4 
lhx1.S 0.7 37.5 20.9 6.3 
map2.S 0.9 132.5 130.9 46.9 
map3k12.S 5.7 33.3 5.8 14.9 
mmp28.L 11.0 199.2 179.1 17.9 
mxra7.L 10.2 380.8 369.8 134.4 
myt1.S 726.4 1958.6 2241.6 1004.7 
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ncam1.S 6.9 131.2 120.8 34.5 
nes.L 2.0 70.8 106.6 128.9 
neurod4.L 1.2 760.6 1314.2 120.2 
neurog2.S 4.0 50.5 39.7 26.2 
nr5a2.L 2.1 8.4 8.2 3.2 
olig2.S 8.9 518.4 542.8 63.8 
onecut1.2.L 191.8 1040.7 672.5 436.2 
otx2.L 69.5 14.6 74.1 224.8 
pax2.L 0.5 8.5 12.0 14.7 
pcdh18.L 0.1 1.0 0.5 3.7 
pck1.L 15.8 222.2 177.1 27.5 
pdia2.L 0.4 7.0 9.7 11.7 
plk3.L 38.6 118.7 165.0 81.0 
pou3f1.S 1.9 480.6 740.8 304.0 
pou3f2.L 11.0 96.0 189.0 42.7 
ppp1r9b.S 3.3 69.0 27.5 31.6 
prdm13.S 0.2 531.2 705.8 272.9 
prdm14.L 128.7 27.3 86.6 147.4 
prph.S 3.0 345.1 393.2 154.0 
prr15l.S 0.3 0.4 0.4 1.6 
rapgef5.L 332.6 220.2 131.5 89.0 
runx1t1.L 5.8 82.0 90.8 7.4 
scrt1.S 0.4 122.9 340.8 115.4 
six3.L 29.2 134.9 143.9 53.6 
slc17a7.L 1.3 0.2 1.6 2.1 
slc18a3.S 5.9 235.1 255.6 129.1 
slc32a1.S 1.1 1.4 1.6 0.6 
slc3a2.L 10.9 640.0 571.7 86.7 
slc43a2.S 3.9 134.9 91.4 63.4 
snai2.L 30.1 126.7 170.1 228.2 
snap25.L 6.2 232.0 121.8 55.4 
snrk.S 21.9 11.9 16.9 100.3 
sox11.L 302.1 734.5 1214.8 729.2 
sox9.L 3.5 25.1 33.0 41.7 
t.S 5.7 0.7 2.1 7.4 
tfap2b.S 1.1 179.5 247.8 347.4 
tlx3.L 12.3 141.6 149.1 109.3 
tox3.L 189.7 534.0 504.7 419.6 
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tubb2b.S 5.9 57.4 37.5 20.8 
tubb3.L 0.1 14.1 14.5 10.3 
vcan.L 3.0 6.2 8.8 15.3 
zc3h12c.L 107.2 944.4 1209.4 1032.3 
odc1.L 5393.4 5003.5 5961.8 4832.0 
ppi1.l 183.5 231.2 273.2 243.0 
rplp0.S 1306.4 1089.4 825.9 1179.1 
 
 
6.2 Summary of the genes analyzed with the Nanostring 
 
Table S7: Summary of the geneses analyzed with Nanostring. Given is the gene 
symbol, its accession number as well as the target region and the target sequence. 
Grey marks the genes analyzed on the 24 gene codeset used for analysis of the 
time course and threonine mutants experiments   
Gene Accession Target region Target Sequence 
odc1.L 
NM_001086
698.1 
856-955 
GGATATAATTGGTGTGAGTTTCCATGTTGGCAGTGGCTGC
ACTGATCCACAGACTTATGTACAAGCTGTCTCAGATGCAC
GATGTGTCTTTGACATGGGG 
ppi1.l 
NM_001193
402.1 
430-529 
AAACAGACTTGGAATGGTGGAAACAGATTCTCAGGACCG
ACCACTTGATGAAGTTCAAGTATTGCGGGCTTATCCATCT
GGCTAAATGGAGGCAGATAAA 
rplp0.S 
NM_001086
665.1 
127-226 
TCAATTGCTCGATGATTATCCAAAATGCTTCATTGTGGGG
GCGGACAATGTTGGTTCAAAACAAATGCAGCAGATCCGTA
TGTCCCTGCGTGGAAAAGCT 
t.S 
NM_001090
578.1 
1530-1629 
TGTAGGCCTCCAAAACAACTTAAAGATGTGCTTAGGCAAG
TTATATCAGTGTTTACCTGCTTCTAAAGACTTCATGGGCCC
AACCAGGTGTGGGTGGTCT 
tubb2b.S 
NM_001086
064.1 
901-1000 
TGCACTTTTTTATGCCAGGCTTTGCCCCATTAACAAGTCG
TGGCAGCCAACAATACCGAGCCCTGACAGTGCCAGAACT
AACACAGCAAATGTTTGATTC 
neurog2.S 
NM_001088
335.1 
1173-1272 
CATCGTTAGCTATGTGTATTAGGAAACTGTCTATCCCTCAT
CTGCACCTGTTAGACTACAGCTACCAACTTCCTGTTACCA
GGGGGCTACTGGGTAATGT 
ebf2.S 
NM_001085
678.1 
1765-1864 
CTCCAATGGTTTCCGAGAAAATCTGTTGAAGGACAGTCCT
GCCATGAGGCAAGGTCAATACTTCGCCCAGTGCAGCAAT
CCCTCAGTGGGTTTCTGGTAG 
tlx3.L 
XM_018252
115.1 
340-439 
ACCTTCATGGATGTGCTGTGAGGAAGACGAAGCGTTTAG
AGGGGAGAGTTCTCATTTGAGACAATAAATCTATCGACGG
AGGATGGATCAGCCAACAACT 
gad1.1.L 
NM_001085
801.1 
795-894 
GGCAGCAGTCCCCAGATTGGTCCTGTTTACTTCAGAACAC
AGCCACTATTCCATAAAGAAAACTGGCGCGGCATTAGGAT
TTGGAAGTGAAAATGTGATC 
slc32a1.S 
NM_001086
492.1 
1078-1177 
TTAATGTACAACAGCTTTCCAAACCTGCCCATATCCCAGA
AGTCTTGGTCCATCATGGCCACTGCTGTGCTCCTGCCCT
GTGCATTTCTCAAGAACCTTA 
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slc17a7.L 
NM_001089
635.1 
2178-2277 
AGTGAATTGAGTTAGATGTACACATTACTGCGTGATTCCC
AGGGATACGGTGTAGAAAATATCCATGAGGATGGGGCAT
GATCAATTCTACATCACTTGG 
prdm14.L 
Xelaev1803
2099m.1 
586-685 
ATCTCCCATAGTCCCCAAAAAGTGCAAAAATGTGTCCCTG
AGTGTCCCCAGCCTACAGGTGAGACCCACTCGCACTTAC
CACTTTACAGAAGAAGACTTA 
prdm13.S 
XM_018265
418.1 
33-132 
ATTGGATTTTTAGGAATGAGAAGGTCGCCTGGACCATTGT
CTGGTTACCATTCATGGGAGCTGATTATGCAGGAGGCTTA
GGGAAAGTCTCCATGTGACC 
zc3h12c.L 
XM_018247
762.1 
86-185 
GTGTCTGAGGCGGGCAGCTTGCTCCCTAATGACTTGGCC
TCTCACTGAGCAGCTGCCTGCTGCCTCCTTTGTGTTGGCC
TATTGTTGCCGCACACCCCTC 
myt1.S 
NM_001088
192.1 
685-784 
GAGCTAAACAATGAAAAGCCAACTTCAGTAAAGTCGGGTC
AAGCGGAAATAGAACAACTTATGGTAGAAGAGGCGTGTG
AGAAAGAAATCATCATCCAGA 
dll1.L 
XM_018263
063.1 
3628-3727 
CCCATGTAACTTCAACAGTATTTCTGGTGGGGGTTCACTG
TGATTGGCAGAGGAGTGGGTGTAGTATCTCTGGCGTCAA
CCCTGCATGCTTTTGGTCCCT 
kirrel2.L 
NM_001086
488.1 
691-790 
CCCAGTCGCCAATGTCCTGCTTGATGTACCCTACAATCTC
ACCTGTCTTGCTTCCGTCGCTAAGCCTGCTGCAGAGATTA
CCTGGTTCCGTGATGGAAAG 
pax2.L 
NM_001086
361.1 
1495-1594 
GAGTGGCCTACTCTGCTTTCCCTACTGACGTTTCTCAGCT
GTAATAAGCTGCTCTTACCTCTGCTGCAAGCCTCTTTGTT
GTTATTGTGCACGGTAGCTA 
lhx1.S 
NM_001090
659.1 
22-121 
TCTATTCTCCTAATCCGCCCATTCCTCTAAAATCCCAAATA
ACCAAAGGCAATGGTTCACTGTGCTGGATGCGAAAGGCC
CATTCTGGACCGTTTCTTGT 
onecut1.2.L 
XM_002935
458.4 
4346-4445 
ATGCTCATTATAACAAGGAGAGTCTGGGGTGAGGTCCCC
AATTTGTGTGGGGGATTCAACTGAGGAACCACAGGAAAT
GCAGGCAAGAAGGGATCTTTTC 
barhl2.L 
NM_001161
386.1 
860-959 
ATTGGAGTTACTAGCCGAAGCTGGCAATTATTCAGCCCTG
CAGAGAATGTTCCCATCACCCTATTTCTATCATCCGAGTC
TGCTGAGCAGTATGGACAGT 
nr5a2.L 
NM_001087
716.1 
152-251 
CCACTTACTCCCTAGCTCATGCTCCCTACGGAACTTGCTT
TATCCGATGACTGTAATTCCAATTCTGCCACAGGACAACC
GACTGATTCACCTCCAAATC 
aldh1b1.L 
XM_018257
027.1 
967-1066 
AGAACAAGCCGTGGAACAATGTCACGAGGCTTTGTTTTTT
AACATGGGACAGTGTTGTGCTGCAGGTTCCAGGACTTTTG
TGGAGGAAACGATCTACCGT 
pdia2.L 
NM_001090
179.1 
882-981 
TGCTGCCCAGATCCCAAACCACTTGTTGCTGTTTATCAAT
AAGAGTGACGATTCCCAACTGGTGCTGCTGGAACATTTCC
GCAAAGCAGCTCCTGACTTT 
arl4a.S 
NM_001090
805.1 
893-992 
AAACACCAGGAAACCTAATGTACGTCAGAGGCTGAAACG
CAATCTAGTCATTGTGAGTGTAAACTGTGAATGTGTGCAG
GGTGTTGAAACAGCTGAGGGT 
elavl3.L 
NM_001090
611.1 
919-1018 
ACATCCCGTATCCTGGTGGATCAAGTGACAGGTGTTTCTC
GAGGTGTGGGCTTTATCCGGTTTGATAAGAGAATAGAGG
CAGAAGAGGCTATTAAAGGCC 
fzd10.S 
NM_001087
457.1 
2470-2569 
AGCAGTCATGGAAATAGTAGTTAGTTCAGTAGGATCTGGA
TTGCTGCAACAGGGCAGTGCCCACCTAAGTTCTTAGCATG
CGTAGGGTTTGCTTGGCTCT 
gfi1.L 
XM_018258
576.1 
735-834 
CCTGCTCTGCACGCGGCTGCTAATCAACAACGGCTCATA
CAAATGCCTTAAATGCAGCAAGGTTTTCTCCACACCCCAT
GGGCTTGAAGTCCATGTACGT 
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hes3.3.S 
XM_018227
971.1 
974-1073 
ACCCTAGGCTGAACGCAGGCAGGCCGGACTTGCAGCCCT
CTGGCAATTTTGCCCTGAGGAAAACTTGCAAATTCTGCAA
TGGTTTATCCATGGCACTTAA 
hes5.1.S 
NM_001095
627.1 
327-426 
CAGAAAATGGAGAAACCCAGATGAAACTGCTTAATCACCT
GCAAGCACCCCAAAGGCTCTCAGTTGCCCCTCACACCTA
TATCCCCAGTGTTTCTGACTC 
hes5.2.S 
NM_001095
626.2 
339-438 
AAGCAGCCAGAAGCAGAAGCCAAGCTAATCAGTCATTTCC
ATTCAAATGCGGCAGCCAGCAGCATGTCGTCTTTTCCTAT
GAGATACAATCAATCCAAGC 
hes9-1.S 
NM_001095
628.1 
352-451 
GCTTCTGCAAAATTTCCATGATGATGTGACAGCGTGTCCT
TCTGTGTCACCTTTTTACCAGAATCCTGCCAAGTGCACAA
CCCCTGAGGCCAACAAAGTT 
slc18a3.S 
XM_018239
458.1 
329-428 
CCAAAATGAGGGAGTCCCGCTCCTATCTGTGATGCTACTG
GAGTCACCATGTGAGAGGGGAGGTTCGCTCACCGGCAAT
TGGTTAATGTTCCTCCATGTG 
mxra7.L 
NM_001094
445.1 
663-762 
ACACATCACCTAGTGGTAGTGGGTGATACTGCAGCGCAA
GATGCTTAAAGACACAGAAACGGTGACCGGCCAATAGAG
TTCTGCAATAACGTGGCAGTGT 
olig2.S 
XM_018248
885.1 
1734-1833 
TTCGGTTCTGTGTCCCAGACACTGACAATGAACTATCAGC
CTGTAAGTCTTAACTACTTCTACCACAGTCAGGTGCAGAT
CACTTTAAATGCCACCAACA 
pcdh18.L 
XM_018231
826.1 
590-689 
TTGTGGCAGCTATATTTATCACTTGGTGGCTGTGTACTTG
GACATGACCAGCCTGCTGCCCTCCAGATGTAGTGGATTG
AAGTGTCAGCAGAGTTTCAAT 
pou3f1.S 
NM_001103
185.1 
424-523 
ATCTACTCGCAGTCCTCCTACACCAACCTGAATGGCATGC
TGGGACCTCAGGCTTCCTCTTTGCACCACAGCATGAGAG
ACCCCTTGCACGATGACCCCG 
id2.L 
NM_001088
433.1 
868-967 
CGACTTTTTGGGCGATAAAAGGAGCGAAGAAGATCGGGA
AACTTATTTCAGTTTTTGCTCGAAGTGTAAAACCAGAAAAC
CTTGAAACCTTCCCATCCCG 
id4.S 
NM_001171
975.1 
149-248 
ATGATATGAATGACTGTTACAGCCGGCTCAAGAGGCTCGT
GCCCACCATTCCACCCAACAAGAAAGTCAGCAAAGTGGA
AATCCTGCAGCATGTTATTGA 
insm1.L 
NM_001110
719.1 
2178-2277 
CAAATGACTGTGTCCGCCCATGAGTCGCTTCTACAATGAG
ATAAATGTATATTGCCCAGTTGCCATCCACTCACTGTTACA
GCATTTGTGATGCCCTGAC 
cbfa2t2.S 
NM_001086
475.1 
2327-2426 
TCATTTGGTTGCTATCAGCTTGCTACAGCCTTCAAATATG
GCCTCAAAGTGCTATCCCAATTATAGACTGCTTACTGGAC
TAAGCCATGTCTGTATTTGG 
chst3.L 
XM_018225
491.1 
4782-4881 
GGTCATCATTGTATCTATCCAGTAAAAGGTATCACCCAAT
CCACAGGATCCACACTTGTGCCCTTACACATACCTATGCT
AAAAGCAGGTATTTTCCAGA 
prr15l.S 
XM_018238
024.1 
249-348 
CGTTCCTTTTGTCGTCCATACCCACCAGCTAGAAAAGGTT
GTAGGTCGGGAAGTCTCAGTTGTACATACAGTTTGCCTCA
AGCAAATCTGAAGGGGCTAT 
six3.L 
NM_001085
702.1 
777-876 
ACAGAGCGGCCGCCGCTAAAAACAGGCTTCAGCACCAAT
CTATCGGACAGAGTGGCATGAGGTCGTTGGCAGATCCCG
GCTGCCCCACACACAGCTCGGC 
snrk.S 
XM_018269
314.1 
2348-2447 
TCGCCCAGAAGTGCTGGAGAGTTGGTGGAAAGTTTAAAA
CTAATGAGCCTCTGTTTGGGCACGCAGCTACATAACGGG
GCTAAGTATATAATTGACTCTC 
tfap2b.S 
NM_001094
232.1 
1243-1342 
CTTTGTAAAGAGTTCACAGATCTTTTGGCCCAAGACAGGA
CACCCATAGGCAACAGTAGGCCCAGTCCAATTTTGGAAC
CTGGAATCCAGAGCTGCTTGA 
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slc43a2.S 
NM_001097
830.1 
3239-3338 
GGTGACCTACTGTCAGTCTTTTGTGTGATCAGAGGTGAAT
CTGGGAAAATGAATGTTTTGGGAAGCAAAACTCAACTCAG
ATACATCTGGCATCAGGACA 
Xetrov90021
170m.L 
XM_018232
445.1 
1120-1219 
TGCCTCTGGCACAGGCTCACCAGACAATTGCTCTTCGTTT
CAAGAGGATGAGGACTTAGATATGGAAAACCTTGGCTGG
CCTGTTAGTAGTTTCACCATC 
Xelaev1800
5831m.g 
XM_018252
463.1 
379-478 
TGGATCCCTCAGCACCATGGGTTCAAGGGATTATCAAGAA
AAATTCTCTACAAGCAGGCAACAGAGATAAGTAAGACAAA
GAAGAAGAGCAAGTCTTCGA 
hoxd1.L 
XM_018235
932.1 
961-1060 
ACGCTTGACTACAGACTCTCAGCTAGAAACCAAATATATG
GGATTGTCTCGTAACACAATGCATACTGCTGCACCCCAAG
CAGCCATAAACTAAGGGGAC 
arid1b.L 
XM_018263
082.1 
193-292 
GCTGAGCACTCTACCAAATGATATGCTTATTGCCAGACTG
TGTCCAAAGTAGGAAAGGGCACCATACATCCTTGGATTCT
TCTTGCTAGAAATCACCTTG 
bhlhe40.L 
XM_018259
016.1 
386-485 
CTCACTAGCCCTGGACGAGCCCATTCGCTCCGTCAGGTT
CATGCCACTGACTGGAATACACACACCCACCCGCTCCATT
CCCAAACAGCTGCCACTCGGG 
dmrta2.L 
XM_018258
408.1 
629-728 
ATAGGGCAGTGAGTGCAGTTATTGGCGCTTTACTGTAGC
GCATAGAGTGTGTATAGAGTTGTACCAGTCAGGGGAGTTT
GTGCCCTTTCCAGTCCCGTGT 
dpysl3.L 
NM_001086
642.1 
80-179 
AAAAAATACATTGCCTGTATCTGATCAGCTGTAAATCAGTC
AGGGGAAGCAGAAGCAGCGGGCTCGGAGGCAAAACATG
TCTTACCAGGGGAAGAAGAAC 
efnb1.L 
NM_001087
479.2 
110-209 
TTATATCTGGAAAGGGCCTGGTTCTATACCCTGAAATTGG
CGACCGCTTGGACATTATCTGCCCCAAGGGGGACTCTTC
CCAGCCTTATGAATACTATAA 
gfra1.S 
XM_018227
240.1 
1934-2033 
ACAAGATCGAGAACAACCAATTCGACTCTAACAGAGGAAA
AATAAAATAAAGACTGCTCTCTGGTATTTAGGGGGTGTTG
TAATTTATCACTGAGGTGCC 
nes.L 
XM_018231
440.1 
6793-6892 
GTACTGTAAGGCTACAGGGTCTTTACAGGCTTGGGATATT
GAGGGTTTAAAATGTTAGCTGTATGGAAATGGGTTGATTC
TTAGGAATGGCAGCTGAGTG 
neurod4.L 
NM_001087
744.1 
666-765 
AGTAATGGATCCTTCTGTGGTAACCCATACACTTAACTGT
ACCACTCCACCATATGAAGGAGCTCTAACACCTCCACTCA
GCATCGGTGGTAATTTTTCT 
plk3.L 
XM_018258
343.1 
2967-3066 
GACTGTTTTTGACGGAACACAAAGCAGACCAGCAATATGC
AACACTTTGTGTAAGAGTAGAGAAAACACTACAGTTGTGG
ATCACTTCAATCAGCAGACC 
snai2.L 
NM_001086
282.1 
554-653 
CTCTACTTTCTCTGGGTTGGCTAAGCACAAGCAGCTGCAT
TGCGACGCCCAGTCTCGGAAATCATTTAGCTGCAAGTACT
GTGAAAAGGAGTATGTGAGC 
sox9.L 
NM_001094
473.1 
163-262 
CTGACTTGGCCACTTCCATTGTTCTCGGTTAAGTTGCGCA
AAGACGCGGCTCTGCGCAAACAGTGCCACCCGCAGCCG
ACGAACTCGCTTTTCCAACATT 
tox3.L 
XM_018257
839.1 
557-656 
ACAAACCGAACAGCTAGCTCCTACCACAGAGACTCCTCTC
TAGATTTTTGTGCGATTGTAAATGCCGAGTAACTGGAAGA
TCTGCCACCAGCCTTTACGC 
vcan.L 
NM_001110
715.1 
433-532 
TCTTTGGATGTTTCAGGAGTCGTGTTTCACTACCGAGCCT
CTACAGACAAGTACTCTTTGGACTTTGAGGCTGCTCAGAA
AGCTTGTATAGACAGCGGTG 
pou3f2.L 
NM_001096
751.1 
29-128 
GCTCAGCATCCCGCAGGTTGGAAAAGGGTGGGCGGGAC
TGTTTGGATCATCATCCAATGGCTACGGCGGAAAGTCTCC
GGTTGCTAGAGGTATCCACGTA 
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scrt1.S 
XM_018238
286.1 
4316-4415 
TAGGCAGGGACTACATATTAGCCGTGTGCTCTTTCTCCAC
CCTATAGTATTTCTTTGGAACAGTTGGAAGGGGCTACTTA
TGAGACTCACGCTCTTCCAT 
hesx1.S 
NM_001085
795.1 
169-268 
TTGAGTGCAGCAGCAAGGTTGACGGCACCTTTTGGCAAA
TCCCATTGATCAGCTATGACCTTCCCGTACAAGTTGACGC
CATGCGCCGATCCGCAGAAGA 
drgx.L 
XM_018225
618.1 
12-111 
ACATGGGACTAGGCAGACAGCGCTAATTCTGACCCGAAG
GGAAGACAAGACTTCCCCTCGAGGATCAAGTCAGCGATC
ATGAGCATGACCATAGCTCCCC 
b4galnt1.S 
XM_018250
090.1 
2683-2782 
TCTGAAGCGCAACTTAGTAAGAGCAAGTAAGAGCCTAGG
ATGCTAGAAAAGAAAGACCTCAACTCCTCCAACCTACATA
ATCACCAAAGCTCCTACCCAT 
map3k12.S 
NM_001100
941.1 
1870-1969 
AGAGGAATGTACCTCAGAAATTATCCCCACATGGGAAAAG
GCCAGACATTTTGAAATCTGAAGTCCTGCTGCCAAAGGTA
GACTCTGTCTTGTCACCCTC 
tubb3.L 
NM_001094
986.1 
1642-1741 
AGGTACTGCACCTTAATAACCCTTTTAACGCTTGCCAGTTT
CAGCAGCAGAGCAATGTTCAGCATTCAACAACATATCATT
GCAGGCTCCAGTGAACAGA 
hoxc4.S 
XM_018250
129.1 
483-582 
TTGGAATGAGCCTCTGGTTCCTTATCCGGGGACCTGAGC
GCACGTTGTGATTGGCTGCCGGAGTCACATGGTGAAAGT
AACTTTACGGGGTCGCCAGCTA 
kif26a.L 
XM_018230
605.1 
118-217 
TTATAAGTATTGATTGATACCCACCTGCCTCTTATTGCACG
GGCTGCACTTCCATTACCACGTGATTGACTACACGACTAA
GTGCTTTCCTTGTAGCTGT 
eya1.L 
NM_001090
419.1 
820-919 
ACAGCCGAATACAGCACTATCCACAGTCCATCAACGCCTA
TTAAAGATTCAGATTCAGATCGATTGCGGCGCAGTTCGGA
TGGAAAGTCACGGGGACGAG 
bgn.L 
NM_001090
709.1 
1208-1307 
GTTGGCGTCAATGACTTCTGCCCTATAGGATTCGGAGTGA
AACGCGCCTACTACAACGGAATTAGTCTATTTAACAACCC
CGTGCCCTACTGGGAAGTGC 
Xelaev1804
0877m.g 
NM_001086
467.1 
1086-1185 
CAACCCCAACGGGATCATTGCCACACCCATCACCCAAATT
AACCCAATCACTTCTTCTTCAGGTACCAGTACTCCACCAA
CACTCACTGCCACTCAAGTA 
LOC100487
395.L 
XM_004911
907.2 
5272-5371 
GCCTTACCACTGACTTCCTCTACTTTGGCCATTTTCTGATA
GGTTACACCCATCTCCGGCCAAGTCCAGAGTCTCTGTAGT
TGTGCTGTGACCTAACAGG 
gas6.L 
NM_001089
688.1 
1811-1910 
TCCTTTGATGGGACCCTCGGACTAAAAGAACTGCCTGATT
CACAGATGCAGATGACTTTGCTTCTGCTAAATGACCACTT
AGGAAAGGGTGTAAAGACAT 
lbx1.S 
XM_018227
455.1 
272-371 
TTCTTTTACCTTCTCCCTGGCCAAAGGATGAATTTAGCTG
GGAGTAGGCTGAATTCTGTTTGAAGGGAAGGAGCCTGAG
ATTGCACAAGAAACATCCAGC 
Xelaev1800
7508m.g 
XR_001935
594.1 
572-671 
CTTCAACAGGATGTGCAGAAGTGAGCACCAAGCACTGGT
AAGATTGCATACACAGAGCTGCAAGAGAGTCCTGGTACTT
ATCCATACAAGACCTCCAGAG 
map2.S 
NM_001086
770.1 
1188-1287 
CCACAAACCAGGTGGTGGACATGTGAGGATTGAAAGTGT
AAAACTTGATTTCAAGGAGAAAGCACAGGCTAAAATTGGC
TCTTTAGACAATGCCAGTCAT 
mmp28.L 
NM_001172
229.2 
14-113 
GGTGAGCAGCTACAGGTCTCAATCCAAGGACTATACCAT
GCCTGGCTGAGAAGAACAGCAGAAGTCTCTGATAACTCT
GCCAAACTCTACACTTGGGAAG 
ncam1.S 
NM_001087
827.1 
45-144 
CATCTGGACTTTATATTTCATAGGAACTGCAGTGGCGTTG
GAAGTGAACATTGTTCCAGATCAAGGAGAAATAAGCCTTG
GGGAGTCCAAATTCTTCCTG 
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otx2.L 
NM_001090
691.1 
43-142 
TCCACTTGTAGAAAATTGTGCGCAAAAAAAAATAAGAAAAA
ACGCCCAACGGATCCAGCAAACACTGATCGCCCGACTTT
GTCGCTGCAACGATTTCTTC 
pck1.L 
NM_001086
683.1 
2306-2405 
TGTAGGGTGGATGTACAAAGCAAAGGCGGTATAGTTTGT
GCCTCTTCTTTATTAGAGGTGGGTCAGTCTAGTGAAATAA
GACTCAATCCAGATTGTCACT 
ppp1r9b.S 
XM_018238
072.1 
3927-4026 
TCCGGCTGCCCCAGATATCCTAGCACCTCTCATGACCCTC
CCGTTGTGTTAAAATTCCACTGTAAGAATGCAGAGGAGGT
TCGCTGTTTGGGGGTGACAT 
snap25.L 
NM_001090
411.1 
495-594 
TAGAGAAACAGAAATGGATGAGAACCTTGAGCAAGTCGG
TGGCATTATTGGAAATCTTCGTCACATGGCCCTCGATATG
GGCAATGAGATTGACACACAA 
sox11.L 
NM_001142
362.1 
593-692 
AGCGGCAGCGGCTCCAAGTCGCTCAGTATCAAGTCCGAG
TACAGCGGCGGCAGCGACGAGTATGTGTTCGGCAGCCC
CAAAGCGTCCGGCAAAGCTGCGG 
prph.S 
NM_001086
386.1 
227-326 
AAGGTCCAGTACCCCTGTCCGAGTCTCATTGGACCGAGT
GGACTTCTCTGCGGCTGAGGCTGTTAACCAAGAATTCCTG
ACCACCCGCAGTAATGAGAAA 
slc3a2.L 
NM_001085
977.1 
855-954 
AGAGTCCTGTTGTTATCCACAAGTAGTGCTCAAAACAACC
TTACTGGTGGCTTCAATGAGACAATAGATGGCACGCTCTT
CTACCGCTTCCTGGGTGCTG 
runx1t1.L 
NM_001095
596.1 
650-749 
ACCTTCATCCTCTTCGTCATCGTCGCTGGCCAATCAGCAG
TTGCCTCCGGCTTGTGGCGCACGGCAGCTCAGTAAGCTC
AAGCGATTCCTCACTACATTG 
dmbx1.S 
XM_018260
870.1 
2128-2227 
TGCGAAAAGGAAATGCTTTAGCTGTAGGGAAGAAAACACT
TTTGGTGTGGACTGTGTTCCGCAGAGACTAGATGCCATAC
TTTTCCTCTGACTGAATGCC 
cacna2d2.L 
XM_018258
986.1 
5458-5557 
ACCTCCCTGTCATACAGTACGGTACCAAAGAAGCAGGTTT
TGACTAAACGTGTTGCATCTCTTCGGCGTAACGTGTCACA
TCTGAACAGGAAGCAATGGC 
rapgef5.L 
XM_018267
363.1 
1998-2097 
CTGCGGGGAAAAACATGAGCTTCTACCAAATGAATTGGTC
CTCTCCAAAACCCTGGAGCCCTCCAACCGTATTTATACTT
ACAGGAAGAGTGACACATTG 
klhl14.L 
XM_018267
966.1 
524-623 
CATTATTGCTACTCGCACATTCCTGCTCTCCCTCGGCGGC
TCATTCACTACTAGGAGCACCATGTTGATGATATACGGAC
AAATACACTGTGAGGAGTGA 
fam102b.L 
XM_018258
650.1 
3715-3814 
GTGCTGCTGATTCACTATAAGAGCAAGTATATTGGCAGTA
GTTCAAAGGGCAGAGGCCAAAACAATTAAAATCGGTGCC
ATTCAGTTGTATGGCAGATAC 
adamts20.L 
XM_018251
404.1 
3770-3869 
CAGCTTCTTGTGGGAGGGGTAATCGTGCTCGATATGTGA
GTTGTAGGGATGCGTTTGGTGGAGTTGCTGAAGAACTGTT
TTGCGCCCATTTTCCACGACC 
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6.3 GO tables RNA sequencing experiments 
6.3.1 RNA sequencing experiment onset of target gene activation by 
Ptf1a 
Gene Ontology (GO) analysis was performed using DAVID (http://david.abcc. 
ncifcrf.gov) as previously described (Dennis et al., 2003). Analyzed were genes 
which were upregulated after 3, 6 and 12 h, respectively. 
6.3.1.1 GO analysis of candidate genes upregulated after 3, 6 or 12 h. 
Given is the biological process, the number of genes and the P-value. Biological 
processes were sorted according to the P-value from lowest to highest. 
 
Table S8: Summary of GO analysis of genes upregulated after 3 h. Shown is the 
top 20 enriched categories in Biological Processes  
Term Count PValue 
GO:0007275~multicellular organism development 29 1.67E-10 
GO:0045944~positive regulation of transcription from RNA polymerase II promoter 25 4.33E-08 
GO:0000122~negative regulation of transcription from RNA polymerase II promoter 21 8.74E-08 
GO:0045893~positive regulation of transcription, DNA-templated 17 1.65E-06 
GO:0006351~transcription, DNA-templated 32 1.93E-06 
GO:0045665~negative regulation of neuron differentiation 7 1.24E-05 
GO:0006355~regulation of transcription, DNA-templated 34 1.30E-05 
GO:0007399~nervous system development 12 4.97E-05 
GO:0048663~neuron fate commitment 5 6.13E-05 
GO:0042472~inner ear morphogenesis 6 1.26E-04 
GO:0045892~negative regulation of transcription, DNA-templated 14 1.47E-04 
GO:0007386~compartment pattern specification 3 2.69E-04 
GO:0001657~ureteric bud development 5 3.05E-04 
GO:0090090~negative regulation of canonical Wnt signaling pathway 6 6.36E-04 
GO:0008045~motor neuron axon guidance 4 8.68E-04 
GO:0014807~regulation of somitogenesis 3 1.23E-03 
GO:0060612~adipose tissue development 4 1.54E-03 
GO:0001822~kidney development 6 1.88E-03 
GO:0045747~positive regulation of Notch signaling pathway 4 1.97E-03 
GO:0043507~positive regulation of JUN kinase activity 4 2.47E-03 
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Table S9: Summary of GO analysis of genes upregulated after 6 h. Shown is the 
top 20 enriched categories in Biological Processes  
Term Count PValue 
GO:0007275~multicellular organism development 57 1.15E-20 
GO:0006351~transcription, DNA-templated 62 8.09E-12 
GO:0045944~positive regulation of transcription from RNA polymerase II promoter 42 3.68E-11 
GO:0006355~regulation of transcription, DNA-templated 67 1.17E-10 
GO:0007399~nervous system development 25 1.40E-10 
GO:0000122~negative regulation of transcription from RNA polymerase II promoter 34 3.61E-10 
GO:0045893~positive regulation of transcription, DNA-templated 29 1.84E-09 
GO:0045665~negative regulation of neuron differentiation 11 4.92E-08 
GO:0001822~kidney development 13 1.25E-07 
GO:0048665~neuron fate specification 6 9.40E-07 
GO:0045892~negative regulation of transcription, DNA-templated 24 1.95E-06 
GO:0007219~Notch signaling pathway 11 5.26E-06 
GO:0030182~neuron differentiation 10 4.12E-05 
GO:0010628~positive regulation of gene expression 17 6.68E-05 
GO:0071599~otic vesicle development 4 7.21E-05 
GO:0030154~cell differentiation 25 7.94E-05 
GO:0061314~Notch signaling involved in heart development 4 1.14E-04 
GO:0014807~regulation of somitogenesis 4 1.14E-04 
GO:0010977~negative regulation of neuron projection development 7 1.76E-04 
GO:0010629~negative regulation of gene expression 13 1.82E-04 
 
 
 
Table S10: Summary of GO analysis of genes upregulated after 12 h. Shown is 
the top 20 enriched categories in Biological Processes  
Term Count PValue 
GO:0007275~multicellular organism development 93 9.40E-25 
GO:0007399~nervous system development 52 1.45E-21 
GO:0006351~transcription, DNA-templated 107 1.89E-13 
GO:0006355~regulation of transcription, DNA-templated 119 1.64E-12 
GO:0030154~cell differentiation 54 8.26E-10 
GO:0030182~neuron differentiation 20 1.59E-09 
GO:0000122~negative regulation of transcription from RNA 
polymerase II promoter 
51 1.88E-09 
GO:0014032~neural crest cell development 9 5.56E-09 
GO:0045893~positive regulation of transcription, DNA-
templated 
43 6.98E-09 
GO:0045944~positive regulation of transcription from RNA 
polymerase II promoter 
59 3.46E-08 
GO:0001822~kidney development 18 8.94E-08 
GO:0007411~axon guidance 18 6.53E-07 
GO:0009952~anterior/posterior pattern specification 15 2.13E-06 
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GO:0045165~cell fate commitment 12 3.66E-06 
GO:0001501~skeletal system development 14 6.74E-06 
GO:0045892~negative regulation of transcription, DNA-
templated 
36 9.39E-06 
GO:0001756~somitogenesis 10 1.85E-05 
GO:0007507~heart development 21 3.31E-05 
GO:0010977~negative regulation of neuron projection 
development 
10 5.54E-05 
GO:0001649~osteoblast differentiation 13 5.90E-05 
 
 
 
6.3.1.2 GO analysis of direct target genes having their onset at 3, 6  or 
12 h. 
Given is the biological process, the number of genes and the P-value. Biological 
processes were sorted according to the P-value from lowest to highest 
 
Table S11: Summary of GO analysis of direct target genes having their onset at 
3 h. Shown is the top 20 enriched categories in Biological Processes  
Term Count PValue 
GO:0045944~positive regulation of transcription from RNA polymerase II 
promoter 
10 2.99E-05 
GO:0006351~transcription, DNA-templated 13 3.37E-05 
GO:0000122~negative regulation of transcription from RNA polymerase II 
promoter 
8 1.90E-04 
GO:0006355~regulation of transcription, DNA-templated 13 2.17E-04 
GO:0045665~negative regulation of neuron differentiation 4 2.95E-04 
GO:0010628~positive regulation of gene expression 6 5.40E-04 
GO:0007275~multicellular organism development 8 
0.00149290
3 
GO:0043507~positive regulation of JUN kinase activity 3 
0.00213050
4 
GO:0061074~regulation of neural retina development 2 
0.00513470
7 
GO:0007420~brain development 4 
0.00590557
2 
GO:0051302~regulation of cell division 2 
0.01024389
6 
GO:0001701~in utero embryonic development 4 
0.01429242
1 
GO:0032308~positive regulation of prostaglandin secretion 2 
0.01532768
8 
GO:0045893~positive regulation of transcription, DNA-templated 5 
0.01621132
8 
GO:0045892~negative regulation of transcription, DNA-templated 5 
0.01649368
9 
GO:0007399~nervous system development 4 
0.02625220
5 
GO:0042491~auditory receptor cell differentiation 2 0.02709179 
GO:0060042~retina morphogenesis in camera-type eye 2 0.02709179 
GO:0014032~neural crest cell development 2 
0.02876123
3 
GO:0050880~regulation of blood vessel size 2 
0.03209180
6 
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Table S12: Summary of GO analysis of direct target genes having their onset at 
6 h. Shown is the top 20 enriched categories in Biological Processes  
Term Count PValue 
GO:0006351~transcription, DNA-templated 21 4.03E-07 
GO:0045944~positive regulation of transcription from RNA polymerase II 
promoter 
15 1.41E-06 
GO:0000122~negative regulation of transcription from RNA polymerase II 
promoter 
13 1.84E-06 
GO:0006355~regulation of transcription, DNA-templated 21 7.97E-06 
GO:0010628~positive regulation of gene expression 9 2.95E-05 
GO:0051302~regulation of cell division 3 1.40E-04 
GO:0007399~nervous system development 8 1.56E-04 
GO:0007219~Notch signaling pathway 5 6.05E-04 
GO:0048666~neuron development 4 7.69E-04 
GO:0010977~negative regulation of neuron projection development 4 
0.00102543
9 
GO:0007275~multicellular organism development 11 
0.00110944
5 
GO:0007405~neuroblast proliferation 3 
0.00155735
3 
GO:0001701~in utero embryonic development 6 
0.00229267
5 
GO:0045840~positive regulation of mitotic nuclear division 3 
0.00362493
3 
GO:0043507~positive regulation of JUN kinase activity 3 0.00681414 
GO:0031018~endocrine pancreas development 3 
0.00714943
3 
GO:0045893~positive regulation of transcription, DNA-templated 7 
0.00857335
3 
GO:0045892~negative regulation of transcription, DNA-templated 7 
0.00878360
2 
GO:0060741~prostate gland stromal morphogenesis 2 
0.00926277
4 
GO:0001660~fever generation 2 
0.01539108
7 
 
 
Table S13: Summary of GO analysis of direct target genes having their onset at 
12 h. 
Term Count PValue 
GO:0098903~regulation of membrane repolarization during action potential 2 0.005135 
GO:0061577~calcium ion transmembrane transport via high voltage-gated 
calcium channel 
2 0.005135 
GO:0007275~multicellular organism development 7 0.007235 
GO:0030182~neuron differentiation 3 0.019926 
GO:0060402~calcium ion transport into cytosol 2 0.020386 
GO:0007399~nervous system development 4 0.026252 
GO:0007411~axon guidance 3 0.026829 
GO:0006351~transcription, DNA-templated 8 0.037116 
GO:0009755~hormone-mediated signaling pathway 2 0.042017 
GO:0042127~regulation of cell proliferation 3 0.057504 
GO:0016358~dendrite development 2 0.059959 
GO:0007017~microtubule-based process 2 0.068006 
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GO:0006355~regulation of transcription, DNA-templated 8 0.086822 
 
 
6.3.2 RNA sequencing experiment Brg1 knock-down 
Gene Ontology (GO) analysis was performed using DAVID (http://david.abcc. 
ncifcrf.gov) as previously described (Dennis et al., 2003). Analyzed were genes 
which were affected by a Brg1 knock-down at stage 14  
 
Table S14: Summary of GO analysis Brg1 affected candidate genes. Shown is 
the top 20 enriched categories in Biological Processes  
Term Count PValue 
GO:0007275~multicellular organism development 11 5.15E-04 
GO:0045944~positive regulation of transcription from RNA polymerase II 
promoter 
10 0.001680363 
GO:0003333~amino acid transmembrane transport 3 0.002068881 
GO:0007420~brain development 5 0.003190223 
GO:0010975~regulation of neuron projection development 3 0.003225707 
GO:0042127~regulation of cell proliferation 5 0.003809389 
GO:0007017~microtubule-based process 3 0.00596161 
GO:0006865~amino acid transport 3 0.006248464 
GO:0009953~dorsal/ventral pattern formation 3 0.008427991 
GO:0006351~transcription, DNA-templated 12 0.014441686 
GO:0015807~L-amino acid transport 2 0.016806335 
GO:0050680~negative regulation of epithelial cell proliferation 3 0.017579689 
GO:0021766~hippocampus development 3 0.018042667 
GO:0045665~negative regulation of neuron differentiation 3 0.019462391 
GO:0021798~forebrain dorsal/ventral pattern formation 2 0.019580338 
GO:0007399~nervous system development 5 0.02153236 
GO:0030154~cell differentiation 7 0.021850607 
GO:0021978~telencephalon regionalization 2 0.022346667 
GO:0001843~neural tube closure 3 0.03062912 
GO:0030336~negative regulation of cell migration 3 0.036028973 
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6.4 RNA-seq data 
 
6.4.1 Candidate gene list for the RNA sequencing analysis of Ptf1a-GR 
time course 
Given are the genes which are differentially expressed between Ptf1a-GR 
overexpressing animal caps over non-injected control caps after 3, 6 and 12 h in two 
individual replicates. Given are the gene ID, the log2FC activation over CC and the 
p-value. 
 
Table S15: Summary of differentially expressed genes activates after 3 h 
ID log2FC P-value 
ptf1a.L 7.97 1.39E-44 
zc3h12c.L 6.21 8.02E-38 
hes5.1.L 6.19 1.55E-28 
prdm13.S 5.62 8.35E-17 
zc3h12c.S 5.40 3.36E-23 
hes5.1.S 5.13 9.48E-43 
hes5_X2.S 5.12 7.14E-11 
ebf2.L 4.93 3.11E-16 
prr15l.S 4.77 4.79E-07 
grb14.L 4.75 3.79E-11 
slc18a3.S 4.73 1.75E-12 
nkx2-1.L 4.71 3.29E-05 
cbfa2t2.S 4.57 1.62E-31 
hes5.2.S 4.55 1.67E-11 
dlc.L 4.50 2.01E-13 
il1b.S 4.48 4.19E-07 
myt1.L 4.47 2.50E-24 
hes5.3.S 4.35 1.02E-14 
mxra7.L 4.24 3.29E-10 
hes9-1.L 4.13 8.82E-08 
fzd10.S 4.12 1.34E-19 
rbm24.L 4.08 4.59E-28 
LOC100494099.S 4.00 5.02E-04 
thbs1.L 3.99 2.46E-24 
pcdh18.L 3.97 5.08E-14 
foxc1.L 3.87 8.53E-08 
nhsl2.L 3.81 5.66E-08 
Appendix  125 
 
hes5.2.L 3.76 6.74E-11 
LOC100495335.L 3.72 2.78E-05 
hepacam2.L 3.69 2.30E-10 
dll1.L 3.67 7.75E-21 
Xelaev18037602m.g 3.64 1.65E-10 
hoxd1.L 3.61 5.49E-06 
gpr63.S 3.52 1.78E-14 
hes9-2.L 3.52 2.55E-05 
lrrn1-like.1.S 3.51 2.48E-13 
arl4a.S 3.50 1.23E-29 
prdm13.L 3.49 3.34E-05 
LOC101733706-like.L 3.48 6.55E-06 
post.L 3.45 7.62E-12 
hes10.L 3.44 3.01E-07 
Xetrov90021170m.L 3.41 7.76E-25 
sp5.L 3.38 3.16E-07 
adam33.S 3.37 5.14E-05 
aldh1b1.L 3.35 1.43E-03 
gfi1.L 3.28 5.02E-04 
post.S 3.25 3.21E-10 
lrrn1-like.1.L 3.23 1.31E-25 
id4.S 3.21 7.30E-15 
pzp.L 3.21 6.20E-05 
dll1.S 3.20 1.76E-10 
hes3.3.S 3.19 3.61E-06 
cd247.S 3.17 8.11E-04 
lrrc36.L 3.16 5.17E-08 
fstl1.S 3.15 7.74E-04 
hes5_X1.L 3.14 5.54E-08 
tfap2b.S 3.14 1.86E-03 
pou3f1.L 3.08 7.70E-06 
dlk2.L 3.07 4.47E-05 
hes6.2.L 3.03 2.12E-02 
hes9-1.S 3.03 1.02E-09 
LOC101733157.L 3.03 2.52E-04 
ebf2.S 3.02 9.24E-06 
insm1.S 3.02 7.99E-06 
elavl3.S 3.01 3.63E-08 
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kcnn1.S 3.01 8.87E-04 
mmp11.S 3.00 3.40E-02 
olig2.S 2.99 2.43E-02 
c8orf46.S 2.98 1.53E-02 
sybu.L 2.98 1.01E-09 
Xelaev18035340m.g 2.98 4.48E-07 
myt1.S 2.92 2.25E-06 
zbtb18.S 2.92 1.01E-09 
cdc25b.L 2.89 1.17E-10 
lmcd1.L 2.86 2.34E-02 
id4.L 2.82 2.55E-03 
LOC100487224.L 2.81 1.34E-08 
numbl.L 2.81 1.00E-10 
LOC100127750.S 2.80 1.12E-04 
cbfa2t2.L 2.72 1.71E-11 
fgf16.L 2.72 6.54E-03 
npnt.S 2.70 2.39E-04 
LOC100489305.S 2.67 9.28E-03 
spo11.L 2.67 7.50E-03 
tril.S 2.65 2.90E-07 
Xelaev18032619m.g 2.63 9.71E-04 
six3.L 2.62 7.74E-04 
hes8.L 2.61 2.74E-02 
tiparp.L 2.61 1.72E-20 
tsc22d3.L 2.56 4.11E-06 
prr7.L 2.53 8.16E-04 
myb.S 2.52 1.17E-06 
lhx4.S 2.51 4.05E-02 
pou3f1.S 2.51 7.32E-08 
ankrd65.L 2.50 4.79E-03 
Xelaev18007001m.g 2.49 4.41E-07 
slc43a2.S 2.47 3.01E-07 
ca2.L 2.44 1.57E-02 
Xelaev18000619m.g 2.44 2.21E-02 
amotl2.L 2.41 3.17E-16 
hes5_X2.L 2.39 3.00E-05 
lhx1.S 2.36 4.47E-05 
atp6v1c2.L 2.35 4.65E-04 
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mmp17.L 2.35 4.90E-02 
nek2.L 2.35 1.32E-03 
egr4.L 2.33 6.54E-03 
manea.L 2.33 1.25E-02 
sec24d-like.1.L 2.32 4.19E-04 
kitlg.S 2.25 3.81E-03 
Xelaev18005831m.g 2.23 1.16E-03 
edn1.L 2.22 1.46E-02 
fam198b.L 2.21 2.73E-06 
ampd2.S 2.17 4.05E-02 
rbl2.L 2.17 1.64E-02 
dkk2.L 2.16 4.05E-02 
znf534.L 2.14 2.44E-03 
aplnr.L 2.13 4.52E-03 
axin2.L 2.13 3.93E-02 
foxi1.L 2.12 1.86E-03 
gjc2.L 2.12 6.77E-03 
insm1.L 2.12 1.96E-03 
lancl3.S 2.12 4.51E-02 
tp73.S 2.10 2.03E-02 
rab15.L 2.09 5.19E-04 
LOC101731452.L 2.07 5.12E-05 
stard4.L 2.07 7.74E-04 
fam101b.L 2.06 2.44E-03 
mxi1.L 2.05 1.16E-04 
myb.L 2.05 5.17E-04 
vash2.S 2.05 1.28E-05 
fzd10.L 2.03 3.57E-03 
prickle1.S 2.03 4.02E-08 
cdknx.L 2.02 1.35E-07 
 
 
Table S16: Summary of differentially expressed genes activates after 6 h 
ID log2FC P-value 
ptf1a.L 8.52 3,81E-43 
prdm13.S 7.86 3,91E-34 
prdm13.L 7.36 7,60E-23 
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ebf2.L 7.08 9,35E-33 
gfi1.L 6.31 9,57E-13 
pou3f1.L 6.27 2,34E-20 
mxra7.L 6.03 6,25E-17 
pou3f1.S 5.88 1,21E-33 
cbfa2t2.S 5.78 2,21E-50 
LOC100127750.S 5.69 3,79E-11 
zc3h12c.L 5.62 2,98E-38 
hes5.2.L 5.6 7,18E-13 
prr15l.S 5.57 2,06E-09 
hes8.L 5.55 4,89E-14 
ebf2.S 5.48 2,28E-17 
hes5.1.L 5.46 2,69E-27 
neurod4.L 5.36 2,16E-09 
grb14.L 5.26 1,29E-08 
LOC100494099.S 5.22 1,99E-07 
fzd10.S 5.11 4,26E-33 
hes8.S 5.11 3,17E-12 
zc3h12c.S 5.09 5,61E-23 
id4.S 4.99 2,69E-46 
gpr63.S 4.96 5,62E-18 
dmrt2.L 4.93 6,25E-17 
hepacam2.L 4.91 1,55E-17 
elavl3.S 4.88 1,32E-17 
hes3.3.S 4.84 6,69E-19 
Xelaev18007001m.g 4.84 9,10E-25 
cd247.S 4.82 4,15E-08 
slc18a3.S 4.78 3,58E-09 
thbs1.L 4.69 2,19E-26 
chst3.L 4.6 2,63E-15 
olig2.S 4.58 4,78E-06 
hes5.1.S 4.56 2,92E-35 
pzp.L 4.54 4,14E-09 
b4galnt1.S 4.53 6,59E-10 
hes9-1.L 4.47 9,16E-09 
fam101b.L 4.45 8,32E-14 
lhx1.S 4.45 5,62E-18 
hoxd1.L 4.44 2,51E-08 
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hes5_X2.S 4.42 5,18E-10 
runx1t1.L 4.39 1,85E-09 
igf2.L 4.36 3,14E-07 
ptger3.L 4.35 1,26E-06 
hes5_X1.L 4.34 1,81E-13 
hes5.3.S 4.29 5,26E-13 
c8orf46.S 4.27 2,17E-06 
foxc1.L 4.26 1,55E-07 
tcf15.L 4.19 1,33E-06 
myt1.S 4.17 7,72E-14 
c8orf46.L 4.16 6,26E-04 
zbtb18.S 4.13 2,29E-17 
myt1.L 4.1 4,67E-21 
tlx3.S 4.03 1,58E-07 
nhsl2.L 4.02 2,52E-07 
six1.L 4.02 9,30E-05 
lhx4.S 3.98 2,77E-06 
hes10.L 3.97 1,59E-09 
mamdc2.L 3.96 5,76E-06 
dlk2.L 3.93 4,14E-09 
numbl.L 3.93 1,06E-22 
drgx.L 3.85 1,75E-04 
scrt1.S 3.84 7,49E-07 
Xelaev18036651m.g 3.84 9,19E-04 
cbfa2t2.L 3.78 3,44E-23 
Xelaev18036200m.g 3.78 9,23E-06 
hes6.2.L 3.77 2,81E-04 
fstl1.S 3.72 1,16E-04 
bmp3.L 3.71 2,15E-05 
Xelaev18037602m.g 3.71 7,13E-11 
cdc25b.L 3.7 4,76E-18 
il1b.S 3.67 2,87E-04 
sybu.L 3.65 5,63E-13 
mmp17.L 3.63 1,12E-04 
kitlg.S 3.59 2,90E-07 
egr4.L 3.58 7,11E-06 
zc3h12a.L 3.55 6,53E-03 
plk3.L 3.51 3,72E-13 
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drgx.S 3.48 4,14E-05 
Xelaev18028850m.g 3.48 7,23E-11 
hnf1b.S 3.44 3,31E-03 
hes6.2.S 3.43 6,91E-03 
myos-like.S 3.41 6,38E-03 
Xetrov90021170m.L 3.38 9,93E-25 
hes9-1.S 3.37 2,09E-11 
adam33.S 3.36 5,10E-05 
gfra1.S 3.36 9,67E-04 
twist1.L 3.36 9,70E-04 
edn1.L 3.35 2,10E-05 
gfra3.S 3.35 1,42E-02 
relt.S 3.35 2,04E-05 
Xelaev18005831m.g 3.31 1,58E-07 
arl4a.S 3.3 2,08E-26 
LOC100036671.L 3.29 3,67E-04 
dpysl3.L 3.28 3,88E-04 
lrrn1-like.1.S 3.28 7,50E-17 
pou3f3.L 3.27 4,64E-03 
slc43a2.S 3.27 2,10E-11 
tril.S 3.26 2,71E-10 
dmrta2.S 3.24 8,19E-06 
fzd10.L 3.23 1,56E-08 
LOC101733706-like.L 3.23 2,44E-03 
rltpr.L 3.23 1,06E-04 
ecel1.S 3.22 2,47E-02 
insm1.S 3.22 6,55E-07 
mmp11.L 3.22 5,56E-03 
Xelaev18036111m.g 3.21 1,19E-07 
shd.L 3.2 5,62E-03 
aldh1b1.L 3.18 4,59E-03 
LOC100495335.L 3.16 3,93E-04 
zc3h12a.S 3.16 7,72E-03 
tlr3.L 3.15 2,21E-02 
LOC101733157.L 3.14 1,38E-03 
foxa1.S 3.13 2,47E-10 
tfe3.L 3.13 1,15E-02 
rbm24.L 3.12 6,25E-17 
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hes9-2.L 3.09 7,34E-04 
LOC100485259.L 3.09 2,97E-17 
arhgef26.L 3.06 4,73E-06 
neurod4.S 3.06 1,06E-03 
Xelaev18019047m.g 3.06 2,20E-03 
hmx3.L 3.05 1,44E-02 
sp5.L 3.05 2,72E-06 
rassf6.L 3.04 2,33E-02 
slc3a2.L 3.02 1,15E-02 
Xelaev18032400m.g 3.02 4,09E-02 
snrk.S 3.01 3,94E-15 
nptx2.L 3 3,50E-02 
axin2.S 2.99 6,69E-03 
ag1.S 2.97 3,67E-09 
fgf16.L 2.97 1,52E-03 
tn3.L 2.97 1,58E-02 
muc1.L 2.96 2,99E-02 
prr7.L 2.95 2,35E-05 
emx1.L 2.94 4,10E-02 
gfi1.S 2.94 1,02E-04 
rab15.L 2.93 3,03E-10 
p2ry4.L 2.91 1,71E-02 
eln2.L 2.9 2,46E-04 
axin2.L 2.88 6,17E-04 
faxc.L 2.88 1,21E-24 
Xetrov90002103m.L 2.87 3,20E-02 
cfap70.L 2.85 7,65E-03 
Xelaev18000619m.g 2.83 1,57E-03 
prr18.L 2.82 1,95E-03 
bhlhe22.L 2.81 1,15E-02 
angptl4.L 2.79 9,30E-05 
galnt12.L 2.78 3,56E-07 
ccdc141.L 2.77 1,62E-03 
pou2f3.L 2.77 2,81E-09 
snai2.L 2.76 8,04E-05 
irx3.L 2.75 3,20E-04 
LOC100493614.S 2.74 8,14E-07 
amotl2.S 2.72 4,42E-16 
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phlda1.L 2.72 1,50E-03 
gch1.L 2.7 3,51E-13 
tfap2b.S 2.69 2,89E-02 
post.L 2.68 1,56E-07 
LOC100494099.L 2.67 1,41E-02 
mdk.S 2.66 1,27E-05 
ncmap.S 2.64 8,17E-03 
post.S 2.64 3,20E-07 
bhlhe40.L 2.63 2,43E-03 
Xelaev18005924m.g 2.63 2,41E-06 
insm1.L 2.62 1,31E-05 
frem2.S 2.6 1,02E-04 
hes3.1.S 2.6 2,50E-09 
rab15.S 2.57 3,20E-02 
arhgap23.L 2.56 4,08E-05 
eya1.S 2.56 2,54E-06 
rnf165.L 2.56 4,03E-08 
vtcn1.L 2.56 1,15E-03 
hes5.2.S 2.55 2,87E-02 
lypd6.L 2.55 4,38E-03 
fjx1.S 2.54 1,68E-02 
kremen2.S 2.53 2,85E-02 
spo11.L 2.53 1,53E-02 
Xetrov90025030m.L 2.53 4,37E-05 
lmcd1.L 2.5 4,34E-02 
gria1-like.1.S 2.49 4,75E-02 
kctd12.L 2.49 1,18E-02 
lrrc36.L 2.49 1,08E-05 
meis1.L 2.48 4,50E-05 
hes5_X2.L 2.47 3,78E-05 
Xetrov90000859m.L 2.47 2,05E-02 
LOC100497338-like.L 2.45 1,27E-05 
vcan.L 2.44 7,74E-03 
ctsk.L 2.43 1,68E-02 
Xelaev18042455m.g 2.43 5,79E-03 
pm20d1.L 2.42 1,88E-05 
tfap2e.S 2.42 6,37E-03 
elavl4.L 2.41 1,15E-02 
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lhx8.L 2.41 4,91E-06 
prickle1.S 2.4 2,09E-11 
bhlhe40.S 2.39 2,71E-03 
tiparp.L 2.38 4,71E-16 
slc1a1.L 2.37 3,03E-02 
dbp.S 2.36 8,24E-05 
irf1.L 2.35 1,83E-07 
cidec.L 2.33 1,19E-16 
glipr2.S 2.33 3,98E-05 
Xelaev18026372m.g 2.32 7,78E-08 
cdknx.L 2.31 2,71E-10 
onecut1.2.L 2.31 3,39E-03 
a2m.S 2.3 4,67E-16 
amotl2.L 2.3 1,85E-15 
aim1l.S 2.28 1,14E-02 
syt16.L 2.28 1,23E-03 
fam214a.S 2.27 2,20E-05 
kcnc4.S 2.27 1,00E-02 
Xelaev18013182m.g 2.27 6,39E-04 
id4.L 2.25 5,22E-05 
plk3.S 2.25 6,95E-05 
atf6b.S 2.24 7,67E-04 
rnf125.L 2.23 2,85E-02 
znf238.2.L 2.21 6,04E-20 
sept5.L 2.2 3,04E-04 
sox9.L 2.19 7,42E-03 
dll1.L 2.18 2,12E-07 
sec24d-like.1.L 2.17 5,16E-03 
serpinf1.L 2.17 4,44E-02 
znf534.L 2.17 3,73E-04 
pcdh18.L 2.15 4,14E-04 
iqca1.S 2.14 2,11E-02 
reep5.S 2.14 4,38E-05 
znf238.2.S 2.13 6,45E-09 
kdm7a.L 2.11 6,68E-04 
c8orf4.L 2.1 1,21E-02 
creb3l2.S 2.1 3,25E-03 
rfk.S 2.1 4,10E-02 
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atp6v0d2.L 2.09 4,81E-02 
dnase1l3.L 2.09 2,12E-02 
eps8l2.L 2.08 3,64E-02 
nes.L 2.08 2,37E-04 
fam83e.S 2.06 6,05E-03 
Xelaev18023501m.g 2.06 3,34E-07 
ankrd65.L 2.05 3,80E-02 
gse1.L 2.02 3,04E-05 
rap1gap.S 2.01 1,47E-02 
xk.L 2.01 2,82E-02 
 
       
       
       
       
Table S17: Summary of differentially expressed genes activates after 12 h 
ID log2FC p-value 
prdm13.L 9.38 1,04E-37 
prdm13.S 9.33 3,02E-45 
neurod4.L 8.84 4,86E-27 
scrt1.S 8.55 2,29E-31 
aldh1b1.L 8.4 3,23E-28 
ptf1a.L 8.38 5,09E-43 
chst3.L 8.06 4,49E-28 
ebf2.L 7.91 8,93E-34 
ebf2.S 7.85 8,56E-27 
neurod4.S 7.56 2,54E-20 
dpysl3.L 7.44 3,18E-47 
pck1.L 7.39 5,55E-22 
Xetrov90027705m.L 7.24 4,51E-15 
ppp1r9b.S 7.1 3,61E-22 
tfap2b.S 7.06 1,27E-24 
bgn.L 7.05 2,26E-31 
mxra7.L 6.89 1,57E-24 
shd.L 6.71 1,88E-19 
slc18a3.S 6.53 4,21E-25 
lbx1.S 6.52 5,90E-11 
drgx.L 6.45 7,42E-13 
pou3f1.L 6.34 8,84E-18 
hesx1.S 6.33 4,28E-27 
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mmp28.L 6.28 6,27E-13 
Xelaev18040877m.g 6.28 5,95E-16 
npb.L 6.23 1,25E-09 
LOC100490531-like.L 6.22 7,15E-10 
igfbpl1.L 6.17 3,59E-11 
prph.S 5.94 5,31E-37 
LOC100487395.L 5.91 9,09E-22 
tubb3.L 5.91 1,47E-11 
igf2.L 5.82 9,07E-13 
kirrel2.L 5.78 6,60E-41 
pou3f1.S 5.77 2,20E-18 
Xelaev18032183m.g 5.7 5,63E-08 
dpysl4.L 5.63 3,67E-08 
nr5a2.L 5.59 1,25E-08 
cd247.S 5.55 3,82E-11 
snap25.L 5.52 5,63E-12 
kirrel2.S 5.5 2,41E-37 
tfap2b.L 5.49 1,52E-07 
map2.S 5.43 1,82E-22 
onecut1.2.L 5.4 4,03E-40 
nova1.L 5.17 7,10E-13 
pyy.L 5.17 4,41E-06 
elavl4.L 5.16 5,31E-15 
LOC101733706-like.L 5.16 1,61E-09 
myl1.L 5.14 1,00E-05 
elavl3.S 5.12 2,58E-27 
barhl2.L 5.09 6,54E-10 
phlda1.L 5.08 8,25E-10 
bmp3.L 5.02 5,90E-11 
nhlh1.S 5.01 4,72E-06 
tcf15.S 5.01 2,37E-06 
tfap2e.S 5 3,53E-15 
nhlh1.L 4.99 8,91E-07 
scrt1.L 4.97 1,49E-06 
gpr63.S 4.96 1,94E-18 
tuba4a.L 4.9 1,52E-28 
st18.L 4.82 1,45E-07 
tlx3.S 4.8 5,65E-10 
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eln2.L 4.79 5,31E-11 
tlx3.L 4.77 1,37E-14 
tubb3.S 4.76 1,44E-16 
dmrta2.L 4.72 4,72E-19 
gch1.L 4.7 2,41E-37 
map3k12.S 4.67 6,04E-09 
pcmtd1.L 4.66 1,26E-05 
ak3.S 4.64 1,34E-08 
Xelaev18007508m.g 4.64 1,25E-04 
LOC100490531-like.S 4.62 8,44E-05 
fitm1.L 4.61 6,16E-05 
tmem116.L 4.6 1,13E-20 
adcyap1.S 4.56 2,19E-05 
LOC100127750.S 4.56 9,24E-08 
cuzd1.L 4.55 1,01E-04 
slc3a2.L 4.53 8,31E-15 
unc5a.L 4.52 2,30E-06 
Xelaev18021728m.g 4.52 8,11E-05 
tcf15.L 4.49 1,79E-10 
Xetrov90027705m.S 4.49 1,15E-04 
mmp17.L 4.48 9,72E-07 
gria1-like.1.S 4.42 1,08E-07 
skor1.S 4.42 1,32E-12 
des.1.S 4.4 1,46E-04 
tal1.L 4.39 1,74E-04 
tespa1.S 4.39 6,16E-05 
sparc.L 4.38 4,17E-07 
aqp3.L 4.37 7,14E-05 
rassf6.L 4.34 3,33E-05 
ptger3.L 4.32 5,67E-08 
mcf2l.S 4.31 7,41E-10 
slc43a2.S 4.31 2,38E-22 
lhx8.L 4.3 2,85E-18 
prdm8.L 4.29 3,03E-04 
cacnb1.S 4.28 2,58E-04 
Xelaev18047032m.g 4.27 7,28E-05 
cyp1c1.L 4.23 2,75E-04 
six1.S 4.23 1,86E-05 
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gad1.1.L 4.2 2,45E-06 
tfap2e.L 4.2 1,15E-06 
emilin1.L 4.19 1,04E-10 
bag2.L 4.16 3,76E-04 
dpp10.S 4.15 5,57E-07 
nat14.S 4.14 5,69E-05 
evi5.L 4.13 2,58E-30 
snai2.L 4.13 6,74E-13 
zc3h12c.S 4.12 4,10E-15 
Xelaev18007001m.g 4.11 2,37E-20 
edn1.L 4.06 7,53E-07 
LOC100487796-like.L 4.03 1,21E-09 
mtcl1.S 4.02 1,14E-05 
Xelaev18006418m.g 4.02 4,59E-04 
kank2.L 4.01 1,06E-03 
neurog2.S 3.99 4,04E-10 
adamtsl1.L 3.9 1,11E-08 
fezf1.L 3.89 3,74E-04 
des.1.L 3.88 7,51E-05 
kiaa1755.L 3.88 1,39E-04 
LOC100496628-like.L 3.87 6,87E-06 
LOC100271753.L 3.86 2,21E-06 
barhl2.S 3.81 4,87E-04 
runx1t1.S 3.77 5,46E-06 
hmox1.L 3.76 3,23E-28 
LOC100488523.L 3.76 6,38E-04 
des.2.L 3.74 3,10E-03 
serpinf1.L 3.74 1,45E-07 
hmox1.S 3.73 1,48E-03 
drgx.S 3.72 9,95E-07 
reep5.S 3.72 1,34E-16 
adcyap1.L 3.69 1,50E-03 
arhgef26.S 3.69 4,63E-05 
atg9b.L 3.69 2,25E-11 
cacna2d2.L 3.68 6,27E-07 
tmem35.L 3.68 7,24E-04 
hes5.2.L 3.67 1,47E-06 
kiaa1715.S 3.66 2,54E-03 
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pou3f2.L 3.66 1,45E-07 
hdac7.S 3.64 4,16E-05 
dlk2.L 3.63 5,60E-05 
bhlhe22.L 3.59 2,83E-04 
eva1b.S 3.59 8,10E-04 
bcar1.S 3.58 2,98E-06 
hoxc5.S 3.58 2,04E-03 
lmo2.S 3.58 2,51E-03 
samd7.L 3.58 3,35E-05 
cbfa2t2.S 3.57 8,07E-21 
runx1t1.L 3.57 3,27E-08 
zc3h12c.L 3.56 5,45E-17 
cbfa2t2.L 3.55 2,37E-20 
ror2.S 3.55 8,28E-12 
cbfa2t3.L 3.52 2,06E-03 
six3.L 3.52 1,08E-08 
lmcd1.S 3.51 8,02E-12 
chat.S 3.49 4,76E-03 
tapbp.L 3.49 3,16E-04 
adam33.S 3.48 9,49E-06 
zbtb16.S 3.47 7,30E-09 
Xetrov90000859m.L 3.46 1,78E-05 
ca14.S 3.41 4,67E-05 
fdft1.L 3.39 1,01E-06 
gas7.L 3.39 2,81E-07 
clip2.S 3.38 2,09E-06 
kank3.L 3.38 1,87E-08 
mespa.S 3.36 7,44E-03 
irx3.L 3.35 3,68E-05 
rgmb.L 3.32 1,86E-11 
skor1.L 3.32 2,52E-06 
pak3.S 3.31 6,49E-23 
rgs10.L 3.31 1,95E-03 
Xelaev18024617m.g 3.31 2,73E-03 
map2.L 3.3 8,94E-05 
p2ry4.L 3.3 1,07E-08 
Xetrov90010371m.L 3.3 7,61E-04 
epb41l1.L 3.29 3,27E-04 
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foxc2.S 3.28 2,51E-03 
sox11.L 3.28 2,79E-17 
zcchc24.L 3.28 7,32E-03 
adprh.S 3.27 2,26E-04 
fam212a.L 3.26 3,93E-16 
ppp1r14b.S 3.26 1,19E-05 
Xetrov90016928m.L 3.25 9,10E-03 
arhgap4.L 3.24 5,60E-05 
c8orf46.S 3.24 1,18E-03 
dennd2c.L 3.24 6,28E-11 
otx2.L 3.24 1,03E-02 
pip4k2b.L 3.24 2,08E-06 
gfra1.S 3.2 2,29E-04 
pmp22.L 3.19 7,49E-03 
gfi1.L 3.16 2,45E-04 
plekhg4.S 3.16 6,32E-10 
celf2.L 3.15 2,67E-04 
ncmap.S 3.15 3,65E-05 
cdc42ep3.S 3.14 1,38E-04 
dbn1.L 3.14 5,50E-34 
nrp2.L 3.14 1,25E-08 
sfrp2.L 3.14 1,53E-11 
zbtb18.S 3.14 4,11E-09 
rundc3a.L 3.13 7,20E-04 
pkdcc.L 3.12 1,06E-03 
sox11.S 3.1 7,43E-13 
aldh1a2.S 3.09 1,74E-09 
dlc.S 3.09 1,20E-04 
nhs.S 3.09 4,17E-04 
nox4.S 3.09 7,20E-03 
faxc.L 3.08 4,03E-24 
olig2.S 3.08 5,22E-03 
ttc9.L 3.08 5,96E-26 
cplx2.S 3.07 2,58E-02 
Xelaev18020376m.g 3.07 3,13E-02 
ptprt.L 3.06 1,68E-04 
plekhg4.L 3.05 8,02E-12 
vim.S 3.03 2,25E-07 
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zeb2.L 3.03 2,50E-05 
dbn1.S 3.02 3,02E-15 
dlx6.L 3.02 1,75E-07 
clstn3.L 3.01 2,28E-02 
dmbx1.S 3.01 2,53E-02 
klf7.L 3.01 7,48E-04 
LOC100125030.S 3.01 5,74E-03 
pla2g12b.S 3.01 6,66E-03 
rnf165.L 3.01 2,97E-11 
Xelaev18021928m.g 3.01 1,96E-15 
LOC100492460.L 2.99 1,91E-02 
s1pr5.S 2.99 4,22E-11 
slc38a8.L 2.99 1,08E-03 
st8sia6.L 2.99 5,41E-07 
aplnr.L 2.98 1,39E-06 
aplnr.S 2.98 2,67E-05 
cplx2.L 2.98 9,09E-04 
crmp1.S 2.98 9,73E-04 
sybu.L 2.98 8,46E-08 
abtb2.S 2.97 2,39E-03 
shox2.L 2.96 3,59E-02 
neurog1.L 2.95 1,62E-02 
Xelaev18041660m.g 2.95 1,58E-02 
cpe.S 2.94 1,00E-02 
emx1.L 2.94 1,30E-02 
slc25a38.L 2.94 1,32E-08 
zic3.L 2.94 1,31E-02 
cables1.L 2.93 6,37E-03 
Xelaev18003350m.g 2.93 2,93E-02 
a2m.S 2.92 5,63E-27 
slc8a2.S 2.91 1,83E-02 
ulk1.L 2.91 7,25E-06 
Xelaev18016582m.g 2.91 1,42E-04 
Xelaev18047968m.g 2.91 2,16E-02 
arid1b.L 2.9 4,23E-19 
cacna2d1.L 2.9 2,18E-09 
Xelaev18030957m.g 2.9 1,80E-02 
il5ra.S 2.88 2,11E-04 
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LOC100487395.S 2.88 4,17E-04 
LOC101733102.L 2.88 5,99E-04 
st18.S 2.88 2,11E-02 
zfhx4.S 2.88 1,32E-06 
cep85l.S 2.87 5,02E-10 
nova2.S 2.87 1,27E-03 
plekhd1.L 2.87 3,27E-02 
hlf.L 2.86 2,53E-03 
pzp.L 2.86 2,17E-04 
asb2.L 2.85 3,87E-02 
bhlhe40.L 2.85 3,94E-04 
pdia2.S 2.85 6,64E-03 
Xelaev18039965m.g 2.85 2,18E-06 
dbndd1.L 2.84 2,95E-02 
LOC100494987-like.L 2.84 2,62E-02 
ankrd6.L 2.83 5,04E-03 
elavl3.L 2.82 4,21E-10 
hoxd1.L 2.82 1,14E-05 
limd2.L 2.82 2,04E-04 
LOC100485834.L 2.82 1,75E-03 
LOC100496678.L 2.81 4,38E-02 
rap1gap.S 2.81 2,53E-05 
slc26a9.S 2.81 9,22E-03 
Xelaev18038420m.g 2.81 7,03E-09 
afap1l1.L 2.8 3,50E-04 
mdk.L 2.8 1,45E-19 
plod2.S 2.8 7,29E-05 
six1.L 2.8 3,80E-03 
asb12.L 2.79 2,95E-03 
lhx1.S 2.79 8,75E-05 
fam102a.S 2.78 2,35E-04 
mamdc2.L 2.78 2,18E-03 
pcdh9.L 2.78 1,69E-04 
plekhg1.L 2.78 6,74E-10 
arhgef26.L 2.77 6,86E-05 
btbd19.L 2.77 4,27E-02 
gcnt1.S 2.77 7,64E-05 
kcna1.S 2.77 8,53E-04 
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draxin.S 2.76 1,90E-02 
nuak1.L 2.76 9,87E-06 
cacnb3.L 2.75 3,23E-02 
msx2.S 2.75 1,86E-08 
hcar3.L 2.74 1,05E-03 
hes5.2.S 2.74 4,75E-03 
ag1.S 2.73 3,03E-08 
cxcr2.L 2.73 4,90E-02 
dnajc6.S 2.73 9,28E-03 
hes6.2.L 2.71 3,04E-02 
tmem169.L 2.7 4,11E-09 
a2m.L 2.69 2,93E-04 
cldn5.L 2.69 5,81E-03 
map3k13.L 2.69 2,23E-02 
sp5.L 2.68 2,48E-06 
tet3.S 2.68 6,20E-04 
glis2.S 2.67 1,07E-05 
Xelaev18043580m.g 2.67 1,34E-08 
insm1.L 2.66 4,72E-06 
pcdh18.L 2.66 3,39E-05 
tie1.S 2.66 1,77E-02 
auts2.S 2.65 1,39E-11 
cited2.L 2.65 7,77E-12 
faxc.S 2.65 2,50E-02 
agbl1.S 2.64 5,80E-08 
agbl1.S 2.64 5,80E-08 
agbl1.S 2.64 5,80E-08 
agbl1.S 2.64 5,80E-08 
LOC100495335.L 2.64 5,69E-03 
limd2.S 2.63 5,21E-06 
dmrta2.S 2.62 3,39E-05 
fam89a.S 2.62 9,85E-06 
grb14.L 2.62 2,91E-02 
hes5_X2.L 2.59 3,16E-06 
lrp4.S 2.59 2,09E-06 
tdrp.L 2.58 3,01E-20 
lrrn1-like.1.S 2.57 3,15E-11 
nes.L 2.57 6,27E-07 
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cel-like.1.S 2.56 7,17E-03 
ctsk.L 2.56 2,32E-03 
irx4.L 2.56 2,60E-02 
lhx5.L 2.55 9,53E-18 
LOC100489305.S 2.55 9,69E-03 
fstl1.L 2.54 3,73E-02 
krt19.S 2.53 2,73E-12 
LOC101733157.L 2.53 3,16E-04 
Xelaev18016676m.g 2.53 5,12E-08 
abtb2.L 2.52 2,05E-03 
pcmtd1.S 2.52 8,75E-05 
f2r.S 2.51 1,65E-02 
st3gal2.1.L 2.51 4,22E-05 
abcb9.L 2.5 2,97E-19 
eya1.L 2.5 2,87E-04 
fam102a.L 2.5 7,55E-05 
frmd6.L 2.49 8,44E-18 
gas1.L 2.49 2,19E-05 
Xelaev18023424m.g 2.49 2,66E-02 
Xelaev18039076m.g 2.49 4,64E-03 
arhgap33.S 2.48 4,91E-05 
hes5.3.S 2.48 9,01E-07 
srrm4.L 2.48 1,50E-03 
egr4.L 2.47 4,01E-02 
fgf16.L 2.47 6,40E-03 
hes2.L 2.47 1,34E-05 
pnhd.S 2.47 2,56E-02 
kansl1l.L 2.45 1,11E-02 
rnf165.S 2.45 3,41E-07 
Xelaev18024498m.g 2.45 3,42E-02 
hand2.S 2.44 3,54E-04 
stk40.L 2.44 2,95E-10 
tox3.L 2.44 3,41E-12 
f3.S 2.43 2,91E-03 
rfk.S 2.43 2,03E-03 
Xelaev18019210m.g 2.43 6,18E-03 
prdm14.L 2.42 2,33E-05 
rnd3.S 2.42 4,59E-05 
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tuba4a.S 2.41 8,16E-05 
fgd1.S 2.4 5,75E-03 
irx1.L 2.4 6,18E-03 
zfhx4.L 2.4 7,52E-04 
LOC100496628-like.S 2.39 4,59E-02 
klhl25.S 2.38 2,12E-03 
cemip.S 2.37 4,46E-04 
mdk.S 2.37 5,63E-05 
slc43a2.L 2.37 1,01E-03 
myt1.L 2.36 6,16E-07 
Xelaev18009525m.g 2.36 6,38E-04 
eya2.S 2.35 4,76E-03 
neurog2.L 2.35 4,08E-02 
slit1.S 2.35 2,52E-03 
znf329.S 2.35 5,74E-04 
aldh1a2.L 2.34 1,17E-07 
cep85l.L 2.33 5,64E-07 
hoxd1.S 2.33 4,77E-02 
lrig1.S 2.33 2,27E-02 
myt1.S 2.33 1,74E-04 
ndst1.S 2.33 7,54E-07 
irf1.L 2.32 3,64E-06 
pitx3.L 2.32 2,33E-02 
spo11.L 2.32 3,16E-02 
btg2.S 2.31 6,38E-04 
mctp2.L 2.31 3,76E-03 
LOC100492804.L 2.3 3,65E-05 
manea.L 2.3 3,97E-03 
mtcl1.L 2.3 1,47E-03 
b4galnt1.S 2.29 2,87E-04 
cldn6.1.L 2.29 2,17E-08 
Xelaev18028850m.g 2.29 5,93E-05 
cpe.L 2.28 6,64E-06 
zeb2.S 2.28 6,74E-04 
dennd2c.S 2.27 3,29E-05 
hes5_X2.S 2.27 1,05E-03 
smoc1.S 2.27 2,48E-02 
arhgap36.L 2.26 9,88E-04 
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ephb3.S 2.26 1,11E-10 
smim3.S 2.25 2,93E-03 
Xelaev18033094m.g 2.25 3,86E-02 
cdc42ep4.L 2.23 2,79E-03 
tmem74b.S 2.23 8,06E-03 
Xelaev18042973m.g 2.23 4,99E-02 
meis1.L 2.22 6,77E-05 
rufy3.L 2.22 4,54E-06 
gtf2ird1.L 2.21 1,94E-02 
rasal2-like.2.S 2.21 8,02E-12 
antxr2.L 2.2 7,09E-04 
rab3a.S 2.2 1,19E-12 
mcc.S 2.19 2,69E-03 
mybl1.S 2.19 1,07E-03 
tuba1b.L 2.19 9,54E-07 
cdyl2.S 2.18 1,74E-02 
gfi1.S 2.18 9,57E-03 
LOC100488626.L 2.18 1,96E-02 
vim.L 2.18 1,13E-06 
acy3.L 2.17 9,06E-07 
numbl.L 2.17 3,10E-07 
ppp1r1a.L 2.17 2,00E-04 
rgma.L 2.17 7,29E-07 
dgki.S 2.16 2,10E-02 
insm2.L 2.15 4,46E-02 
krt18.S 2.15 6,89E-07 
cuedc1.S 2.14 1,06E-11 
lhx1.L 2.14 4,68E-02 
ptch2.S 2.14 2,65E-02 
rph3al.S 2.14 2,13E-02 
tuft1.L 2.14 3,29E-02 
Xelaev18016674m.g 2.14 8,87E-04 
dact1.L 2.13 9,63E-13 
fsd1.L 2.13 2,13E-02 
foxc1.S 2.12 3,99E-02 
mcf2l.2.L 2.12 6,42E-03 
pak3.L 2.11 1,84E-03 
sall3.L 2.11 1,87E-08 
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aim1l.S 2.1 1,15E-02 
dlk2.S 2.1 1,80E-02 
hes8.L 2.1 8,78E-05 
dnajc6.L 2.09 2,00E-02 
cdc42se2-like.1.L 2.08 1,29E-05 
dclk1.S 2.08 3,44E-02 
insm1.S 2.08 3,83E-03 
tmem170b.L 2.08 3,64E-03 
kctd1.L 2.07 2,42E-03 
map1lc3a.L 2.07 1,95E-03 
nckap5l.L 2.06 3,82E-05 
fbxo32.L 2.05 2,16E-02 
pik3r3.L 2.05 2,54E-04 
rbm38.L 2.05 1,74E-09 
rexo1.S 2.05 4,59E-05 
rnf130.S 2.05 2,99E-05 
kiaa1468.L 2.04 1,08E-03 
rasl10b.L 2.04 1,09E-06 
Xelaev18044942m.g 2.04 1,75E-04 
tes.L 2.03 4,43E-03 
cttnbp2nl.L 2.02 7,68E-04 
scamp4.S 2.02 4,56E-02 
sfrp2.S 2.02 1,01E-14 
stmn1.S 2.02 2,81E-08 
hoxc4.S 2.01 2,06E-02 
fstl1.S 2 1,39E-02 
LOC100496433.1.L 2 1,68E-04 
lrp4.L 2 4,06E-06 
pmp22.S 2 1,78E-02 
 
 
6.4.2 Candidate gene list for the RNA sequencing analysis of Brg1 
knock-down experiment 
Given are the genes which are differentially expressed between Ptf1a-GR + cMO or 
Ptf1a-GR + Brg1MO overexpressing animal caps over non-injected control caps in 
two individual replicates. Given are the gene ID, the log2FC activation over CC and 
the p-value. 
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Table S18: Summary of differentially expressed genes by Ptf1a + cMO 
ID log2FC P-value 
Xelaev18007508m.g 14.26 9.14E-18 
neurod4.L 12.86 4.40E-14 
prdm13.L 12.29 4.88E-14 
prph.S 12.22 6.31E-28 
neurod4.S 11.98 1.88E-11 
nhlh1.L 11.94 4.57E-13 
pou3f1.L 11.65 1.21E-11 
prdm13.S 11.46 7.21E-19 
nhlh1.S 11.42 1.87E-11 
scrt1.S 11.25 3.90E-12 
igfbpl1.L 11.16 7.42E-11 
dpysl4.L 10.93 6.15E-10 
st18.L 10.78 2.33E-10 
neurog1.L 10.75 1.53E-10 
des.2.L 10.49 1.78E-08 
hoxc3.L 10.43 4.64E-07 
prdm8.L 10.31 2.43E-04 
lmo2.S 10.28 4.37E-09 
lbx1.S 10.14 1.36E-08 
LOC100490531-like.L 9.95 3.31E-09 
LOC100496628-like.L 9.89 1.83E-07 
pyy.L 9.88 1.72E-07 
hes5.2.L 9.75 7.77E-07 
aqp3.L 9.69 1.68E-04 
ebf2.L 9.65 6.74E-32 
fezf1.L 9.64 1.12E-05 
Xetrov90027705m.L 9.54 8.64E-15 
nr5a2.L 9.43 1.86E-06 
skor1.S 9.36 6.12E-12 
Xelaev18047032m.g 9.35 8.25E-05 
kiaa1755.L 9.26 4.74E-21 
adcyap1.S 9.19 3.14E-06 
aldh1b1.L 9.13 6.83E-06 
Xelaev18032183m.g 9.06 1.65E-06 
mllt11.S 9.01 2.31E-06 
tfap2b.S 9.01 8.87E-36 
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skor2.S 8.94 6.35E-04 
pcdh9.L 8.92 8.63E-06 
map3k13.L 8.87 9.24E-05 
Xelaev18002612m.g 8.83 1.62E-03 
Xelaev18018357m.g 8.82 1.44E-05 
Xelaev18004302m.g 8.81 1.49E-05 
tespa1.S 8.77 1.14E-05 
shox2.L 8.76 9.85E-06 
prdm8.S 8.73 1.70E-04 
igfbpl1.S 8.73 5.92E-05 
tubb3.L 8.70 7.68E-07 
shd.L 8.64 5.11E-12 
hesx1.S 8.56 1.26E-09 
des.1.L 8.52 2.53E-10 
foxd2.L 8.48 7.82E-05 
tfap2e.L 8.35 4.09E-06 
ebf2.S 8.34 8.84E-31 
dpysl3.L 8.27 5.82E-79 
nova2.S 8.27 9.24E-05 
nes.L 8.27 1.68E-19 
pou3f1.S 8.20 8.52E-03 
Xelaev18000445m.g 8.19 5.78E-05 
tcf15.S 8.14 2.74E-04 
Xetrov90027705m.S 8.14 8.38E-05 
barhl2.S 8.03 7.62E-09 
nts.L 8.03 1.67E-03 
nkx3-2.S 8.01 5.50E-03 
foxb1.S 7.99 2.18E-03 
ptger3.L 7.99 1.32E-04 
hmx1.1 7.97 5.85E-03 
clstn3.L 7.93 2.51E-12 
hes6.2.L 7.92 5.89E-03 
LOC100490531-like.S 7.91 4.37E-04 
sybu.L 7.89 6.70E-08 
gad1.1.L 7.87 1.29E-16 
ptf1a.L 7.83 6.09E-05 
slc26a9.S 7.83 1.28E-04 
spry4.S 7.74 1.96E-03 
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pnhd.S 7.72 1.88E-04 
Xelaev18047333m.g 7.71 6.45E-05 
eva1b.S 7.70 7.41E-05 
bgn.L 7.68 3.14E-45 
fam212b.L 7.66 6.98E-04 
Xelaev18040877m.g 7.63 5.34E-18 
Xelaev18045246m.g 7.62 7.76E-04 
map2.S 7.58 8.87E-36 
vsx1.S 7.56 6.56E-04 
tal1.L 7.54 8.62E-08 
stk32a.L 7.48 3.78E-04 
map3k12.S 7.47 3.14E-07 
Xelaev18036651m.g 7.46 1.23E-35 
Xelaev18001525m.g 7.44 1.89E-02 
nptx2.L 7.44 1.05E-02 
mmp17.L 7.43 2.71E-04 
chst15.L 7.41 3.38E-03 
elavl3.S 7.41 2.06E-04 
barhl2.L 7.40 4.55E-04 
myl1.L 7.36 2.56E-04 
LOC100489771.L 7.35 3.58E-03 
tmem116.L 7.34 2.77E-17 
slc1a2.S 7.33 4.01E-02 
pdyn.S 7.33 1.24E-02 
tubb3.S 7.33 6.66E-37 
pcdh8.S 7.33 3.38E-04 
neurod1.S 7.32 4.31E-03 
kirrel2.L 7.24 2.18E-81 
chat.S 7.23 3.03E-03 
lrrn1-like.1.S 7.18 1.15E-45 
kiaa1715.S 7.17 6.42E-03 
foxd3.L 7.17 3.60E-05 
dmrta2.L 7.14 1.77E-04 
zeb2.L 7.14 1.44E-25 
olig3.S 7.11 6.49E-03 
plekhd1.L 7.11 7.85E-04 
spns2.L 7.09 7.42E-04 
dmrta1.L 7.05 5.53E-03 
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nat14.S 7.05 2.20E-03 
dpp10.S 7.01 2.55E-28 
ppp1r9b.S 6.97 2.20E-06 
ppp1r9b.L 6.96 3.46E-11 
myo3b.L 6.96 6.33E-03 
nes.S 6.95 3.22E-24 
cdh1.L 6.95 6.54E-12 
Xelaev18042973m.g 6.94 1.05E-05 
paqr9.L 6.94 1.23E-08 
neurod1.L 6.93 1.11E-02 
zeb2.S 6.93 8.19E-27 
LOC101732256-like.L 6.92 4.00E-02 
Xelaev18033867m.g 6.91 7.82E-03 
cacnb1.S 6.89 7.51E-06 
Xetrov90008914m.L 6.88 2.01E-02 
Xelaev18004376m.g 6.87 4.33E-02 
hes5.2.S 6.84 1.05E-02 
chst3.L 6.84 2.61E-13 
pnhd.L 6.83 2.05E-07 
Xelaev18026149m.g 6.83 3.58E-03 
shox2.S 6.75 1.51E-03 
hoxd1.S 6.75 5.72E-03 
myod1.S 6.74 1.51E-03 
tal1.S 6.69 4.31E-06 
ror2.S 6.67 2.53E-21 
kirrel2.S 6.66 1.22E-64 
mmp28.L 6.62 2.56E-02 
slc18a3.S 6.61 1.19E-03 
chrd.S 6.60 9.99E-04 
Xelaev18022024m.g 6.59 2.08E-05 
nova1.L 6.55 9.18E-18 
lhx1.S 6.49 1.89E-02 
LOC100127750.S 6.45 2.00E-02 
slc24a2.L 6.41 1.93E-02 
sp5.S 6.40 2.75E-02 
mnx1.L 6.39 1.70E-02 
olig2.S 6.34 1.49E-20 
Xelaev18046363m.g 6.33 3.12E-02 
Appendix  151 
 
Xelaev18020334m.g 6.31 3.76E-03 
phlda1.L 6.29 5.18E-08 
Xelaev18002611m.g 6.25 4.86E-05 
LOC100487395.L 6.23 3.28E-34 
LOC100487395.S 6.23 2.25E-12 
tapbp.L 6.22 3.18E-03 
faxc.S 6.21 7.27E-05 
hes5_X2.L 6.21 9.17E-11 
pax2.L 6.19 2.92E-07 
elavl4.L 6.18 3.06E-10 
dmbx1.L 6.17 9.20E-08 
onecut1.2.L 6.16 1.74E-19 
slc32a1.S 6.16 9.89E-03 
LOC100490819.L 6.15 2.61E-02 
mxra7.L 6.15 3.76E-23 
tub.L 6.08 8.56E-03 
LOC100496628-like.S 6.05 4.31E-15 
sostdc1.S 6.04 2.05E-02 
adcyap1.L 6.04 5.59E-05 
Xelaev18044103m.g 6.01 4.81E-04 
six1.S 6.01 4.12E-03 
zic3.S 5.99 1.06E-03 
mecom.L 5.99 4.08E-06 
wnt8a.L 5.99 7.45E-04 
slc3a2.L 5.96 7.20E-03 
plod2.S 5.96 4.04E-02 
sp5.L 5.95 9.89E-03 
limd2.L 5.95 7.84E-23 
bmp3.L 5.95 2.87E-02 
pck1.L 5.93 3.80E-14 
tfap2b.L 5.92 8.73E-21 
scrt1.L 5.92 1.75E-05 
tpbg.L 5.91 3.02E-03 
dkk1.L 5.91 3.92E-02 
gria1-like.1.S 5.91 1.48E-12 
slc1a3.L 5.91 1.60E-02 
myct1.L 5.90 1.04E-03 
Xetrov90000859m.L 5.89 1.72E-10 
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cldn3.L 5.89 5.43E-03 
skor1.L 5.83 1.02E-05 
kif26a.S 5.83 1.39E-17 
gad1.1.S 5.83 1.72E-05 
hcrtr2.L 5.79 1.66E-02 
LOC100495096.1 5.77 1.43E-02 
tmem35.L 5.75 1.33E-12 
Xelaev18024653m.g 5.75 1.40E-06 
Xelaev18025499m.g 5.74 3.60E-05 
cyp1a1.S 5.73 3.42E-02 
neurog2.S 5.72 1.55E-03 
kcnj2.S 5.70 1.08E-02 
bhlhe22.L 5.68 3.35E-02 
nkx6-2.L 5.67 7.65E-04 
neurog2.L 5.67 3.40E-02 
sall3.L 5.66 2.74E-10 
snap25.L 5.63 3.22E-24 
drgx.L 5.62 2.70E-04 
cplx2.L 5.57 1.26E-15 
mamdc2.L 5.55 6.26E-05 
tubb2b.S 5.55 1.31E-07 
kiaa0408.L 5.55 4.64E-02 
tox2.S 5.55 6.62E-25 
stxbp1.S 5.53 6.87E-03 
pax8.L 5.52 2.82E-09 
LOC100487796-like.L 5.50 1.23E-25 
Xelaev18026630m.g 5.49 5.46E-06 
pla2g12b.S 5.48 3.04E-02 
st18.S 5.47 1.39E-06 
kank2.L 5.47 4.16E-02 
homer3.L 5.46 2.63E-02 
Xelaev18015119m.g 5.44 1.65E-06 
c8orf46.S 5.41 5.50E-05 
Xelaev18039076m.g 5.41 5.02E-26 
Xetrov90016928m.L 5.39 5.16E-04 
Xelaev18007001m.g 5.39 2.00E-14 
hapln3.S 5.37 3.19E-08 
c8orf46.L 5.37 7.03E-03 
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igf2.L 5.36 2.49E-03 
st8sia1.S 5.36 1.61E-02 
cbfa2t3.L 5.36 2.32E-06 
pax8.S 5.35 7.94E-03 
six1.L 5.35 2.54E-02 
rph3al.S 5.33 1.10E-03 
Xelaev18024617m.g 5.33 7.28E-12 
Xelaev18047557m.g 5.32 2.01E-02 
gpx3.S 5.31 2.55E-03 
slc43a2.S 5.28 1.82E-28 
tfap2e.S 5.24 6.45E-14 
Xetrov90008930m.S 5.24 1.45E-03 
sox9.L 5.24 2.40E-02 
adora2a.L 5.24 7.28E-03 
aldh1a2.L 5.24 2.27E-09 
LOC100496446.L 5.22 1.57E-02 
celf2.L 5.22 4.54E-13 
hoxc3.S 5.21 1.16E-02 
pmp22.L 5.21 1.74E-12 
Xelaev18021728m.g 5.17 1.53E-12 
mcf2l.S 5.16 2.81E-09 
gpr63.S 5.15 2.37E-07 
kremen2.S 5.10 9.50E-07 
hes5_X2.S 5.09 4.52E-04 
Xelaev18015305m.g 5.09 1.40E-02 
dbn1.L 5.08 3.22E-27 
Xelaev18018196m.g 5.08 1.63E-06 
dlx6.L 5.07 1.68E-19 
Xelaev18016582m.g 5.07 5.34E-19 
sacs.L 5.07 1.16E-05 
dbn1.S 5.06 2.56E-20 
dnajc6.S 5.05 1.83E-08 
nrp1.L 5.05 5.16E-12 
nrp2.L 5.04 1.64E-16 
abcd2.S 5.04 4.17E-02 
Xelaev18005831m.g 5.04 3.34E-05 
Xetrov90016831m.L 5.03 5.99E-05 
jam3.S 5.03 1.25E-05 
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tmeff1.S 5.02 1.14E-09 
insm1.L 4.99 8.73E-03 
gli2.S 4.98 6.18E-11 
kif26a.L 4.95 5.42E-09 
fam198b.L 4.94 8.39E-03 
runx1t1.S 4.94 9.66E-09 
crabp2.S 4.90 1.25E-10 
syt2-like.S 4.90 1.96E-03 
clip2.S 4.89 1.16E-04 
npr3.L 4.88 1.55E-02 
LOC101734468.L 4.87 4.56E-02 
arhgap4.L 4.87 1.42E-18 
rab3b.S 4.87 4.16E-04 
pax2.S 4.86 1.83E-09 
tbx22.S 4.85 4.31E-02 
tuba4a.L 4.85 3.70E-23 
slc38a8.L 4.83 5.61E-03 
ube2ql1.S 4.82 2.40E-02 
arx.L 4.80 4.96E-02 
asb2.L 4.80 2.07E-03 
dmbx1.S 4.78 1.40E-04 
flnc.S 4.78 1.77E-08 
plekhg4.S 4.77 6.24E-07 
Xelaev18044320m.g 4.77 3.66E-05 
nr2f2.L 4.73 1.76E-03 
hdac7.S 4.73 2.27E-05 
cacnb3.L 4.72 3.97E-02 
LOC100488523.L 4.72 1.99E-03 
nkx2-6.S 4.70 1.97E-04 
pak3.S 4.70 5.13E-21 
Xelaev18043580m.g 4.69 3.76E-24 
sox11.L 4.66 3.76E-04 
hes5.3.S 4.66 5.74E-04 
fstl1.S 4.66 6.57E-08 
Xelaev18013307m.g 4.64 4.51E-02 
Xelaev18042154m.g 4.64 1.28E-08 
kif5a.L 4.63 6.32E-03 
faxc.L 4.63 3.01E-12 
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bcam.S 4.62 9.73E-06 
emilin1.L 4.62 5.88E-13 
zic3.L 4.61 3.97E-04 
six3.S 4.60 5.50E-09 
bmpr1b.L 4.58 2.91E-02 
st6galnac6.L 4.57 3.88E-03 
Xelaev18025917m.g 4.56 3.15E-06 
adamtsl1.L 4.55 1.80E-11 
scg3.L 4.55 1.71E-02 
lef1.S 4.55 1.18E-05 
LOC100489483-like.S 4.55 1.64E-02 
pak3.L 4.55 7.82E-05 
rgs9bp.S 4.53 6.82E-05 
runx1t1.L 4.53 1.12E-05 
aldh1a2.S 4.53 8.36E-17 
slco5a1.S 4.52 4.40E-07 
limd2.S 4.51 5.67E-05 
b4galnt1.S 4.49 1.10E-08 
gfra1.S 4.46 2.12E-11 
plekho1.L 4.46 4.33E-05 
nckap5l.L 4.45 1.46E-19 
prph.L 4.45 4.92E-14 
hdac9.S 4.44 4.00E-02 
cited2.L 4.43 7.42E-14 
ebf3.L 4.42 3.97E-03 
pitx2.L 4.39 4.02E-03 
otx2.L 4.38 2.27E-09 
unc5a.L 4.37 4.99E-03 
ssbp4.S 4.37 4.02E-03 
Xelaev18019210m.g 4.37 2.19E-13 
unc45b.S 4.36 2.60E-12 
tmem116.S 4.36 6.02E-09 
cpe.S 4.35 2.85E-07 
auts2.S 4.34 4.42E-07 
cxcr2.L 4.34 1.08E-02 
insm2.L 4.33 2.09E-06 
fgf16.L 4.32 3.10E-07 
des.1.S 4.31 9.24E-06 
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six3.L 4.30 1.56E-29 
srrm4.L 4.29 6.76E-05 
tcf15.L 4.29 5.39E-04 
pip4k2b.L 4.25 1.77E-16 
pou3f2.S 4.25 9.24E-05 
cacna2d1.L 4.25 7.42E-04 
bag2.L 4.23 7.74E-04 
cacna2d2.L 4.21 1.41E-04 
itga8.L 4.21 2.60E-03 
sfrp2.L 4.20 1.67E-20 
skor2.L 4.19 7.95E-03 
itgb8.L 4.18 1.98E-02 
ppp1r9a.S 4.17 2.84E-02 
nkx6-1.L 4.16 9.80E-04 
Xelaev18024654m.g 4.16 7.21E-08 
cep85l.L 4.15 6.18E-08 
lrat.S 4.15 5.56E-03 
pax6.S 4.14 5.29E-09 
zfhx4.S 4.12 1.85E-14 
pmp22.S 4.11 4.06E-13 
zcchc24.L 4.10 9.16E-03 
cbfa2t2.L 4.10 9.62E-12 
eln2.L 4.09 9.78E-03 
tlx3.L 4.09 1.74E-02 
evi5.L 4.08 4.52E-26 
rgmb.L 4.08 7.61E-05 
lhx5.L 4.08 2.25E-02 
cyp26c1.L 4.07 9.77E-04 
dnajc6.L 4.05 1.12E-07 
hes2.L 4.04 1.27E-04 
dpysl3.S 4.03 1.68E-19 
klf7.L 4.02 1.40E-02 
pde11a.S 4.02 1.22E-02 
pde11a.S 4.02 1.22E-02 
crmp1.L 4.01 1.00E-02 
mctp2.L 4.01 4.11E-05 
vim.S 4.00 5.77E-03 
fam212a.L 3.99 4.79E-08 
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Xelaev18004886m.g 3.99 2.16E-08 
nuak1.L 3.98 3.50E-07 
sncb.L 3.98 8.27E-10 
tdrp.L 3.98 3.22E-24 
pcdh8.L 3.98 1.45E-03 
serpinf1.L 3.97 1.35E-04 
ror2.L 3.94 1.25E-10 
map3k13.S 3.94 2.90E-02 
Xelaev18008189m.g 3.93 4.58E-05 
cbfa2t2.S 3.92 7.07E-13 
mex3b.L 3.92 1.10E-09 
gngt2.1.S 3.92 3.68E-02 
cdc42ep3.S 3.90 3.95E-07 
arl8a.S 3.89 1.72E-04 
Xelaev18003346m.g 3.89 3.48E-03 
prr5l.S 3.88 6.16E-03 
scn8a.L 3.88 2.89E-02 
elavl3.L 3.88 5.43E-18 
fam110b.L 3.87 1.11E-06 
foxg1.L 3.86 7.65E-08 
Xelaev18023457m.g 3.86 1.01E-03 
mef2d.S 3.86 1.73E-08 
zc3h12c.L 3.85 8.45E-15 
slc6a5.L 3.84 4.72E-02 
LOC100494817.L 3.82 9.87E-06 
dpysl4.S 3.82 4.34E-02 
hes8.L 3.82 1.74E-12 
dbndd1.L 3.80 2.05E-05 
lhx5.S 3.78 1.52E-06 
dennd2c.L 3.78 9.03E-11 
hes10.L 3.77 1.18E-06 
gcnt1.S 3.75 1.18E-05 
hes5.1.L 3.74 4.31E-06 
mdk.L 3.73 3.40E-17 
tox.L 3.73 1.04E-05 
spon1.S 3.72 5.18E-04 
cdc42bpa.S 3.71 1.04E-13 
adamdec1.L 3.71 1.10E-02 
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fn1.S 3.70 1.47E-19 
Xelaev18037602m.g 3.69 7.76E-10 
map2.L 3.69 5.12E-05 
sox9.S 3.68 1.89E-05 
edn1.L 3.67 2.50E-03 
hnrnpll.S 3.67 2.69E-13 
mtcl1.L 3.67 1.81E-04 
mycl.S 3.67 3.02E-08 
nr5a2.S 3.66 1.22E-08 
nox4.S 3.64 6.16E-03 
dll1.L 3.62 9.68E-07 
Xelaev18044758m.g 3.61 4.33E-02 
sgip1.L 3.60 1.23E-06 
Xelaev18020376m.g 3.60 1.01E-02 
klhl35.S 3.60 1.38E-03 
st3gal2.2.L 3.60 3.57E-02 
sox11.S 3.58 1.43E-02 
nceh1.L 3.57 2.09E-05 
manea.S 3.57 3.67E-03 
ulk1.L 3.56 2.07E-08 
spon1.L 3.56 9.47E-06 
rnf165.L 3.56 1.22E-03 
cplx2.S 3.55 2.37E-02 
dst.L 3.54 8.87E-05 
slc43a2.L 3.54 2.77E-07 
mxi1.S 3.54 5.02E-05 
gsta1.L 3.53 5.27E-03 
cdc42ep4.L 3.53 3.79E-04 
kcnq3.S 3.52 2.77E-07 
ncam1.S 3.52 6.76E-11 
creb3l1.S 3.51 1.03E-07 
aplnr.S 3.51 4.93E-04 
xkr4.L 3.49 1.39E-06 
lrch2.L 3.48 9.72E-08 
sp5l.S 3.48 2.17E-03 
gfi1.L 3.47 1.85E-02 
dennd2c.S 3.46 1.83E-07 
zic2.L 3.44 2.27E-04 
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rassf6.L 3.44 2.51E-03 
hes9-1.L 3.44 6.62E-04 
dact1.L 3.43 2.38E-06 
st8sia1.L 3.43 3.02E-05 
wipf1.L 3.42 1.64E-02 
eya1.S 3.42 4.20E-07 
slco5a1.L 3.41 3.63E-09 
fbxo10.L 3.41 1.35E-10 
sox4.S 3.41 5.45E-05 
LOC105946937.L 3.41 2.26E-05 
dusp4.S 3.40 9.50E-07 
zbtb16.S 3.40 7.24E-05 
LOC100490436.L 3.39 2.57E-02 
cdc42se2-like.1.L 3.39 1.64E-09 
LOC100494502.L 3.38 1.14E-02 
ap3b2.L 3.38 2.70E-04 
bmpr1b.S 3.37 1.95E-03 
asb1.L 3.37 2.15E-07 
flrt3.L 3.37 7.45E-04 
fam134b.S 3.37 1.29E-02 
dlc.S 3.35 8.87E-05 
crabp2.L 3.34 1.08E-05 
lmcd1.S 3.34 2.63E-02 
gch1.L 3.34 6.12E-05 
gli2.L 3.34 4.31E-11 
ell3.L 3.32 4.08E-02 
ag1.S 3.32 1.31E-10 
tmod4.S 3.32 2.31E-02 
Xelaev18030284m.g 3.31 4.39E-03 
hes9-1.S 3.31 7.49E-14 
sesn1.L 3.31 4.16E-06 
sulf1.S 3.31 3.55E-03 
mcf2l.2.L 3.30 2.56E-05 
rundc3a.L 3.30 2.58E-04 
LOC101732576.S 3.30 4.01E-02 
ppp1r14b.S 3.29 3.10E-07 
tmem169.S 3.29 3.01E-04 
arid1b.L 3.28 1.99E-13 
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reep5.S 3.28 2.29E-24 
cd82.L 3.26 4.77E-07 
fam43a.S 3.25 1.79E-03 
cttnbp2nl.L 3.25 4.11E-04 
arhgef26.S 3.25 1.08E-02 
sfrp2.S 3.24 3.87E-39 
sparc.L 3.24 7.18E-04 
tmem169.L 3.22 4.37E-04 
fyn-like.L 3.22 6.87E-03 
Xelaev18027950m.g 3.21 4.03E-10 
plekhg1.L 3.21 6.37E-06 
Xelaev18044942m.g 3.19 3.18E-02 
ak3.S 3.19 3.89E-10 
lrpprc.S 3.19 5.15E-04 
dclk1.S 3.19 9.03E-03 
tmem158.L 3.19 1.36E-05 
lrp4.L 3.17 1.12E-05 
irx1.L 3.17 1.23E-06 
st6galnac1.S 3.17 2.50E-03 
bcar1.S 3.15 1.41E-04 
LOC100498409-like.S 3.15 2.72E-03 
LOC100170576.L 3.15 7.02E-10 
otx1.S 3.14 9.33E-06 
MGC147600.S 3.13 3.85E-02 
eya2.S 3.12 6.03E-04 
fmnl2-like.S 3.12 3.61E-02 
pkdcc.L 3.11 2.80E-15 
mybl1.S 3.11 2.22E-02 
nr2e1.S 3.11 4.31E-03 
Xelaev18024436m.g 3.11 1.94E-06 
fgfr1.S 3.10 8.39E-13 
LOC100487080-like.L 3.10 1.46E-02 
cdk5r1.S 3.10 5.85E-06 
arhgef40.S 3.10 1.34E-02 
LOC101730599.S 3.10 1.29E-03 
egln2.L 3.09 9.62E-04 
emx2.S 3.09 4.41E-02 
pag1.S 3.08 2.06E-05 
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psat1.L 3.07 2.34E-05 
sulf1.L 3.07 2.74E-10 
cel-like.1.S 3.06 2.21E-02 
zfhx4.L 3.06 2.63E-09 
Xelaev18029662m.g 3.05 2.77E-02 
znf219.L 3.04 3.06E-03 
plekhg4.L 3.04 1.80E-07 
abcb9.L 3.03 1.48E-05 
tnni1.2.L 3.02 4.82E-02 
tuba4a.S 3.02 1.22E-03 
pdia2.S 3.01 2.87E-02 
rnf165.S 3.00 4.61E-12 
trabd2a.L 3.00 7.06E-07 
ptch2.S 2.99 2.26E-02 
ngfr.L 2.98 1.43E-06 
manea.L 2.98 1.62E-03 
ptprt.L 2.97 4.02E-03 
tpbg.S 2.97 1.17E-04 
pik3r3.L 2.97 1.18E-04 
afap1.S 2.96 3.94E-03 
cblb.L 2.94 3.52E-06 
plxnb1.L 2.94 5.45E-09 
ptch1.L 2.93 8.95E-06 
Xelaev18016487m.g 2.93 2.37E-02 
fdft1.L 2.93 1.02E-03 
fgfr4.L 2.93 1.34E-11 
prickle1.S 2.92 7.63E-09 
spsb4-like.L 2.92 1.33E-03 
pitx2.S 2.92 2.76E-02 
dclk1.L 2.91 2.70E-02 
rgma.L 2.91 1.09E-06 
LOC100498368-like.L 2.90 2.04E-02 
smim3.S 2.90 7.08E-04 
amotl2.L 2.90 1.15E-08 
gas7.L 2.89 5.18E-03 
mgc69520.S 2.88 2.15E-07 
slit1.S 2.88 2.77E-02 
sox4.L 2.88 8.44E-04 
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myh6.L 2.88 1.72E-02 
ncam1.L 2.88 9.12E-06 
Xelaev18044438m.g 2.87 9.51E-03 
znf608.S 2.87 6.99E-16 
Xelaev18003796m.g 2.86 1.67E-02 
homer1.S 2.85 7.12E-03 
tmem132a.L 2.85 5.71E-04 
il17rd.S 2.85 2.47E-04 
Xetrov90002103m.L 2.85 3.27E-03 
lmx1b.1.L 2.85 6.18E-03 
ankrd65.L 2.85 2.70E-03 
akap12.L 2.83 1.65E-06 
rfk.S 2.82 8.23E-04 
lfng.L 2.82 4.22E-10 
mtcl1.S 2.82 1.19E-02 
mex3a.S 2.81 7.45E-04 
Xelaev18015889m.g 2.81 4.70E-03 
hes3.3.L 2.80 1.04E-06 
calb1.S 2.80 2.20E-02 
kank3.L 2.80 1.07E-03 
Xetrov90009914m.S 2.79 1.24E-04 
arhgap36.L 2.79 1.70E-11 
scamp4.S 2.79 4.96E-04 
gmnn.L 2.79 4.12E-20 
rai2.S 2.79 2.04E-03 
st3gal6.L 2.78 1.42E-04 
mamld1.L 2.77 2.18E-02 
afap1l1.L 2.77 2.27E-19 
dsc3.S 2.77 8.95E-03 
ndst1.S 2.77 2.95E-07 
Xelaev18010427m.g 2.76 2.53E-04 
rbm38.S 2.76 6.82E-10 
LOC100492579.S 2.76 2.49E-03 
rnf130.S 2.75 4.50E-02 
lrrn1-like.1.L 2.75 8.62E-08 
plxnb1.S 2.75 1.71E-04 
spry2.L 2.74 7.60E-03 
vcan.L 2.74 4.26E-04 
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auts2.L 2.73 8.62E-08 
ulk1.S 2.73 7.06E-06 
pros1.S 2.73 2.05E-04 
prtg.L 2.73 1.55E-02 
crmp1.S 2.73 1.27E-02 
Xelaev18004582m.g 2.73 2.35E-02 
Xelaev18030439m.g 2.72 1.19E-02 
scn1b.L 2.70 3.97E-02 
magi1.S 2.70 8.65E-06 
LOC100489386-like.L 2.70 8.48E-04 
pcmtd1.S 2.69 1.64E-05 
Xelaev18038420m.g 2.69 4.79E-06 
myt1.L 2.69 1.66E-04 
tmem198.S 2.68 2.15E-07 
ptpru.L 2.68 4.99E-05 
fam102b.S 2.67 3.56E-02 
pkdcc.S 2.67 1.48E-02 
fam222a.L 2.67 1.13E-07 
rtn2.L 2.67 2.59E-09 
irf1.L 2.66 1.05E-02 
fgf8.L 2.66 1.69E-02 
tmem55a.S 2.65 1.69E-02 
atp8a1.L 2.65 2.15E-03 
sst.S 2.64 1.71E-02 
twist1.L 2.64 1.31E-05 
cables1.L 2.64 4.43E-02 
fmn2.L 2.64 1.95E-02 
LOC100492639-like.L 2.63 1.93E-09 
Xelaev18027769m.g 2.63 3.42E-03 
fgd1.S 2.63 1.24E-04 
epn1.S 2.62 4.49E-06 
slc27a3.L 2.61 1.57E-18 
acer2.L 2.61 8.32E-06 
btbd11.L 2.61 2.90E-02 
hes8.S 2.60 7.63E-09 
lrp4.S 2.60 3.56E-05 
rcor2.L 2.60 1.35E-10 
LOC496795.L 2.60 1.54E-03 
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tet3.S 2.59 5.99E-05 
cdc42se2-like.1.S 2.58 1.73E-04 
gdpd5.S 2.57 4.02E-05 
rnf125.S 2.57 7.33E-03 
spry2.S 2.57 3.58E-03 
gnao1.S 2.56 2.07E-06 
skida1.S 2.56 5.20E-11 
sh2b2.L 2.56 8.47E-03 
nkx3-1.L 2.56 2.87E-02 
rassf2.L 2.56 1.11E-04 
gse1.L 2.56 2.46E-07 
psat1.S 2.55 4.53E-02 
mospd1.L 2.55 2.27E-09 
Xetrov90023254m.S 2.55 3.36E-03 
enpp2.L 2.54 1.37E-03 
pcbp2.S 2.54 8.59E-05 
cpe.L 2.54 3.04E-04 
zc4h2.L 2.54 6.02E-07 
ano8.L 2.53 9.38E-03 
fam222a.S 2.53 3.37E-03 
lrrn1-like.2.L 2.53 2.28E-03 
cuedc1.L 2.51 1.57E-04 
map1lc3a.L 2.51 1.13E-03 
rufy3.L 2.50 8.24E-10 
gramd1a.L 2.49 3.43E-03 
sh3glb2.S 2.49 1.57E-02 
Xelaev18000699m.g 2.48 2.95E-03 
onecut2.L 2.48 4.86E-03 
chst8.S 2.48 1.78E-02 
cass4.L 2.48 2.33E-06 
krt19.S 2.48 2.70E-04 
a2m.S 2.47 5.92E-06 
rnd3.S 2.45 1.40E-02 
best2.S 2.45 1.15E-02 
epb41l1.L 2.45 5.25E-05 
Xelaev18031949m.g 2.44 9.04E-03 
lpar4.S 2.43 7.38E-07 
Xelaev18021928m.g 2.43 8.13E-05 
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Xelaev18039965m.g 2.43 4.09E-11 
myt1.S 2.43 1.28E-05 
hnrnpll.L 2.43 1.39E-04 
mob3b.L 2.42 3.12E-02 
tox3.L 2.42 3.79E-03 
nxpe3.L 2.42 3.24E-02 
pik3r3.S 2.41 9.24E-05 
efnb2.S 2.41 1.40E-03 
rnf125.L 2.40 9.26E-05 
lrrc8b.S 2.40 1.44E-03 
Xelaev18009525m.g 2.40 1.63E-03 
mex3b.S 2.40 2.55E-04 
hdac4.L 2.40 2.77E-02 
atg9b.L 2.40 1.21E-02 
dlx6.S 2.40 2.95E-03 
lrig3.L 2.39 2.38E-06 
clic5.S 2.38 1.18E-03 
tet3.L 2.38 3.74E-04 
cybrd1.L 2.38 3.13E-08 
st3gal2.1.S 2.38 4.18E-04 
fyn-like.S 2.38 4.42E-03 
stx2.L 2.37 5.27E-05 
fam102a.L 2.37 3.27E-05 
dock6-like.L 2.37 1.11E-06 
cyp27c1.S 2.37 3.82E-04 
LOC100145446.S 2.37 2.84E-02 
mmp14.L 2.36 3.18E-05 
rgs10.L 2.36 3.31E-02 
slc23a2.L 2.36 5.63E-05 
myh6.S 2.36 2.75E-02 
pknox2.L 2.36 4.31E-06 
srrm4.S 2.35 3.69E-02 
rimbp2.L 2.34 2.61E-02 
tuba1b.L 2.33 7.24E-09 
Xetrov90025030m.L 2.33 3.88E-03 
map1lc3b.S 2.32 2.45E-02 
jag1.L 2.32 9.73E-04 
hectd4.L 2.32 1.18E-04 
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cyyr1.L 2.31 1.02E-02 
aplnr.L 2.31 5.80E-07 
rufy3.S 2.30 4.99E-02 
fam211b.S 2.30 2.37E-02 
vim.L 2.30 9.84E-07 
rnf130.L 2.30 5.49E-03 
kctd1.S 2.29 8.02E-08 
epha4.L 2.28 4.47E-03 
nkain1.L 2.28 2.36E-02 
ephb3.S 2.27 3.76E-09 
onecut1.2.S 2.27 3.26E-05 
b4galt4.S 2.26 3.90E-04 
sept5.L 2.26 8.33E-08 
rtbdn.S 2.26 2.34E-04 
LOC100489897.L 2.26 4.67E-02 
gas1.S 2.26 5.39E-04 
cdc25b.L 2.25 2.47E-04 
LOC100492859.L 2.25 3.77E-02 
fnbp1.S 2.25 3.58E-03 
smarcc2.S 2.24 2.89E-02 
fam43a.L 2.24 1.45E-02 
cep85l.S 2.24 2.37E-02 
nrarp.L 2.24 2.27E-04 
Xelaev18019689m.g 2.24 3.48E-02 
Xelaev18016676m.g 2.24 8.81E-05 
kctd1.L 2.24 6.53E-03 
fam189a1.L 2.24 1.51E-02 
map4k4-like.L 2.23 5.45E-09 
hmox1.L 2.23 1.01E-09 
pcsk5.S 2.23 1.67E-03 
sox2.S 2.22 3.18E-02 
notch1.L 2.22 1.06E-04 
Xelaev18044381m.g 2.22 2.39E-06 
Xelaev18016675m.g 2.20 2.30E-06 
tubb2b.L 2.19 8.41E-04 
bhlhe40.L 2.19 7.01E-04 
hes9-2.L 2.19 3.96E-02 
bcr.L 2.18 1.90E-06 
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mylip.S 2.18 1.56E-02 
frmd4a.S 2.18 4.40E-07 
spire2.S 2.17 2.38E-02 
tacc1.L 2.17 3.48E-02 
prnp.S 2.17 3.11E-03 
dact1.S 2.17 7.08E-03 
acy3.L 2.16 7.06E-06 
znf850.L 2.16 2.41E-03 
cdc42ep4.S 2.16 4.57E-03 
hes6.1.S 2.16 3.75E-03 
zbtb18.S 2.15 4.19E-02 
Xelaev18024012m.g 2.15 8.14E-03 
dkk1.S 2.15 3.07E-02 
lrig3.S 2.14 2.16E-02 
tes.L 2.14 1.42E-02 
Xelaev18044325m.g 2.13 2.32E-05 
p2ry4.L 2.13 4.23E-07 
arid1b.S 2.12 4.50E-03 
numbl.L 2.12 1.35E-02 
gatm.S 2.12 3.17E-02 
fgfr1.L 2.12 7.61E-09 
marcks.S 2.12 8.29E-10 
lhx2.L 2.11 3.88E-02 
Xelaev18028757m.g 2.11 3.94E-02 
ppm1e.S 2.11 7.40E-03 
cbfb.S 2.11 9.12E-06 
mprip.L 2.11 2.06E-02 
meis2.L 2.11 2.45E-02 
cuedc1.S 2.10 4.17E-07 
tmem2.L 2.10 9.24E-05 
Xelaev18043719m.g 2.10 1.22E-02 
smtn.L 2.09 1.43E-03 
msi1.L 2.09 9.71E-04 
bach2.S 2.09 2.18E-02 
sh3rf1.S 2.09 1.44E-04 
rbms1.S 2.08 3.39E-04 
atat1.L 2.08 9.96E-06 
LOC100493716.S 2.07 1.04E-06 
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stk40.L 2.07 1.27E-03 
lppr3.S 2.07 3.82E-02 
fzd2.L 2.07 2.05E-05 
grm7.S 2.07 3.31E-02 
lace1.L 2.06 2.47E-03 
rftn1.L 2.05 3.27E-02 
vegfa.L 2.05 1.38E-02 
Xetrov90024734m.L 2.05 2.64E-05 
rab11fip4l.S 2.05 2.78E-02 
vav2.S 2.05 3.75E-04 
Xelaev18010400m.g 2.05 1.85E-02 
tspan17.S 2.05 2.51E-06 
sesn1.S 2.04 8.95E-07 
tiparp.L 2.04 1.35E-04 
LOC100489393.L 2.04 4.10E-03 
hes5.1.S 2.03 5.25E-03 
fsd1.L 2.03 8.36E-04 
ankrd10.L 2.02 4.16E-04 
paqr4-like.S 2.02 3.36E-02 
irx2.L 2.01 4.57E-05 
draxin.S 2.01 2.68E-02 
fgfr4.S 2.00 6.94E-10 
dock4.L 2.00 5.02E-03 
amotl2.S 2.00 4.42E-03 
 
 
Table S19: Summary of differentially expressed genes by Ptf1a + Brg1MO 
ID log2FC P-value 
Xelaev18007508m.g 12.92 2.82E-14 
neurod4.L 11.64 2.14E-11 
prdm13.L 10.92 5.72E-11 
pnhd.S 10.65 3.20E-08 
prph.S 10.55 2.20E-20 
neurod4.S 10.49 1.02E-08 
prdm13.S 10.45 2.57E-15 
scrt1.S 9.99 1.73E-09 
pou3f1.L 9.59 7.06E-08 
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prdm8.L 9.58 6.76E-04 
neurog1.L 9.55 2.85E-08 
igfbpl1.L 9.37 1.21E-07 
dpysl4.L 9.08 7.21E-07 
fezf1.L 9.05 4.24E-05 
eva1b.S 9.00 1.57E-06 
st18.L 8.95 3.86E-07 
LOC100490531-like.L 8.84 2.66E-07 
Xetrov90027705m.L 8.63 6.53E-12 
des.2.L 8.59 9.57E-06 
foxd2.L 8.58 5.57E-05 
shd.L 8.43 2.83E-11 
ebf2.L 8.41 1.15E-23 
slc26a9.S 8.36 2.91E-05 
hes5.2.L 8.30 4.58E-05 
pyy.L 8.25 2.52E-05 
aldh1b1.L 8.16 8.16E-05 
tfap2b.S 8.14 1.39E-28 
LOC100496628-like.L 8.06 4.50E-05 
slc18a3.S 8.05 3.01E-05 
tespa1.S 8.02 7.93E-05 
olig3.S 8.01 1.22E-03 
Xelaev18032183m.g 7.98 3.98E-05 
tubb3.L 7.94 8.95E-06 
shox2.L 7.91 9.14E-05 
skor1.S 7.86 2.10E-08 
Xelaev18047032m.g 7.84 1.42E-03 
adcyap1.S 7.81 1.29E-04 
sp9.L 7.79 1.47E-02 
tfap2e.L 7.68 2.89E-05 
des.1.L 7.63 3.06E-08 
chat.S 7.58 1.39E-03 
sag.S 7.58 2.40E-03 
admp.L 7.57 1.65E-02 
fam212b.L 7.55 7.85E-04 
ptf1a.L 7.55 1.07E-04 
nhlh1.L 7.51 3.24E-05 
Xelaev18000445m.g 7.51 2.94E-04 
Appendix  170 
 
Xelaev18018357m.g 7.49 3.84E-04 
slc46a2.L 7.45 1.51E-02 
kirrel2.L 7.44 5.77E-86 
hoxd1.S 7.44 1.44E-03 
egr4.L 7.43 3.14E-03 
dpysl3.L 7.36 5.79E-62 
mllt11.S 7.31 2.71E-04 
pnhd.L 7.15 4.38E-08 
bgn.L 7.10 4.49E-38 
aqp3.L 7.07 9.68E-03 
nr5a2.L 7.06 7.56E-04 
ebf2.S 7.05 2.59E-21 
lbx1.S 7.04 3.03E-04 
barhl2.L 6.99 9.12E-04 
hesx1.S 6.97 1.83E-06 
sybu.L 6.97 3.28E-06 
Xelaev18040877m.g 6.96 1.47E-14 
prdm8.S 6.95 4.51E-03 
vsx1.S 6.93 2.12E-03 
pcdh9.L 6.89 1.08E-03 
elavl3.S 6.86 6.30E-04 
nptx2.L 6.84 1.89E-02 
clstn3.L 6.84 4.64E-09 
shox2.S 6.84 1.07E-03 
Xetrov90027705m.S 6.83 1.41E-03 
kiaa1755.L 6.82 3.89E-11 
Xelaev18046363m.g 6.82 1.42E-02 
map2.S 6.80 4.04E-28 
tapbp.L 6.79 8.13E-04 
ptger3.L 6.74 1.78E-03 
LOC100490531-like.S 6.74 3.97E-03 
hspb8.L 6.73 2.82E-02 
nhlh1.S 6.71 4.78E-04 
barhl2.S 6.70 3.51E-06 
mnx1.L 6.69 9.01E-03 
tcf15.S 6.65 4.71E-03 
gad1.1.L 6.63 1.47E-11 
nkx3-2.S 6.63 2.69E-02 
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spry4.S 6.60 1.06E-02 
Xelaev18045246m.g 6.60 4.97E-03 
admp.S 6.60 4.95E-02 
skor2.S 6.59 1.96E-02 
myod1.S 6.57 1.83E-03 
kirrel2.S 6.54 5.79E-62 
hmx1.1 6.50 3.13E-02 
sox17a.L 6.49 1.35E-03 
Xelaev18033867m.g 6.42 1.40E-02 
Xelaev18020334m.g 6.39 2.71E-03 
Xelaev18036651m.g 6.28 2.51E-24 
myo3b.L 6.23 1.67E-02 
tmem116.L 6.22 4.53E-12 
mmp17.L 6.21 3.34E-03 
hes6.2.L 6.21 4.19E-02 
nova2.S 6.18 6.24E-03 
nes.L 6.16 1.76E-10 
sostdc1.S 6.15 1.45E-02 
mmp28.L 6.12 3.62E-02 
neurod1.L 6.11 2.89E-02 
ror2.S 6.09 2.63E-17 
lmo2.S 6.08 1.91E-03 
Xelaev18034787m.g 6.08 1.57E-02 
pla2g12b.S 6.07 1.06E-02 
lrrn1-like.1.S 6.06 9.05E-32 
Xelaev18042973m.g 6.01 2.14E-04 
chst3.L 5.96 5.95E-10 
cdh1.L 5.94 1.53E-08 
tmem47.L 5.93 2.47E-02 
Xelaev18026532m.g 5.90 1.35E-02 
sp5.L 5.88 8.84E-03 
matn4.S 5.88 2.25E-02 
LOC100495096.1 5.87 1.01E-02 
chrd.S 5.85 4.11E-03 
bmp3.L 5.82 2.82E-02 
igf2.L 5.78 7.57E-04 
Xelaev18035158m.g 5.76 4.19E-02 
olig2.S 5.74 2.57E-16 
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usp13.S 5.71 1.90E-03 
LOC100489771.L 5.70 3.60E-02 
limd2.L 5.67 3.98E-20 
tubb3.S 5.67 2.86E-21 
mxra7.L 5.67 4.50E-19 
Xelaev18004302m.g 5.65 1.53E-02 
map3k13.L 5.63 3.05E-02 
fam198b.L 5.62 1.56E-03 
plekhd1.L 5.61 1.23E-02 
neurog2.S 5.54 1.93E-03 
neurod1.S 5.50 4.96E-02 
neurog2.L 5.50 3.42E-02 
dmrta2.L 5.49 6.01E-03 
hoxc3.L 5.49 2.77E-02 
lhx8.L 5.47 1.51E-02 
hcrtr2.L 5.42 2.46E-02 
nova1.L 5.41 1.10E-11 
wnt8a.L 5.40 2.82E-03 
hes5_X2.L 5.40 5.35E-08 
Xelaev18025499m.g 5.39 1.32E-04 
nkx2-6.S 5.36 1.14E-05 
dpp10.S 5.35 8.39E-16 
Xelaev18015119m.g 5.33 3.04E-06 
tlx3.L 5.31 6.78E-04 
zeb2.L 5.28 2.34E-13 
LOC101730771-like.L 5.28 4.13E-04 
sez6.S 5.26 9.88E-05 
zeb2.S 5.25 1.47E-14 
LOC100487395.L 5.25 1.90E-23 
six1.S 5.24 1.33E-02 
bhlhe22.L 5.23 4.68E-02 
elavl4.L 5.22 2.73E-07 
fam212a.L 5.22 1.47E-13 
tub.L 5.22 2.88E-02 
spns2.L 5.20 2.31E-02 
Xelaev18026630m.g 5.20 1.88E-05 
gpr63.S 5.19 1.81E-07 
nmb.S 5.17 1.55E-03 
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tal1.L 5.14 7.85E-04 
faxc.S 5.11 1.85E-03 
skor2.L 5.10 5.37E-04 
npr3.L 5.09 8.67E-03 
onecut1.2.L 5.08 5.74E-13 
stk32a.L 5.06 3.08E-02 
pax2.L 5.06 6.42E-05 
ppp1r9b.S 5.03 1.33E-03 
nes.S 5.00 6.41E-12 
slc32a1.S 4.94 4.98E-02 
hes5_X1.L 4.92 4.89E-02 
cplx2.L 4.92 8.77E-12 
phlda1.L 4.91 6.03E-05 
LOC100492420.L 4.91 3.43E-02 
sox9.L 4.88 3.30E-02 
sall3.L 4.87 1.51E-07 
adcyap1.L 4.86 1.90E-03 
tal1.S 4.86 1.96E-03 
Xelaev18003346m.g 4.85 9.53E-05 
map3k12.S 4.85 2.66E-03 
tfap2b.L 4.85 2.40E-13 
map3k12.L 4.85 2.42E-05 
dmbx1.L 4.82 8.47E-05 
eda2r.L 4.79 2.63E-17 
crabp2.S 4.78 5.95E-10 
mcf2l.S 4.78 6.86E-08 
nt5e.S 4.76 4.56E-02 
cacna2d1.L 4.74 1.02E-04 
Xelaev18007001m.g 4.74 5.35E-11 
LOC100494774.L 4.74 2.75E-02 
des.1.S 4.72 7.11E-07 
Xelaev18005831m.g 4.72 1.18E-04 
Xetrov90000859m.L 4.72 1.36E-06 
mycl.S 4.71 2.08E-13 
vegt.S 4.70 4.58E-03 
arx.L 4.70 4.66E-02 
stxbp1.S 4.69 2.67E-02 
gcnt1.S 4.69 1.18E-08 
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Xelaev18016582m.g 4.68 1.07E-15 
zic3.S 4.68 1.65E-02 
hdac9.S 4.68 2.34E-02 
LOC100487395.S 4.65 8.27E-07 
slc38a8.L 4.65 7.49E-03 
LOC100492804.S 4.64 9.94E-03 
bhlhe22.S 4.64 1.30E-02 
plekhg4.S 4.64 1.50E-06 
ankrd65.L 4.62 4.21E-08 
pax2.S 4.62 2.21E-08 
efemp2.L 4.60 4.15E-02 
myl1.L 4.59 4.76E-02 
wipf1.L 4.55 4.09E-04 
rufy2.L 4.53 8.98E-04 
skor1.L 4.53 1.04E-03 
insm1.L 4.51 1.76E-02 
hes5_X2.S 4.48 2.79E-03 
runx1t1.S 4.48 3.74E-07 
mtmr7-like.L 4.47 2.51E-04 
LOC100487796-like.L 4.46 6.78E-16 
faxc.L 4.46 3.63E-11 
lef1.S 4.43 2.07E-05 
celf2.L 4.43 4.34E-09 
asb2.L 4.42 5.32E-03 
pck1.L 4.42 8.35E-08 
dlx6.L 4.41 2.44E-14 
Xelaev18038044m.g 4.39 5.84E-03 
gfra1.S 4.39 7.78E-11 
adora2a.L 4.36 3.28E-02 
nyx.S 4.35 1.84E-02 
cxcr2.L 4.35 9.45E-03 
Xetrov90016928m.L 4.34 8.02E-03 
klf7.L 4.32 5.92E-03 
cfd.L 4.32 2.60E-02 
foxd3.L 4.31 2.92E-02 
sema3d.L 4.31 1.04E-04 
kif26a.S 4.29 4.64E-09 
Xelaev18030284m.g 4.28 7.28E-05 
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serpinf1.L 4.27 2.74E-05 
pitx2.L 4.27 5.05E-03 
Xetrov90008930m.S 4.23 1.51E-02 
dbn1.S 4.22 7.23E-14 
spon1.S 4.21 5.16E-05 
gad1.1.S 4.21 4.56E-03 
Xelaev18042154m.g 4.20 4.48E-07 
Xelaev18002611m.g 4.20 1.23E-02 
snap25.L 4.20 5.96E-13 
Xelaev18024617m.g 4.19 3.74E-07 
cbfa2t2.L 4.18 5.24E-12 
lhx5.L 4.16 1.53E-02 
tmeff1.S 4.14 1.50E-06 
hes5.3.S 4.14 2.78E-03 
sncb.L 4.14 2.09E-10 
dbn1.L 4.12 1.96E-17 
itga2b.1-like.S 4.12 2.10E-06 
c8orf46.S 4.12 4.41E-03 
st8sia6.L 4.11 1.94E-02 
Xelaev18021728m.g 4.10 1.23E-07 
gngt2.1.S 4.09 2.28E-02 
aldh1a2.L 4.08 9.73E-06 
bcam.S 4.08 1.60E-04 
dnajc6.S 4.06 1.66E-05 
Xelaev18018196m.g 4.06 3.16E-04 
LOC100489305.S 4.06 4.89E-02 
kremen2.S 4.06 2.14E-04 
plekho1.L 4.05 3.03E-04 
hes7.L 4.04 1.21E-02 
tbx6.L 4.04 1.04E-03 
crabp2.L 4.04 3.56E-08 
hes8.L 4.03 1.15E-13 
hoxd1.L 4.03 2.83E-03 
Xelaev18025917m.g 4.02 7.63E-05 
dmbx1.S 4.01 1.99E-03 
gfi1.L 4.00 3.73E-03 
crybb3.L 4.00 5.61E-03 
mamdc2.L 3.99 9.01E-03 
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asb1.L 3.98 3.36E-10 
Xelaev18039076m.g 3.98 1.89E-13 
hdac7.S 3.97 5.99E-04 
nrp2.L 3.97 6.14E-10 
rab3b.S 3.95 6.48E-03 
sacs.L 3.95 1.33E-03 
mecom.L 3.92 6.80E-03 
nox4.S 3.92 2.27E-03 
st6galnac6.L 3.87 1.87E-02 
gli2.S 3.87 1.29E-06 
cpe.S 3.84 9.43E-06 
pde10a.L 3.84 9.58E-03 
fn1.S 3.83 1.41E-20 
zc3h12c.L 3.82 2.44E-14 
gipr.L 3.82 4.09E-02 
tmcc2.S 3.81 3.08E-02 
zcchc24.L 3.80 1.62E-02 
crmp1.L 3.80 1.49E-02 
fstl1.S 3.79 3.13E-05 
dennd2c.L 3.78 1.18E-10 
st3gal2.2.L 3.78 2.08E-02 
clip2.S 3.77 5.35E-03 
manea.L 3.77 2.06E-05 
ssbp4.S 3.75 1.62E-02 
plekhg4.L 3.73 4.11E-11 
sox11.L 3.72 6.24E-03 
ulk1.L 3.72 5.04E-09 
lhx5.S 3.71 2.72E-06 
pmp22.L 3.70 2.41E-06 
st18.S 3.69 3.58E-03 
tuba4a.L 3.67 1.47E-12 
Xelaev18008189m.g 3.67 1.77E-04 
ror2.L 3.66 4.64E-09 
srrm4.L 3.65 9.79E-04 
insm2.L 3.65 1.19E-04 
cd82.L 3.64 1.10E-08 
jam3.S 3.64 3.63E-03 
nr2f2.L 3.63 2.48E-02 
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dennd2c.S 3.63 4.25E-08 
cyp1c1.L 3.62 3.99E-02 
cbfa2t2.S 3.62 7.57E-11 
ppp1r9b.L 3.61 3.61E-03 
LOC101734175.L 3.60 4.55E-02 
cacna2d2.L 3.59 1.83E-03 
artn.S 3.58 2.02E-02 
dnajc6.L 3.55 6.61E-06 
lrp4.L 3.54 4.79E-07 
elavl3.L 3.54 1.80E-14 
runx1t1.L 3.53 1.09E-03 
Xelaev18043580m.g 3.53 6.95E-13 
hes10.L 3.53 8.68E-06 
limd2.S 3.52 3.03E-03 
tox.L 3.52 4.70E-05 
eln2.L 3.51 2.99E-02 
cdk5r2.L 3.51 3.35E-02 
mdk.L 3.51 7.13E-15 
vim.S 3.50 1.66E-02 
hes2.L 3.49 1.27E-03 
mtcl1.L 3.48 4.41E-04 
Xelaev18044438m.g 3.45 9.17E-04 
tmem35.L 3.44 1.84E-04 
sp5l.S 3.43 2.26E-03 
LOC100498368-like.L 3.43 3.42E-03 
zfhx4.S 3.42 9.24E-10 
lrrn1-like.1.L 3.41 9.20E-12 
cyyr1.L 3.40 2.37E-05 
myh6.L 3.39 2.66E-03 
adamtsl1.L 3.38 4.08E-06 
aldh1a2.S 3.37 4.12E-09 
mcf2l.2.L 3.36 1.60E-05 
rgmb.L 3.36 1.63E-03 
abcb9.L 3.36 9.36E-07 
cttnbp2nl.L 3.36 2.25E-04 
lppr3.S 3.36 8.24E-05 
Xelaev18029662m.g 3.35 1.06E-02 
slco5a1.S 3.35 4.80E-04 
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lrfn1.S 3.33 3.98E-02 
LOC101732555.L 3.33 2.16E-02 
arl8a.S 3.32 1.99E-03 
pak3.L 3.32 8.96E-03 
gli2.L 3.31 1.45E-10 
LOC105946937.L 3.31 4.75E-05 
tfap2e.S 3.31 1.50E-05 
gria1-like.1.S 3.30 6.72E-04 
Xelaev18012713m.g 3.29 1.15E-02 
Xelaev18007062m.g 3.29 5.12E-07 
evi5.L 3.27 3.05E-16 
zic3.L 3.27 2.06E-02 
LOC100490436.L 3.27 3.08E-02 
Xelaev18047968m.g 3.26 3.83E-02 
Xelaev18004582m.g 3.26 3.55E-03 
rassf6.L 3.26 4.08E-03 
rgs3.L 3.26 6.20E-03 
Xelaev18032990m.g 3.24 3.80E-02 
mxi1.S 3.24 2.94E-04 
Xelaev18001443m.g 3.24 1.66E-03 
ulk1.S 3.24 4.05E-08 
sgip1.L 3.23 2.68E-05 
Xelaev18027950m.g 3.23 6.77E-10 
sox11.S 3.22 2.70E-02 
sesn1.L 3.21 9.96E-06 
hapln3.S 3.20 4.31E-03 
btbd19.S 3.20 1.19E-02 
arid1b.L 3.18 2.21E-12 
Xelaev18028200m.g 3.17 4.85E-02 
pax8.L 3.17 2.84E-03 
cmtm4.S 3.17 2.33E-02 
unc45b.S 3.16 2.15E-06 
eya1.S 3.16 3.86E-06 
kif26a.L 3.15 8.12E-04 
lrpprc.S 3.15 5.54E-04 
rnf165.L 3.15 4.89E-03 
LOC100496628-like.S 3.13 5.26E-04 
xkr4.L 3.12 3.03E-05 
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pip4k2b.L 3.12 1.35E-08 
foxf1.L 3.11 2.18E-02 
cdc42ep3.S 3.11 1.25E-04 
dll1.L 3.11 4.08E-05 
pak3.S 3.10 1.74E-08 
pole3.S 3.09 2.23E-02 
auts2.S 3.09 8.08E-04 
st3gal5.S 3.09 2.49E-02 
b4galnt1.S 3.07 3.39E-04 
pik3r3.S 3.06 1.94E-07 
tdrp.L 3.06 1.05E-13 
Xelaev18044942m.g 3.06 3.49E-02 
slc43a2.S 3.05 6.22E-09 
Xelaev18016487m.g 3.04 1.56E-02 
tars2.L 3.04 6.88E-04 
dlx6.S 3.03 5.56E-05 
Xelaev18037602m.g 3.02 1.61E-06 
nrp1.L 3.02 2.34E-04 
prr5l.S 3.01 4.80E-02 
creb3l1.S 3.01 9.56E-06 
dkk1.S 3.00 6.83E-04 
dact1.L 3.00 5.75E-05 
hes3.3.L 2.99 1.44E-07 
dpysl3.S 2.99 3.05E-10 
nkx6-1.L 2.98 3.08E-02 
Xelaev18027769m.g 2.97 5.10E-04 
larp6-like.1.S 2.97 3.56E-04 
fam222a.L 2.97 2.38E-09 
ptch2.S 2.96 2.16E-02 
sulf1.L 2.96 1.63E-09 
vim.L 2.96 5.23E-11 
plekhg1.L 2.96 3.84E-05 
cdc42ep4.S 2.95 2.20E-05 
aplnr.L 2.95 3.63E-11 
enpp1.L 2.95 3.54E-02 
mex3a.S 2.95 3.58E-04 
epn1.S 2.94 1.66E-07 
ap3b2.L 2.94 2.21E-03 
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LOC100498215-like.L 2.94 2.65E-10 
reep5.S 2.93 5.80E-19 
tmem169.S 2.93 1.72E-03 
fgfr4.L 2.91 3.07E-11 
rev1.L 2.88 1.01E-04 
tox2.S 2.88 3.84E-06 
rundc3a.L 2.87 2.03E-03 
st3gal6.L 2.87 8.07E-05 
spsb4-like.L 2.87 1.41E-03 
six3.L 2.87 1.33E-12 
map2.L 2.86 3.50E-03 
ag1.S 2.86 6.90E-08 
rgs9bp.S 2.86 2.73E-02 
cited2.L 2.85 1.64E-05 
slco5a1.L 2.85 2.67E-06 
tmem116.S 2.82 7.76E-04 
cemip.S 2.82 2.31E-02 
numbl.L 2.80 3.53E-04 
Xelaev18003796m.g 2.79 1.70E-02 
Xelaev18019210m.g 2.79 2.68E-05 
gsta1.L 2.78 3.66E-02 
akap12.L 2.78 3.13E-06 
fam222a.S 2.77 8.29E-04 
znf219.L 2.76 7.32E-03 
sparc.L 2.76 5.09E-03 
slc27a3.L 2.76 4.21E-20 
psat1.S 2.75 2.26E-02 
mex3b.L 2.75 6.51E-05 
sox4.S 2.75 1.74E-03 
rnf165.S 2.74 6.87E-10 
plxnb1.S 2.74 1.54E-04 
hes9-1.S 2.74 4.64E-09 
cep85l.S 2.73 2.78E-03 
LOC100145446.S 2.73 7.33E-03 
nipa1.L 2.72 2.37E-04 
rpa2.S 2.72 1.23E-02 
dgki.S 2.72 4.10E-02 
twist1.L 2.72 7.98E-06 
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hes5.1.L 2.72 1.79E-03 
sox21-like.S 2.71 9.94E-03 
otx2.L 2.71 7.06E-04 
LOC733561.S 2.71 6.98E-08 
LOC100485511-like.S 2.71 1.36E-02 
znf608.S 2.70 1.28E-13 
vcan.L 2.69 6.14E-04 
irf1.L 2.69 8.14E-03 
ptpdc1.L 2.68 4.18E-04 
crmp1.S 2.68 1.24E-02 
enpp2.L 2.67 5.83E-04 
lrp4.S 2.67 1.77E-05 
smarcc2.S 2.67 4.94E-03 
rgma.L 2.65 1.14E-05 
LOC100492639-like.L 2.65 2.79E-09 
lrwd1.L 2.64 3.33E-14 
edn1.L 2.63 4.61E-02 
fgf16.L 2.63 6.52E-03 
lmx1b.1.L 2.63 1.33E-02 
sulf1.S 2.62 2.77E-02 
pik3r3.L 2.62 8.73E-04 
tox3.L 2.61 1.09E-03 
nckap5l.L 2.61 1.69E-06 
nkd1.S 2.60 1.09E-02 
spry2.S 2.60 2.61E-03 
ak3.S 2.59 1.76E-06 
Xelaev18032779m.g 2.59 2.10E-02 
gse1.L 2.59 1.66E-07 
efnb2.S 2.58 3.96E-04 
kcnq3.S 2.58 5.85E-04 
lrch2.L 2.58 2.50E-04 
ncam1.S 2.58 8.07E-06 
fam43a.S 2.57 2.05E-02 
ckap2.S 2.57 2.08E-03 
nxpe3.L 2.56 1.79E-02 
s1pr5.L 2.56 2.62E-03 
zic2.L 2.56 1.01E-02 
ppp1r14b.S 2.55 2.15E-04 
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Xelaev18010427m.g 2.55 8.48E-04 
tacc1.L 2.55 7.07E-03 
Xelaev18021928m.g 2.55 2.97E-05 
fbxo10.L 2.54 9.01E-06 
cdk5r1.S 2.54 3.59E-04 
hnrnpll.S 2.54 3.81E-06 
hes8.S 2.53 3.04E-08 
sox9.S 2.53 6.34E-03 
LOC100489393.L 2.53 1.41E-04 
magi1.S 2.53 3.94E-05 
fgfr1.S 2.51 2.81E-08 
cdc42bpa.S 2.51 3.10E-06 
hes9-1.L 2.51 2.37E-02 
pou5f3.2.S 2.51 4.97E-03 
homer3.S 2.51 3.75E-02 
aim1l.S 2.50 1.03E-11 
jag1.L 2.50 2.69E-04 
fdft1.L 2.49 6.78E-03 
pkdcc.L 2.48 2.05E-09 
ttc9.L 2.48 4.45E-08 
cbfb.S 2.48 7.74E-08 
irx2.L 2.47 1.70E-07 
fndc3b.S 2.47 2.10E-02 
cyp27c1.S 2.47 1.67E-04 
cdc42ep4.L 2.46 2.28E-02 
sh2b2.L 2.46 1.19E-02 
riok3.S 2.46 3.63E-11 
dnajc11.S 2.45 2.92E-06 
Xelaev18015889m.g 2.45 1.80E-02 
stx2.L 2.45 3.15E-05 
krt19.S 2.44 2.85E-04 
aplnr.S 2.44 2.78E-02 
scamp4.S 2.44 3.30E-03 
tmem169.L 2.44 1.41E-02 
pdgfb.L 2.44 7.32E-03 
hn1.S 2.43 8.06E-10 
Xetrov90002103m.L 2.43 1.50E-02 
lmx1b.1.S 2.42 3.86E-02 
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sfrp2.L 2.42 9.20E-07 
Xelaev18028757m.g 2.42 1.18E-02 
tpbg.S 2.42 2.75E-03 
sesn1.S 2.41 3.77E-09 
egln2.L 2.41 1.49E-02 
pmp22.S 2.40 1.59E-04 
Xetrov90025030m.L 2.40 2.27E-03 
slit1.L 2.40 3.43E-02 
plxnb1.L 2.40 4.79E-06 
zbtb16.S 2.39 1.09E-02 
lims1.L 2.39 8.02E-03 
Xelaev18029838m.g 2.38 8.02E-03 
ngfr.L 2.37 3.17E-04 
rbm38.L 2.37 2.10E-08 
hdac4.L 2.37 2.58E-02 
trmt6.S 2.36 1.79E-05 
spon1.L 2.36 8.84E-03 
gas7.L 2.35 3.15E-02 
fmn2.L 2.34 4.16E-02 
dbndd1.L 2.34 2.41E-02 
mprip.L 2.33 6.68E-03 
nuak1.L 2.33 8.38E-03 
pag1.S 2.33 2.63E-03 
rcan1.S 2.33 2.27E-03 
lysmd2.S 2.32 2.68E-02 
hunk.S 2.32 8.85E-03 
stk40.L 2.31 2.15E-04 
draxin.S 2.31 7.33E-03 
mycn.L 2.30 8.31E-03 
prph.L 2.30 5.18E-04 
hmox1.L 2.30 3.86E-10 
notch1.L 2.30 4.59E-05 
rcor2.L 2.30 5.43E-08 
bach2.S 2.30 8.17E-03 
bcar1.S 2.29 1.01E-02 
smarca5.L 2.29 1.03E-06 
ephb3.S 2.29 3.37E-09 
cybrd1.L 2.29 1.34E-07 
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rassf2.L 2.29 7.91E-04 
irx1.L 2.28 1.01E-03 
zc4h2.L 2.28 1.18E-05 
zfhx4.L 2.28 2.81E-05 
Xetrov90018501m.S 2.28 2.68E-02 
psat1.L 2.28 3.50E-03 
lhfpl2.L 2.27 1.01E-02 
fam69a.L 2.27 6.59E-03 
dock6-like.L 2.27 4.41E-06 
fam43a.L 2.27 1.16E-02 
LOC100492804.L 2.27 4.29E-03 
gatm.S 2.26 1.60E-02 
Xelaev18024436m.g 2.25 1.27E-03 
ubac1.S 2.25 1.21E-02 
smim3.S 2.25 1.28E-02 
Xelaev18030439m.g 2.24 4.68E-02 
ptprt.L 2.24 4.46E-02 
Xelaev18015058m.g 2.24 1.53E-12 
fat1.S 2.23 3.77E-09 
fzd2.L 2.23 3.70E-06 
tfap2a.S 2.22 1.16E-05 
spry2.L 2.21 4.27E-02 
hyal2.S 2.20 7.57E-03 
hes6.1.S 2.20 2.43E-03 
rcor1.L 2.19 4.65E-08 
hand2.S 2.19 5.45E-04 
dicer1.S 2.18 2.09E-06 
Xetrov90009914m.S 2.18 5.28E-03 
rai2.S 2.18 2.28E-02 
calb2.S 2.17 1.57E-02 
LOC100144919.L 2.17 2.33E-05 
t.S 2.17 4.49E-02 
rfk.S 2.16 1.49E-02 
ndst1.S 2.16 1.31E-04 
rasgef1b.L 2.16 1.57E-06 
nkain1.L 2.16 3.02E-02 
cdc25b.L 2.15 4.39E-04 
hes3.3.S 2.15 1.06E-03 
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ano8.L 2.14 3.71E-02 
lfng.L 2.14 6.97E-06 
afap1l1.L 2.14 3.54E-11 
cdc25b.S 2.14 3.12E-04 
nrarp.L 2.14 4.87E-04 
cdc42se2-like.1.S 2.13 3.42E-03 
cdc42se2-like.1.L 2.12 6.47E-04 
cmip.L 2.12 4.41E-03 
fgd1.S 2.12 3.11E-03 
nceh1.L 2.11 2.82E-02 
sox4.L 2.11 2.23E-02 
acer2.L 2.11 6.78E-04 
LOC733709.S 2.11 4.71E-02 
sh3glb2.S 2.11 4.86E-02 
ets2.S 2.10 4.15E-02 
srgap2.S 2.10 2.81E-05 
dusp4.S 2.10 7.46E-03 
st3gal2.1.L 2.10 8.50E-04 
lifr.L 2.09 1.46E-03 
ccnt2.S 2.09 6.53E-09 
atg9b.L 2.09 3.05E-02 
fgfr4.S 2.09 1.32E-10 
wasf3.L 2.09 1.22E-02 
snx7.S 2.07 7.40E-03 
sox2.S 2.07 4.30E-02 
LOC100145450.S 2.07 4.11E-03 
tfap2a.L 2.06 2.57E-08 
Xelaev18041479m.g 2.06 2.14E-02 
slc23a2.S 2.06 2.58E-02 
prickle1.S 2.05 1.83E-04 
plekha3.L 2.05 1.99E-02 
myt1.S 2.05 3.35E-04 
cuedc1.L 2.05 3.61E-03 
rap2b.S 2.05 5.86E-14 
clic5.S 2.04 7.53E-03 
lpar4.S 2.04 8.07E-05 
gpatch11.L 2.04 3.76E-05 
memo1.L 2.03 2.34E-03 
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Xetrov90025030m.S 2.03 6.19E-03 
aen.L 2.03 1.82E-03 
eya2.S 2.02 4.82E-02 
myt1.L 2.02 7.32E-03 
auts2.L 2.02 2.25E-04 
il5ra.S 2.02 4.44E-02 
gas1.S 2.01 2.52E-03 
arhgap4.L 2.01 2.86E-03 
kiaa1755-like.S 2.01 1.37E-02 
dynll2.L 2.00 3.27E-03 
mex3b.S 2.00 3.12E-03 
mapkapk5.L 2.00 6.71E-06 
amotl2.L 2.00 2.50E-04 
 
6.4.3 Candidate gene list for the RNA sequencing analysis of Brg1 
knock-down affected genes 
Given are the genes which are differentially expressed between Ptf1a-GR + cMO 
overexpressing animal caps over Ptf1a-GR + Brg1MO overexpressing caps in two 
individual replicates. Given are the gene ID, the log2FC activation over CC and the p-
value. 
 
Table S20: Summary of genes Ptf1a + cMO vs. Ptf1a + Brg1MO (downregulated 
by Brg1 knock-down) 
ID log2FC P-value 
cacnb1.S 5.02 2.69E-03 
paqr9.L 4.94 4.11E-05 
hoxc3.L 4.94 7.45E-03 
nhlh1.S 4.72 2.24E-10 
nhlh1.L 4.43 9.66E-16 
scrt1.L 4.28 1.51E-02 
tubb2b.S 4.20 2.13E-03 
lmo2.S 4.19 3.31E-06 
Xetrov90016831m.L 4.06 1.94E-02 
dnajc18.L 3.94 2.43E-02 
Xelaev18024654m.g 3.94 3.29E-05 
Xelaev18024653m.g 3.87 1.22E-02 
tvp23a.S 3.84 1.93E-02 
Xelaev18044320m.g 3.78 1.77E-02 
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Xelaev18047333m.g 3.74 1.22E-02 
ppp1r9b.L 3.35 2.35E-03 
six3.S 3.25 1.60E-03 
emilin1.L 3.17 4.11E-05 
lbx1.S 3.11 3.27E-03 
LOC100496628-like.S 2.92 7.87E-04 
arhgap4.L 2.86 9.77E-06 
pax6.S 2.86 2.27E-03 
flnc.S 2.80 1.26E-02 
manbal.S 2.75 1.61E-02 
tox2.S 2.67 1.09E-06 
gria1-like.1.S 2.61 6.01E-03 
Xelaev18011187m.g 2.53 7.05E-03 
mef2d.S 2.53 6.95E-03 
gch1.L 2.51 3.91E-02 
trabd2a.L 2.46 2.27E-03 
kiaa1755.L 2.44 8.21E-03 
Xelaev18004886m.g 2.41 1.74E-02 
cep85l.L 2.39 3.87E-02 
tmem35.L 2.32 2.50E-02 
traf4.S 2.27 2.56E-02 
slc43a2.L 2.25 2.33E-02 
slc43a2.S 2.23 6.30E-05 
ptch1.L 2.21 1.81E-02 
ypel1.S 2.15 2.90E-03 
prph.L 2.14 1.37E-02 
guca1a.S 2.11 2.87E-02 
nes.L 2.11 4.42E-03 
rufy3.L 1.98 7.73E-05 
plxna3.L 1.97 1.18E-02 
nr5a2.S 1.96 4.78E-02 
nes.S 1.95 8.62E-03 
dpy19l4.L 1.93 1.97E-02 
pgs1.S 1.93 2.13E-03 
zeb2.L 1.85 2.76E-03 
st18.L 1.84 4.09E-02 
nckap5l.L 1.83 6.95E-03 
nfe2l3.L 1.80 8.97E-03 
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acy3.L 1.79 4.42E-03 
sfrp2.S 1.78 3.34E-10 
sfrp2.L 1.77 6.49E-03 
fbrsl1.S 1.73 1.26E-03 
slc25a28.L 1.71 2.47E-04 
zeb2.S 1.68 5.64E-03 
prph.S 1.66 3.23E-06 
tubb3.S 1.66 1.90E-02 
slc7a7.L 1.62 4.11E-03 
pak3.S 1.60 1.58E-02 
lrrc45.L 1.54 1.26E-02 
plk3.L 1.54 2.35E-03 
c1orf194.L 1.54 2.92E-02 
ak2.S 1.51 1.97E-02 
klhdc7a.S 1.47 2.92E-02 
bcr.L 1.45 3.51E-02 
six3.L 1.44 1.05E-02 
slc7a8.S 1.42 4.44E-02 
sp8.S 1.41 2.50E-02 
ifitm10-like.L 1.40 3.63E-02 
nrm.L 1.34 4.87E-04 
spata18-like.S 1.34 2.50E-02 
skida1.S 1.31 2.70E-02 
tuba1b.L 1.30 3.73E-02 
fbrsl1.L 1.22 1.34E-02 
sp7.L 1.20 3.37E-02 
ypel1.L 1.19 1.51E-02 
asna1.S 1.19 2.11E-02 
c19orf43.S 1.14 1.17E-02 
pxmp4.L 1.10 6.33E-03 
slc7a6.L 1.08 4.92E-02 
ube2r2.L 1.08 2.29E-02 
ubap2.S 1.05 3.20E-02 
gmnn.L 1.04 3.08E-02 
mfsd9.L 1.02 4.43E-02 
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Table S21: Summary of genes Ptf1a + cMO vs. Ptf1a + Brg1MO (upregulated by 
Brg1 knock-down) 
ID log2FC P-value 
LOC101730771-like.L -4.84 8.60E-03 
larp6-like.1.S -3.74 7.21E-05 
LOC100485511-like.S -3.55 1.06E-02 
eda2r.L -3.12 8.29E-07 
pou5f3.2.L -3.07 6.55E-06 
itga2b.1-like.S -3.00 7.74E-03 
tars2.L -2.97 1.04E-02 
LOC733561.S -2.67 2.54E-06 
LOC100495756-like.S -2.61 2.54E-06 
pou5f3.2.S -2.57 3.49E-02 
nipa1.L -2.37 1.58E-02 
rev1.L -2.28 2.96E-02 
hand2.S -2.19 6.95E-03 
riok3.S -2.14 3.32E-07 
lrwd1.L -2.12 6.11E-08 
nudt22.L -1.82 1.31E-03 
ctnnal1.S -1.79 1.18E-02 
dicer1.S -1.79 2.27E-03 
LOC100144919.L -1.76 9.06E-03 
tinf2.L -1.71 3.27E-03 
Xelaev18043774m.g -1.70 2.40E-02 
Xelaev18034615m.g -1.68 2.40E-03 
Xelaev18043947m.g -1.66 3.75E-02 
tex2.2.L -1.63 7.05E-03 
itpr1.S -1.58 4.47E-05 
skil.S -1.56 2.41E-02 
cog5.L -1.51 1.51E-02 
cdo1.S -1.50 1.51E-02 
Xelaev18034617m.g -1.49 1.31E-02 
srsf5.S -1.45 3.35E-02 
kitlg.S -1.44 6.33E-03 
ska3.L -1.43 7.49E-03 
rest.S -1.43 2.76E-03 
pou5f3.1.S -1.39 1.93E-02 
pawr.S -1.37 9.92E-03 
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plekhn1.S -1.35 2.57E-03 
ccdc30.L -1.35 2.35E-03 
pdgfa.S -1.32 3.44E-02 
rnf168.L -1.26 1.56E-02 
gata2.L -1.25 1.41E-04 
cdkn2aip.L -1.22 3.51E-02 
Xelaev18036901m.g -1.20 1.04E-03 
marveld3.L -1.19 2.92E-02 
ccnt2.S -1.17 3.19E-02 
tob1.S -1.17 3.91E-03 
snrpb2.S -1.17 2.13E-03 
bambi.S -1.15 7.73E-05 
ccna2.S -1.15 3.05E-03 
znf654.L -1.14 2.02E-02 
hal.1.L -1.13 6.72E-03 
Xelaev18024066m.g -1.13 4.66E-02 
Xelaev18023103m.g -1.12 4.09E-03 
tp53.L -1.12 2.67E-02 
tacc2.L -1.10 1.99E-02 
ptpn2.S -1.02 1.58E-02 
bambi.L -1.00 3.97E-02 
 
 
6.5 Quantification of the BiFC assay 
Given are the corresponding N- and C-terminal Venus-constructs used for 
the BiFC analysis, the relative amount of EYFP positive cells compared to 
the total number of mRFP positive cells, the total number of mRFP positive 
cells, and the SEM value 
 
TableS22: Quantification of the BiFC 
Vc-construct Vn-construct 
EYFP pos cells 
(in %) 
total 
number 
of cells 
SEM 
Ptf1a-Vn 
E12-Vc 80% 165 20% 
Rbpj-Vc 84% 1118 9% 
Prdm13-Vc 3% 657 2% 
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Ptf1aW224A/W242A-Vn 
E12-Vc 71% 196 20% 
Rbpj-Vc 0% 659 0% 
Prdm13-Vc 3% 494 3% 
Ptf1aT243A-Vn 
E12-Vc 73% 59 20% 
Rbpj-Vc 84% 1182 16% 
Prdm13-Vc 49% 697 2% 
Ptf1aT243E-Vn 
E12-Vc 100% 57 0% 
Rbpj-Vc 88% 336 2% 
Prdm13-Vc 40% 777 24% 
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